199 results on '"Noor, NM"'
Search Results
2. The unfinished agenda of communicable diseases among children and adolescents before the COVID-19 pandemic, 1990-2019: a systematic analysis of the Global Burden of Disease Study 2019
- Author
-
Azzopardi, PS, Kerr, JA, Francis, KL, Sawyer, SM, Kennedy, EC, Steer, AC, Graham, SM, Viner, RM, Ward, JL, Hennegan, J, Pham, M, Habito, CMD, Kurji, J, Cini, K, Beeson, JG, Brown, A, Murray, CJL, Abbasi-Kangevari, M, Abolhassani, H, Adekanmbi, V, Agampodi, SB, Ahmed, MB, Ajami, M, Akbarialiabad, H, Akbarzadeh-Khiavi, M, AL-Ahdal, TMA, Ali, MM, Samakkhah, SA, Alimohamadi, Y, Alipour, V, Al-Jumaily, A, Amiri, S, Amirzade-Iranaq, MH, Anoushiravani, A, Anvari, D, Arabloo, J, Arab-Zozani, M, Arkew, M, Armocida, B, Asadi-Pooya, AA, Asemi, Z, Asgary, S, Athari, SS, Azami, H, Azangou-Khyavy, M, Azizi, H, Bagheri, N, Bagherieh, S, Barone-Adesi, F, Barteit, S, Basu, S, Belete, MA, Belo, L, Berhie, AY, Bijani, A, Bikbov, B, Burkart, K, Carreras, G, Charalampous, P, Abebe, EC, Cruz-Martins, N, Dai, X, Dandona, L, Dandona, R, Degualem, SM, Demetriades, AK, Demlash, AA, Desta, AA, Dianatinasab, M, Doaei, S, Dorostkar, F, Effendi, DE, Emami, A, Bain, LE, Eskandarieh, S, Esmaeilzadeh, F, Faramarzi, A, Fatehizadeh, A, Ferrara, P, Fetensa, G, Fischer, F, Flor, LS, Forouhari, A, Foroutan, M, Gaihre, S, Galehdar, N, Gallus, S, Gautam, RK, Gebrehiwot, M, Gebremeskel, TG, Getacher, L, Getachew, ME, Ghamari, S-H, Nour, MG, Goleij, P, Golitaleb, M, Gorini, G, Gupta, VK, Hashemian, M, Hassankhani, H, Heidari, M, Heyi, DZ, Isola, G, Jaafari, J, Javanmardi, F, Jonas, JB, Jozwiak, JJ, Juerisson, M, Kabir, A, Kabir, Z, Kalankesh, LR, Kalhor, R, Kauppila, JH, Kaur, H, Kayode, GA, Keikavoosi-Arani, L, Khammarnia, M, AB Khan, M, Khatab, K, Kashani, HRK, Kolahi, A-A, Koohestani, HR, Koyanagi, A, Kumar, GA, Kurmi, OP, Kyu, HH, La Vecchia, C, Lallukka, T, Lim, SS, Loureiro, JA, Mahjoub, S, Mahmoudi, R, Majeed, A, Rad, EM, Maleki, A, Mansour-Ghanaei, F, Marjani, A, Mathioudakis, AG, Mehri, F, Mentis, A-FA, Mestrovic, T, Mirica, A, Misganaw, A, Mohammadian-Hafshejani, A, Mohammed, H, Mohammed, S, Mokdad, AH, Mokhtarzadehazar, P, Monasta, L, Moradi, M, Moradzadeh, M, Morovatdar, N, Mueller, UO, Mulita, F, Mulu, GBB, Muthupandian, S, Naik, GR, Nashwan, AJJ, Nejadghaderi, SA, Netsere, HB, Noor, NM, Noori, M, Oancea, B, Oguntade, AS, Okati-Aliabad, H, Otoiu, A, Padron-Monedero, A, Pakzad, R, Pandey, A, Pardhan, S, Parikh, RR, Patel, J, Pensato, U, Peprah, P, Perico, N, Poddighe, D, Postma, MJ, Rahim, F, Rahimi-Movaghar, V, Rahmani, S, Rahmanian, V, Rawaf, S, Razeghian-Jahromi, I, Regasa, MT, Remuzzi, G, Rezaeian, M, Riad, A, Romero-Rodriguez, E, Ronfani, L, Pramanik, KR, Sabour, S, Sadeghian, S, Saeb, MR, Safary, A, Sahebkar, A, Sahiledengle, B, Samadzadeh, S, Sarveazad, A, Sethi, Y, Shahabi, S, Shahraki-Sanavi, F, Shams-Beyranvand, M, Sharafi, K, Sharew, NT, Sheikh, A, Sheikhi, RA, Shiri, R, Socea, B, Soltani-Zangbar, MS, Tabares-Seisdedos, R, Tabatabai, S, Soodejani, MT, Oliaee, RT, Tiyuri, A, Tovani-Palone, MR, Tualeka, AR, Valizadeh, R, Van den Eynde, J, Vasankari, TJ, Vos, T, Walde, MT, Wang, Y, Wei, F-L, Westerman, R, Yadav, V, Yaya, S, Zare, I, Zhu, B, Zoladl, M, Zumla, A, Hay, S, Patton, GC, Azzopardi, PS, Kerr, JA, Francis, KL, Sawyer, SM, Kennedy, EC, Steer, AC, Graham, SM, Viner, RM, Ward, JL, Hennegan, J, Pham, M, Habito, CMD, Kurji, J, Cini, K, Beeson, JG, Brown, A, Murray, CJL, Abbasi-Kangevari, M, Abolhassani, H, Adekanmbi, V, Agampodi, SB, Ahmed, MB, Ajami, M, Akbarialiabad, H, Akbarzadeh-Khiavi, M, AL-Ahdal, TMA, Ali, MM, Samakkhah, SA, Alimohamadi, Y, Alipour, V, Al-Jumaily, A, Amiri, S, Amirzade-Iranaq, MH, Anoushiravani, A, Anvari, D, Arabloo, J, Arab-Zozani, M, Arkew, M, Armocida, B, Asadi-Pooya, AA, Asemi, Z, Asgary, S, Athari, SS, Azami, H, Azangou-Khyavy, M, Azizi, H, Bagheri, N, Bagherieh, S, Barone-Adesi, F, Barteit, S, Basu, S, Belete, MA, Belo, L, Berhie, AY, Bijani, A, Bikbov, B, Burkart, K, Carreras, G, Charalampous, P, Abebe, EC, Cruz-Martins, N, Dai, X, Dandona, L, Dandona, R, Degualem, SM, Demetriades, AK, Demlash, AA, Desta, AA, Dianatinasab, M, Doaei, S, Dorostkar, F, Effendi, DE, Emami, A, Bain, LE, Eskandarieh, S, Esmaeilzadeh, F, Faramarzi, A, Fatehizadeh, A, Ferrara, P, Fetensa, G, Fischer, F, Flor, LS, Forouhari, A, Foroutan, M, Gaihre, S, Galehdar, N, Gallus, S, Gautam, RK, Gebrehiwot, M, Gebremeskel, TG, Getacher, L, Getachew, ME, Ghamari, S-H, Nour, MG, Goleij, P, Golitaleb, M, Gorini, G, Gupta, VK, Hashemian, M, Hassankhani, H, Heidari, M, Heyi, DZ, Isola, G, Jaafari, J, Javanmardi, F, Jonas, JB, Jozwiak, JJ, Juerisson, M, Kabir, A, Kabir, Z, Kalankesh, LR, Kalhor, R, Kauppila, JH, Kaur, H, Kayode, GA, Keikavoosi-Arani, L, Khammarnia, M, AB Khan, M, Khatab, K, Kashani, HRK, Kolahi, A-A, Koohestani, HR, Koyanagi, A, Kumar, GA, Kurmi, OP, Kyu, HH, La Vecchia, C, Lallukka, T, Lim, SS, Loureiro, JA, Mahjoub, S, Mahmoudi, R, Majeed, A, Rad, EM, Maleki, A, Mansour-Ghanaei, F, Marjani, A, Mathioudakis, AG, Mehri, F, Mentis, A-FA, Mestrovic, T, Mirica, A, Misganaw, A, Mohammadian-Hafshejani, A, Mohammed, H, Mohammed, S, Mokdad, AH, Mokhtarzadehazar, P, Monasta, L, Moradi, M, Moradzadeh, M, Morovatdar, N, Mueller, UO, Mulita, F, Mulu, GBB, Muthupandian, S, Naik, GR, Nashwan, AJJ, Nejadghaderi, SA, Netsere, HB, Noor, NM, Noori, M, Oancea, B, Oguntade, AS, Okati-Aliabad, H, Otoiu, A, Padron-Monedero, A, Pakzad, R, Pandey, A, Pardhan, S, Parikh, RR, Patel, J, Pensato, U, Peprah, P, Perico, N, Poddighe, D, Postma, MJ, Rahim, F, Rahimi-Movaghar, V, Rahmani, S, Rahmanian, V, Rawaf, S, Razeghian-Jahromi, I, Regasa, MT, Remuzzi, G, Rezaeian, M, Riad, A, Romero-Rodriguez, E, Ronfani, L, Pramanik, KR, Sabour, S, Sadeghian, S, Saeb, MR, Safary, A, Sahebkar, A, Sahiledengle, B, Samadzadeh, S, Sarveazad, A, Sethi, Y, Shahabi, S, Shahraki-Sanavi, F, Shams-Beyranvand, M, Sharafi, K, Sharew, NT, Sheikh, A, Sheikhi, RA, Shiri, R, Socea, B, Soltani-Zangbar, MS, Tabares-Seisdedos, R, Tabatabai, S, Soodejani, MT, Oliaee, RT, Tiyuri, A, Tovani-Palone, MR, Tualeka, AR, Valizadeh, R, Van den Eynde, J, Vasankari, TJ, Vos, T, Walde, MT, Wang, Y, Wei, F-L, Westerman, R, Yadav, V, Yaya, S, Zare, I, Zhu, B, Zoladl, M, Zumla, A, Hay, S, and Patton, GC
- Abstract
BACKGROUND: Communicable disease control has long been a focus of global health policy. There have been substantial reductions in the burden and mortality of communicable diseases among children younger than 5 years, but we know less about this burden in older children and adolescents, and it is unclear whether current programmes and policies remain aligned with targets for intervention. This knowledge is especially important for policy and programmes in the context of the COVID-19 pandemic. We aimed to use the Global Burden of Disease (GBD) Study 2019 to systematically characterise the burden of communicable diseases across childhood and adolescence. METHODS: In this systematic analysis of the GBD study from 1990 to 2019, all communicable diseases and their manifestations as modelled within GBD 2019 were included, categorised as 16 subgroups of common diseases or presentations. Data were reported for absolute count, prevalence, and incidence across measures of cause-specific mortality (deaths and years of life lost), disability (years lived with disability [YLDs]), and disease burden (disability-adjusted life-years [DALYs]) for children and adolescents aged 0-24 years. Data were reported across the Socio-demographic Index (SDI) and across time (1990-2019), and for 204 countries and territories. For HIV, we reported the mortality-to-incidence ratio (MIR) as a measure of health system performance. FINDINGS: In 2019, there were 3·0 million deaths and 30·0 million years of healthy life lost to disability (as measured by YLDs), corresponding to 288·4 million DALYs from communicable diseases among children and adolescents globally (57·3% of total communicable disease burden across all ages). Over time, there has been a shift in communicable disease burden from young children to older children and adolescents (largely driven by the considerable reductions in children younger than 5 years and slower progress elsewhere), although children younger than 5 years still accounte
- Published
- 2023
3. Compatibility of Porous Chitosan Scaffold with the Attachment and Proliferation of human Adipose-Derived Stem Cells In Vitro
- Author
-
Gomathysankar S, Halim AS, Yaacob NS, Noor NM, and Mohamed M
- Subjects
Adipose-derived stem cells ,Porous chitosan scaffold ,Multi-differentiation ,Proliferation ,Structural morphology ,Medicine ,Medicine (General) ,R5-920 - Abstract
Adipose-derived stem cells (ASCs) have potential applications in the repair and regeneration of various tissues and organs. The use of various scaffold materials as an excellent template for mimicking the extracellular matrix to induce the attachment and proliferation of different cell types has always been of interest in the field of tissue engineering because ideal biomaterials are in great demand. Chitosan, a marine polysaccharide, have wide clinical applications and it acts as a promising scaffold for cell migration and proliferation. ASCs, with their multi-differentiation potential, and chitosan, with its great biocompatibility with ASCs, were investigated in the present study. ASCs were isolated and were characterized by two different methods: immunocytochemistry and flow cytometry, using the mesenchymal stem cell markers CD90, CD105, CD73 and CD29. The ASCs were then induced to differentiate into adipogenic, osteogenic and chondrogenic lineages. These ASCs were incorporated into a porous chitosan scaffold (PCS), and their structural morphology was studied using a scanning electron microscope and hematoxylin and eosin staining. The proliferation rate of the ASCs on the PCS was assessed using a PrestoBlue viability assay. The results indicated that the PCS provides an excellent template for the adhesion and proliferation of ASCs. Thus, this study revealed that PCS is a promising biomaterial for inducing the proliferation of ASCs, which could lead to successful tissue reconstruction in the field of tissue engineering.
- Published
- 2016
4. Quantitative uncertainty analysis in the calibration coefficients of GeDCOF and TLD-100 for absorbed dose measurement to water in megavoltage photon beams
- Author
-
Fadzil, MSA, primary, Ung, NM, additional, Dolah, MT, additional, Abdullah, N, additional, Tamchek, N, additional, and Noor, NM, additional
- Published
- 2022
- Full Text
- View/download PDF
5. The global burden of cancer attributable to risk factors, 2010-19: a systematic analysis for the Global Burden of Disease Study 2019
- Author
-
Khanh, BT, Lang, JJ, Compton, K, Xu, R, Acheson, AR, Henrikson, HJ, Kocarnik, JM, Penberthy, L, Aali, A, Abbas, Q, Abbasi, B, Abbasi-Kangevari, M, Abbasi-Kangevari, Z, Abbastabar, H, Abdelmasseh, M, Abd-Elsalam, S, Abdelwahab, AA, Abdoli, G, Abdulkadir, HA, Abedi, A, Abegaz, KH, Abidi, H, Aboagye, RG, Abolhassani, H, Absalan, A, Abtew, YD, Ali, HA, Abu-Gharbieh, E, Achappa, B, Acuna, JM, Addison, D, Addo, IY, Adegboye, OA, Adesina, MA, Adnan, M, Adnani, QES, Advani, SM, Afrin, S, Afzal, MS, Aggarwal, M, Ahinkorah, BO, Ahmad, AR, Ahmad, R, Ahmad, S, Ahmadi, S, Ahmed, H, Ahmed, LA, Ahmed, MB, Rashid, TA, Aiman, W, Ajami, M, Akalu, GT, Akbarzadeh-Khiavi, M, Aklilu, A, Akonde, M, Akunna, CJ, Al Hamad, H, Alahdab, F, Alanezi, FM, Alanzi, TM, Alessy, SA, Algammal, AM, Al-Hanawi, MK, Alhassan, RK, Ali, BA, Ali, L, Ali, SS, Alimohamadi, Y, Alipour, V, Aljunid, SM, Alkhayyat, M, Al-Maweri, SAA, Almustanyir, S, Alonso, N, Alqalyoobi, S, Al-Raddadi, RM, Al-Rifai, RHH, Al-Sabah, SK, Al-Tammemi, AB, Altawalah, H, Alvis-Guzman, N, Amare, F, Ameyaw, EK, Dehkordi, JJA, Amirzade-Iranaq, MH, Amu, H, Amusa, GA, Ancuceanu, R, Anderson, JA, Animut, YA, Anoushiravani, A, Anoushirvani, AA, Ansari-Moghaddam, A, Ansha, MG, Antony, B, Antwi, MH, Anwar, SL, Anwer, R, Anyasodor, AE, Arabloo, J, Arab-Zozani, M, Aremu, O, Argaw, AM, Ariffin, H, Aripov, T, Arshad, M, Al, A, Arulappan, J, Aruleba, RT, Aryannejad, A, Asaad, M, Asemahagn, MA, Asemi, Z, Asghari-Jafarabadi, M, Ashraf, T, Assadi, R, Athar, M, Athari, SS, Null, MMWA, Attia, S, Aujayeb, A, Ausloos, M, Avila-Burgos, L, Awedew, AF, Awoke, MA, Awoke, T, Quintanilla, BPA, Ayana, TM, Ayen, SS, Azadi, D, Null, SA, Azami-Aghdash, S, Azanaw, MM, Azangou-Khyavy, M, Jafari, AA, Azizi, H, Azzam, AYY, Babajani, A, Badar, M, Badiye, AD, Baghcheghi, N, Bagheri, N, Bagherieh, S, Bahadory, S, Baig, AA, Baker, JL, Bakhtiari, A, Bakshi, RK, Banach, M, Banerjee, I, Bardhan, M, Barone-Adesi, F, Barra, F, Barrow, A, Bashir, NZ, Bashiri, A, Basu, S, Batiha, A-MM, Begum, A, Bekele, AB, Belay, AS, Belete, MA, Belgaumi, UI, Bell, AW, Belo, L, Benzian, H, Berhie, AY, Bermudez, ANC, Bernabe, E, Bhagavathula, AS, Bhala, N, Bhandari, BB, Bhardwaj, N, Bhardwaj, P, Bhattacharyya, K, Bhojaraja, VS, Bhuyan, SS, Bibi, S, Bilchut, AH, Bintoro, BS, Biondi, A, Birega, MGB, Birhan, HE, Bjorge, T, Blyuss, O, Bodicha, BBA, Bolla, SR, Boloor, A, Bosetti, C, Braithwaite, D, Brauer, M, Brenner, H, Briko, AN, Briko, NI, Buchanan, CM, Bulamu, NB, Bustamante-Teixeira, MT, Butt, MH, Butt, NS, Butt, ZA, Caetano dos Santos, FL, Camera, LA, Cao, C, Cao, Y, Carreras, G, Carvalho, M, Cembranel, F, Cerin, E, Chakraborty, PA, Charalampous, P, Chattu, VK, Chimed-Ochir, O, Chirinos-Caceres, JL, Cho, DY, Cho, WCS, Christopher, DJ, Chu, D-T, Chukwu, IS, Cohen, AJ, Conde, J, Cortas, S, Costa, VM, Cruz-Martins, N, Culbreth, GT, Dadras, O, Dagnaw, FT, Dahlawi, SMA, Dai, X, Dandona, L, Dandona, R, Daneshpajouhnejad, P, Danielewicz, A, An, TMD, Soltani, RDC, Darwesh, AM, Das, S, Davitoiu, DV, Esmaeili, ED, De la Hoz, FP, Debela, SA, Dehghan, A, Demisse, B, Demisse, FW, DenovaGutiA, E, Derakhshani, A, Molla, MD, Dereje, D, Deribe, KS, Desai, R, Desalegn, MD, Dessalegn, FN, Dessalegni, SAA, Dessie, G, Desta, AA, Dewan, SMR, Dharmaratne, SD, Dhimal, M, Dianatinasab, M, Diao, N, Diaz, D, Digesa, LE, Dixit, SG, Doaei, S, Linh, PD, Doku, PN, Dongarwar, D, dos Santos, WM, Driscoll, TR, Dsouza, HL, Durojaiye, OC, Edalati, S, Eghbalian, F, Ehsani-Chimeh, E, Eini, E, Ekholuenetale, M, Ekundayo, TC, Ekwueme, DU, El Tantawi, M, Elbahnasawy, MA, Elbarazi, I, Elghazaly, H, Elhadi, M, El-Huneidi, W, Emamian, MH, Bain, LE, Enyew, DB, Erkhembayar, R, Eshetu, T, Eshrati, B, Eskandarieh, S, Espinosa-Montero, J, Etaee, F, Etemadimanesh, A, Eyayu, T, Ezeonwumelu, IJ, Ezzikouri, S, Fagbamigbe, AF, Fahimi, S, Fakhradiyev, IR, Faraon, EJA, Fares, J, Farmany, A, Farooque, U, Farrokhpour, H, Fasanmi, AO, Fatehizadeh, A, Fatima, W, Fattahi, H, Fekadu, G, Feleke, BE, Ferrari, AA, Ferrero, S, Desideri, LF, Filip, I, Fischer, F, Foroumadi, R, Foroutan, M, Fukumoto, T, Gaal, PA, Gad, MM, Gadanya, MA, Gaipov, A, Galehdar, N, Gallus, S, Garg, T, Fonseca, MG, Gebremariam, YH, Gebremeskel, TG, Gebremichael, MA, Geda, YF, Gela, YY, Gemeda, BNB, Getachew, M, Getachew, ME, Ghaffari, K, Ghafourifard, M, Ghamari, S-H, Nour, MG, Ghassemi, F, Ghimire, A, Ghith, N, Gholamalizadeh, M, Navashenaq, JG, Ghozy, S, Gilani, SA, Gill, PS, Ginindza, TG, Gizaw, ATT, Glasbey, JC, Godos, J, Goel, A, Golechha, M, Goleij, P, Golinelli, D, Golitaleb, M, Gorini, G, Goulart, BNG, Grosso, G, Guadie, HA, Gubari, MIM, Gudayu, TW, Guerra, MR, Gunawardane, DA, Gupta, B, Gupta, S, Gupta, V, Gupta, VK, Gurara, MK, Guta, A, Habibzadeh, P, Avval, AH, Hafezi-Nejad, N, Ali, AH, Haj-Mirzaian, A, Halboub, ES, Halimi, A, Halwani, R, Hamadeh, RR, Hameed, S, Hamidi, S, Hanif, A, Hariri, S, Harlianto, N, Haro, JM, Hartono, RK, Hasaballah, A, Hasan, SMM, Hasani, H, Hashemi, SM, Hassan, AM, Hassanipour, S, Hayat, K, Heidari, G, Heidari, M, Heidarymeybodi, Z, Herrera-Serna, BY, Herteliu, C, Hezam, K, Hiraike, Y, Hlongwa, MM, Holla, R, Holm, M, Horita, N, Hoseini, M, Hossain, MM, Hossain, MBH, Hosseini, M-S, Hosseinzadeh, A, Hosseinzadeh, M, Hostiuc, M, Hostiuc, S, Househ, M, Huang, J, Hugo, FN, Humayun, A, Hussain, S, Hussein, NR, Hwang, B-F, Ibitoye, SE, Iftikhar, PM, Ikuta, KS, Ilesanmi, OS, Ilic, IM, Ilic, MD, Immurana, M, Innos, K, Iranpour, P, Irham, LM, Islam, MS, Islam, RM, Islami, F, Ismail, NE, Isola, G, Iwagami, M, Merin, LJ, Jaiswal, A, Jakovljevic, M, Jalili, M, Jalilian, S, Jamshidi, E, Jang, S-I, Jani, CT, Javaheri, T, Jayarajah, UU, Jayaram, S, Jazayeri, SB, Jebai, R, Jemal, B, Jeong, W, Jha, RP, Jindal, HA, John-Akinola, YO, Jonas, JB, Joo, T, Joseph, N, Joukar, F, Jozwiak, JJ, Jarisson, M, Kabir, A, Kacimi, SEO, Kadashetti, V, Kahe, F, Kakodkar, PV, Kalankesh, LR, Kalhor, R, Kamal, VK, Kamangar, F, Kamath, A, Kanchan, T, Kandaswamy, E, Kandel, H, Kang, H, Kanno, GG, Kapoor, N, Kar, SS, Karanth, SD, Karaye, IM, Karch, A, Karimi, A, Kassa, BG, Katoto, PDMC, Kauppila, JH, Kaur, H, Kebede, AG, Keikavoosi-Arani, L, Kejela, GG, Bohan, PMK, Keramati, M, Keykhaei, M, Khajuria, H, Khan, A, Khan, AAK, Khan, EA, Khan, G, Khan, MN, Ab Khan, M, Khanali, J, Khatab, K, Khatatbeh, MM, Khatib, MN, Khayamzadeh, M, Kashani, HRK, Tabari, MAK, Khezeli, M, Khodadost, M, Kim, MS, Kim, YJ, Kisa, A, Kisa, S, Klugar, M, Klugarova, J, Kolahi, A-A, Kolkhir, P, Kompani, F, Koul, PA, Laxminarayana, SLK, Koyanagi, A, Krishan, K, Krishnamoorthy, Y, Bicer, BK, Kugbey, N, Kulimbet, M, Kumar, A, Kumar, GA, Kumar, N, Kurmi, OP, Kuttikkattu, A, La Vecchia, C, Lahiri, A, Lal, DK, Lam, J, Lan, Q, Landires, I, Larijani, B, Lasrado, S, Lau, J, Lauriola, P, Ledda, C, Lee, S-W, Lee, SWH, Lee, W-C, Lee, YY, Lee, YH, Legesse, SM, Leigh, J, Leong, E, Li, M-C, Lim, SS, Liu, G, Liu, J, Lo, C-H, Lohiya, A, Lopukhov, PD, Lorenzovici, L, Lotfi, M, Loureiro, JA, Lunevicius, R, Madadizadeh, F, Mafi, AR, Magdeldin, S, Mahjoub, S, Mahmoodpoor, A, Mahmoudi, M, Mahmoudimanesh, M, Mahumud, RA, Majeed, A, Majidpoor, J, Makki, A, Makris, KC, Rad, EM, Malekpour, M-R, Malekzadeh, R, Malik, AA, Mallhi, TH, Mallya, SD, Mamun, MA, Manda, AL, Mansour-Ghanaei, F, Mansouri, B, Mansournia, MA, Mantovani, LG, Martini, S, Martorell, M, Masoudi, S, Masoumi, SZ, Matei, CN, Mathews, E, Mathur, MR, Mathur, V, McKee, M, Meena, JK, Mehmood, K, Nasab, EM, Mehrotra, R, Melese, A, Mendoza, W, Menezes, RG, Mengesha, SD, Mensah, LG, Mentis, A-FA, Mera-Mamian, AYM, Meretoja, TJ, Merid, MW, Mersha, AG, Meselu, BT, Meshkat, M, Mestrovic, T, Jonasson, JM, Miazgowski, T, Michalek, IM, Mijena, GFW, Miller, TR, Mir, SA, Mirinezhad, SK, Mirmoeeni, S, Mirza-Aghazadeh-Attari, M, Mirzaei, H, Mirzaei, HR, Misganaw, AS, Misra, S, AbdulmuhsinMohammad, K, Mohammadi, E, Mohammadi, M, Mohammadian-Hafshejani, A, Mohammadpourhodki, R, Mohammed, A, Mohammed, S, Mohan, S, Mohseni, M, Moka, N, Mokdad, AH, Molassiotis, A, Molokhia, M, Momenzadeh, K, Momtazmanesh, S, Monasta, L, Mons, U, Al Montasir, A, Montazeri, F, Montero, A, Moosavi, MA, Moradi, A, Moradi, Y, Sarabi, MM, Moraga, P, Morawska, L, Morrison, SD, Morze, J, Mosapour, A, Mostafavi, E, Mousavi, SM, Isfahani, HM, Khaneghah, AM, Mpundu-Kaambwa, C, Mubarik, S, Mulita, F, Munblit, D, Munro, SB, Murillo-Zamora, E, Musa, J, Nabhan, AF, Nagarajan, AJ, Nagaraju, SP, Nagel, G, Naghipour, M, Naimzada, MD, Nair, TS, Naqvi, AA, Swamy, SN, Narayana, AI, Nassereldine, H, Natto, ZS, Nayak, BP, Ndejjo, R, Nduaguba, SO, Negash, WW, Nejadghaderi, SA, Nejati, K, Kandel, SN, Huy, VNN, Niazi, RK, Noor, NM, Noori, M, Noroozi, N, Nouraei, H, Nowroozi, A, Nunez-Samudio, V, Nzoputam, CI, Nzoputam, OJ, Oancea, B, Odukoya, OO, Oghenetega, OB, Ogunsakin, RE, Oguntade, AS, Oh, I-H, Okati-Aliabad, H, Okekunle, AP, Olagunju, AT, Olagunju, TO, Olakunde, BO, Olufadewa, II, Omer, E, Omonisi, AEE, Ong, S, Onwujekwe, OE, Orru, H, Otstavnov, SS, Oulhaj, A, Oumer, B, Owopetu, OF, Oyinloye, BE, Mahesh, PA, Padron-Monedero, A, Padubidri, JR, Pakbin, B, Pakshir, K, Pakzad, R, Palicz, T, Pana, A, Pandey, A, Pant, S, Pardhan, S, Park, E-K, Park, S, Patel, J, Pati, S, Paudel, R, Paudel, U, Paun, M, Toroudi, HP, Peng, M, Pereira, J, Pereira, RB, Perna, S, Perumalsamy, N, Pestell, RG, Pezzani, R, Piccinelli, C, Pillay, JD, Piracha, ZZ, Pischon, T, Postma, MJ, Langroudi, AP, Pourshams, A, Pourtaheri, N, Prashant, A, Qadir, MMF, Syed, ZQ, Rabiee, M, Rabiee, N, Radfar, A, Radhakrishnan, RA, Radhakrishnan, V, Raeisi, M, Rafiee, A, Rafiei, A, Raheem, N, Rahim, F, Rahman, MO, Rahman, M, Rahman, MA, Rahmani, AM, Rahmani, S, Rahmanian, V, Rajai, N, Rajesh, A, Ram, P, Ramezanzadeh, K, Rana, J, Ranabhat, K, Ranasinghe, P, Rao, CR, Rao, SJ, Rashedi, S, Rashidi, A, Rashidi, M-M, Ratan, ZA, Rawaf, DL, Rawaf, S, Rawal, L, Rawassizadeh, R, Razeghinia, MS, Rehman, AU, Rehman, IU, Reitsma, MB, Renzaho, AMN, Rezaei, M, Rezaei, N, Rezaei, S, Rezaeian, M, Rezapour, A, Riad, A, Rikhtegar, R, Rios-Blancas, M, Roberts, TJ, Rohloff, P, Romero-Rodriguez, E, Roshandel, G, Rwegerera, GM, Manjula, S, Saber-Ayad, MM, Saberzadeh-Ardestani, B, Sabour, S, Saddik, B, Sadeghi, E, Saeb, MR, Saeed, U, Safaei, M, Safary, A, Sahebazzamani, M, Sahebkar, A, Sahoo, H, Sajid, MR, Salari, H, Salehi, S, Salem, MR, Salimzadeh, H, Samodra, YL, Samy, AM, Sanabria, J, Sankararaman, S, Sanmarchi, F, Santric-Milicevic, MM, Saqib, MAN, Sarveazad, A, Sarvi, F, Sathian, B, Satpathy, M, Sayegh, N, Schneider, IJC, Schwarzinger, M, Sekerija, M, Senthilkumaran, S, Sepanlou, SG, Seylani, A, Seyoum, K, Sha, F, Shafaat, O, Shah, PA, Shahabi, S, Shahid, I, Shahrbaf, MA, Shahsavari, HR, Shaikh, MA, Shaka, MF, Shaker, E, Shannawaz, M, Sharew, MMS, Sharifi, A, Sharifi-Rad, J, Sharma, P, Shashamo, BB, Sheikh, A, Sheikh, M, Sheikhbahaei, S, Sheikhi, RA, Sheikhy, A, Shepherd, PR, Shetty, A, Shetty, JK, Shetty, RS, Shibuya, K, Shirkoohi, R, Shirzad-Aski, H, Shivakumar, KM, Shivalli, S, Shivarov, V, Shobeiri, P, Varniab, ZS, Shorofi, SA, Shrestha, S, Sibhat, MM, Malleshappa, SS, Sidemo, NB, Silva, DAS, Silva, LMLR, Julian, GS, Silvestris, N, Simegn, W, Singh, AD, Singh, A, Singh, G, Singh, H, Singh, JA, Singh, JK, Singh, P, Singh, S, Sinha, DN, Sinke, AH, Siraj, MS, Sitas, F, Siwal, SS, Skryabin, VY, Skryabina, AA, Socea, B, Soeberg, MJ, Sofi-Mahmudi, A, Solomon, Y, Soltani-Zangbar, MS, Song, S, Song, Y, Sorensen, RJD, Soshnikov, S, Sotoudeh, H, Sowe, A, Sufiyan, MB, Suk, R, Suleman, M, Abdulkader, RS, Sultana, S, Sur, D, Szacska, M, Tabaeian, SP, Tabares-Seisdedos, R, Tabatabaei, SM, Tabuchi, T, Tadbiri, H, Taheri, E, Taheri, M, Soodejani, MT, Takahashi, K, Talaat, IM, Tampa, M, Tan, K-K, Tat, NY, Tat, VY, Tavakoli, A, Tehrani-Banihashemi, A, Tekalegn, Y, Tesfay, FH, Thapar, R, Thavamani, A, Chandrasekar, VT, Thomas, N, Thomas, NK, Ticoalu, JHV, Tiyuri, A, Tollosa, DN, Topor-Madry, R, Touvier, M, Tovani-Palone, MR, Traini, E, Mai, TNT, Tripathy, JP, Ukke, GG, Ullah, I, Ullah, S, Unnikrishnan, B, Vacante, M, Vaezi, M, Tahbaz, SV, Valdez, PR, Vardavas, C, Varthya, SB, Vaziri, S, Velazquez, DZ, Veroux, M, Villeneuve, PJ, Violante, FS, Vladimirov, SK, Vlassov, V, Vo, B, Vu, LG, Wadood, AW, Waheed, Y, Walde, MT, Wamai, RG, Wang, C, Wang, F, Wang, N, Wang, Y, Ward, P, Waris, A, Westerman, R, Wickramasinghe, ND, Woldemariam, M, Woldu, B, Xiao, H, Xu, S, Xu, X, Yadav, L, Jabbari, SHY, Yang, L, Yazdanpanah, F, Yeshaw, Y, Yismaw, Y, Yonemoto, N, Younis, MZ, Yousefi, Z, Yousefian, F, Yu, C, Yu, Y, Yunusa, I, Zahir, M, Zaki, N, Zaman, BA, Zangiabadian, M, Zare, F, Zare, I, Zareshahrabadi, Z, Zarrintan, A, Zastrozhin, MS, Zeineddine, MA, Zhang, D, Zhang, J, Zhang, Y, Zhang, Z-J, Zhou, L, Zodpey, S, Zoladl, M, Vos, T, Hay, S, Force, LM, Murray, CJL, Khanh, BT, Lang, JJ, Compton, K, Xu, R, Acheson, AR, Henrikson, HJ, Kocarnik, JM, Penberthy, L, Aali, A, Abbas, Q, Abbasi, B, Abbasi-Kangevari, M, Abbasi-Kangevari, Z, Abbastabar, H, Abdelmasseh, M, Abd-Elsalam, S, Abdelwahab, AA, Abdoli, G, Abdulkadir, HA, Abedi, A, Abegaz, KH, Abidi, H, Aboagye, RG, Abolhassani, H, Absalan, A, Abtew, YD, Ali, HA, Abu-Gharbieh, E, Achappa, B, Acuna, JM, Addison, D, Addo, IY, Adegboye, OA, Adesina, MA, Adnan, M, Adnani, QES, Advani, SM, Afrin, S, Afzal, MS, Aggarwal, M, Ahinkorah, BO, Ahmad, AR, Ahmad, R, Ahmad, S, Ahmadi, S, Ahmed, H, Ahmed, LA, Ahmed, MB, Rashid, TA, Aiman, W, Ajami, M, Akalu, GT, Akbarzadeh-Khiavi, M, Aklilu, A, Akonde, M, Akunna, CJ, Al Hamad, H, Alahdab, F, Alanezi, FM, Alanzi, TM, Alessy, SA, Algammal, AM, Al-Hanawi, MK, Alhassan, RK, Ali, BA, Ali, L, Ali, SS, Alimohamadi, Y, Alipour, V, Aljunid, SM, Alkhayyat, M, Al-Maweri, SAA, Almustanyir, S, Alonso, N, Alqalyoobi, S, Al-Raddadi, RM, Al-Rifai, RHH, Al-Sabah, SK, Al-Tammemi, AB, Altawalah, H, Alvis-Guzman, N, Amare, F, Ameyaw, EK, Dehkordi, JJA, Amirzade-Iranaq, MH, Amu, H, Amusa, GA, Ancuceanu, R, Anderson, JA, Animut, YA, Anoushiravani, A, Anoushirvani, AA, Ansari-Moghaddam, A, Ansha, MG, Antony, B, Antwi, MH, Anwar, SL, Anwer, R, Anyasodor, AE, Arabloo, J, Arab-Zozani, M, Aremu, O, Argaw, AM, Ariffin, H, Aripov, T, Arshad, M, Al, A, Arulappan, J, Aruleba, RT, Aryannejad, A, Asaad, M, Asemahagn, MA, Asemi, Z, Asghari-Jafarabadi, M, Ashraf, T, Assadi, R, Athar, M, Athari, SS, Null, MMWA, Attia, S, Aujayeb, A, Ausloos, M, Avila-Burgos, L, Awedew, AF, Awoke, MA, Awoke, T, Quintanilla, BPA, Ayana, TM, Ayen, SS, Azadi, D, Null, SA, Azami-Aghdash, S, Azanaw, MM, Azangou-Khyavy, M, Jafari, AA, Azizi, H, Azzam, AYY, Babajani, A, Badar, M, Badiye, AD, Baghcheghi, N, Bagheri, N, Bagherieh, S, Bahadory, S, Baig, AA, Baker, JL, Bakhtiari, A, Bakshi, RK, Banach, M, Banerjee, I, Bardhan, M, Barone-Adesi, F, Barra, F, Barrow, A, Bashir, NZ, Bashiri, A, Basu, S, Batiha, A-MM, Begum, A, Bekele, AB, Belay, AS, Belete, MA, Belgaumi, UI, Bell, AW, Belo, L, Benzian, H, Berhie, AY, Bermudez, ANC, Bernabe, E, Bhagavathula, AS, Bhala, N, Bhandari, BB, Bhardwaj, N, Bhardwaj, P, Bhattacharyya, K, Bhojaraja, VS, Bhuyan, SS, Bibi, S, Bilchut, AH, Bintoro, BS, Biondi, A, Birega, MGB, Birhan, HE, Bjorge, T, Blyuss, O, Bodicha, BBA, Bolla, SR, Boloor, A, Bosetti, C, Braithwaite, D, Brauer, M, Brenner, H, Briko, AN, Briko, NI, Buchanan, CM, Bulamu, NB, Bustamante-Teixeira, MT, Butt, MH, Butt, NS, Butt, ZA, Caetano dos Santos, FL, Camera, LA, Cao, C, Cao, Y, Carreras, G, Carvalho, M, Cembranel, F, Cerin, E, Chakraborty, PA, Charalampous, P, Chattu, VK, Chimed-Ochir, O, Chirinos-Caceres, JL, Cho, DY, Cho, WCS, Christopher, DJ, Chu, D-T, Chukwu, IS, Cohen, AJ, Conde, J, Cortas, S, Costa, VM, Cruz-Martins, N, Culbreth, GT, Dadras, O, Dagnaw, FT, Dahlawi, SMA, Dai, X, Dandona, L, Dandona, R, Daneshpajouhnejad, P, Danielewicz, A, An, TMD, Soltani, RDC, Darwesh, AM, Das, S, Davitoiu, DV, Esmaeili, ED, De la Hoz, FP, Debela, SA, Dehghan, A, Demisse, B, Demisse, FW, DenovaGutiA, E, Derakhshani, A, Molla, MD, Dereje, D, Deribe, KS, Desai, R, Desalegn, MD, Dessalegn, FN, Dessalegni, SAA, Dessie, G, Desta, AA, Dewan, SMR, Dharmaratne, SD, Dhimal, M, Dianatinasab, M, Diao, N, Diaz, D, Digesa, LE, Dixit, SG, Doaei, S, Linh, PD, Doku, PN, Dongarwar, D, dos Santos, WM, Driscoll, TR, Dsouza, HL, Durojaiye, OC, Edalati, S, Eghbalian, F, Ehsani-Chimeh, E, Eini, E, Ekholuenetale, M, Ekundayo, TC, Ekwueme, DU, El Tantawi, M, Elbahnasawy, MA, Elbarazi, I, Elghazaly, H, Elhadi, M, El-Huneidi, W, Emamian, MH, Bain, LE, Enyew, DB, Erkhembayar, R, Eshetu, T, Eshrati, B, Eskandarieh, S, Espinosa-Montero, J, Etaee, F, Etemadimanesh, A, Eyayu, T, Ezeonwumelu, IJ, Ezzikouri, S, Fagbamigbe, AF, Fahimi, S, Fakhradiyev, IR, Faraon, EJA, Fares, J, Farmany, A, Farooque, U, Farrokhpour, H, Fasanmi, AO, Fatehizadeh, A, Fatima, W, Fattahi, H, Fekadu, G, Feleke, BE, Ferrari, AA, Ferrero, S, Desideri, LF, Filip, I, Fischer, F, Foroumadi, R, Foroutan, M, Fukumoto, T, Gaal, PA, Gad, MM, Gadanya, MA, Gaipov, A, Galehdar, N, Gallus, S, Garg, T, Fonseca, MG, Gebremariam, YH, Gebremeskel, TG, Gebremichael, MA, Geda, YF, Gela, YY, Gemeda, BNB, Getachew, M, Getachew, ME, Ghaffari, K, Ghafourifard, M, Ghamari, S-H, Nour, MG, Ghassemi, F, Ghimire, A, Ghith, N, Gholamalizadeh, M, Navashenaq, JG, Ghozy, S, Gilani, SA, Gill, PS, Ginindza, TG, Gizaw, ATT, Glasbey, JC, Godos, J, Goel, A, Golechha, M, Goleij, P, Golinelli, D, Golitaleb, M, Gorini, G, Goulart, BNG, Grosso, G, Guadie, HA, Gubari, MIM, Gudayu, TW, Guerra, MR, Gunawardane, DA, Gupta, B, Gupta, S, Gupta, V, Gupta, VK, Gurara, MK, Guta, A, Habibzadeh, P, Avval, AH, Hafezi-Nejad, N, Ali, AH, Haj-Mirzaian, A, Halboub, ES, Halimi, A, Halwani, R, Hamadeh, RR, Hameed, S, Hamidi, S, Hanif, A, Hariri, S, Harlianto, N, Haro, JM, Hartono, RK, Hasaballah, A, Hasan, SMM, Hasani, H, Hashemi, SM, Hassan, AM, Hassanipour, S, Hayat, K, Heidari, G, Heidari, M, Heidarymeybodi, Z, Herrera-Serna, BY, Herteliu, C, Hezam, K, Hiraike, Y, Hlongwa, MM, Holla, R, Holm, M, Horita, N, Hoseini, M, Hossain, MM, Hossain, MBH, Hosseini, M-S, Hosseinzadeh, A, Hosseinzadeh, M, Hostiuc, M, Hostiuc, S, Househ, M, Huang, J, Hugo, FN, Humayun, A, Hussain, S, Hussein, NR, Hwang, B-F, Ibitoye, SE, Iftikhar, PM, Ikuta, KS, Ilesanmi, OS, Ilic, IM, Ilic, MD, Immurana, M, Innos, K, Iranpour, P, Irham, LM, Islam, MS, Islam, RM, Islami, F, Ismail, NE, Isola, G, Iwagami, M, Merin, LJ, Jaiswal, A, Jakovljevic, M, Jalili, M, Jalilian, S, Jamshidi, E, Jang, S-I, Jani, CT, Javaheri, T, Jayarajah, UU, Jayaram, S, Jazayeri, SB, Jebai, R, Jemal, B, Jeong, W, Jha, RP, Jindal, HA, John-Akinola, YO, Jonas, JB, Joo, T, Joseph, N, Joukar, F, Jozwiak, JJ, Jarisson, M, Kabir, A, Kacimi, SEO, Kadashetti, V, Kahe, F, Kakodkar, PV, Kalankesh, LR, Kalhor, R, Kamal, VK, Kamangar, F, Kamath, A, Kanchan, T, Kandaswamy, E, Kandel, H, Kang, H, Kanno, GG, Kapoor, N, Kar, SS, Karanth, SD, Karaye, IM, Karch, A, Karimi, A, Kassa, BG, Katoto, PDMC, Kauppila, JH, Kaur, H, Kebede, AG, Keikavoosi-Arani, L, Kejela, GG, Bohan, PMK, Keramati, M, Keykhaei, M, Khajuria, H, Khan, A, Khan, AAK, Khan, EA, Khan, G, Khan, MN, Ab Khan, M, Khanali, J, Khatab, K, Khatatbeh, MM, Khatib, MN, Khayamzadeh, M, Kashani, HRK, Tabari, MAK, Khezeli, M, Khodadost, M, Kim, MS, Kim, YJ, Kisa, A, Kisa, S, Klugar, M, Klugarova, J, Kolahi, A-A, Kolkhir, P, Kompani, F, Koul, PA, Laxminarayana, SLK, Koyanagi, A, Krishan, K, Krishnamoorthy, Y, Bicer, BK, Kugbey, N, Kulimbet, M, Kumar, A, Kumar, GA, Kumar, N, Kurmi, OP, Kuttikkattu, A, La Vecchia, C, Lahiri, A, Lal, DK, Lam, J, Lan, Q, Landires, I, Larijani, B, Lasrado, S, Lau, J, Lauriola, P, Ledda, C, Lee, S-W, Lee, SWH, Lee, W-C, Lee, YY, Lee, YH, Legesse, SM, Leigh, J, Leong, E, Li, M-C, Lim, SS, Liu, G, Liu, J, Lo, C-H, Lohiya, A, Lopukhov, PD, Lorenzovici, L, Lotfi, M, Loureiro, JA, Lunevicius, R, Madadizadeh, F, Mafi, AR, Magdeldin, S, Mahjoub, S, Mahmoodpoor, A, Mahmoudi, M, Mahmoudimanesh, M, Mahumud, RA, Majeed, A, Majidpoor, J, Makki, A, Makris, KC, Rad, EM, Malekpour, M-R, Malekzadeh, R, Malik, AA, Mallhi, TH, Mallya, SD, Mamun, MA, Manda, AL, Mansour-Ghanaei, F, Mansouri, B, Mansournia, MA, Mantovani, LG, Martini, S, Martorell, M, Masoudi, S, Masoumi, SZ, Matei, CN, Mathews, E, Mathur, MR, Mathur, V, McKee, M, Meena, JK, Mehmood, K, Nasab, EM, Mehrotra, R, Melese, A, Mendoza, W, Menezes, RG, Mengesha, SD, Mensah, LG, Mentis, A-FA, Mera-Mamian, AYM, Meretoja, TJ, Merid, MW, Mersha, AG, Meselu, BT, Meshkat, M, Mestrovic, T, Jonasson, JM, Miazgowski, T, Michalek, IM, Mijena, GFW, Miller, TR, Mir, SA, Mirinezhad, SK, Mirmoeeni, S, Mirza-Aghazadeh-Attari, M, Mirzaei, H, Mirzaei, HR, Misganaw, AS, Misra, S, AbdulmuhsinMohammad, K, Mohammadi, E, Mohammadi, M, Mohammadian-Hafshejani, A, Mohammadpourhodki, R, Mohammed, A, Mohammed, S, Mohan, S, Mohseni, M, Moka, N, Mokdad, AH, Molassiotis, A, Molokhia, M, Momenzadeh, K, Momtazmanesh, S, Monasta, L, Mons, U, Al Montasir, A, Montazeri, F, Montero, A, Moosavi, MA, Moradi, A, Moradi, Y, Sarabi, MM, Moraga, P, Morawska, L, Morrison, SD, Morze, J, Mosapour, A, Mostafavi, E, Mousavi, SM, Isfahani, HM, Khaneghah, AM, Mpundu-Kaambwa, C, Mubarik, S, Mulita, F, Munblit, D, Munro, SB, Murillo-Zamora, E, Musa, J, Nabhan, AF, Nagarajan, AJ, Nagaraju, SP, Nagel, G, Naghipour, M, Naimzada, MD, Nair, TS, Naqvi, AA, Swamy, SN, Narayana, AI, Nassereldine, H, Natto, ZS, Nayak, BP, Ndejjo, R, Nduaguba, SO, Negash, WW, Nejadghaderi, SA, Nejati, K, Kandel, SN, Huy, VNN, Niazi, RK, Noor, NM, Noori, M, Noroozi, N, Nouraei, H, Nowroozi, A, Nunez-Samudio, V, Nzoputam, CI, Nzoputam, OJ, Oancea, B, Odukoya, OO, Oghenetega, OB, Ogunsakin, RE, Oguntade, AS, Oh, I-H, Okati-Aliabad, H, Okekunle, AP, Olagunju, AT, Olagunju, TO, Olakunde, BO, Olufadewa, II, Omer, E, Omonisi, AEE, Ong, S, Onwujekwe, OE, Orru, H, Otstavnov, SS, Oulhaj, A, Oumer, B, Owopetu, OF, Oyinloye, BE, Mahesh, PA, Padron-Monedero, A, Padubidri, JR, Pakbin, B, Pakshir, K, Pakzad, R, Palicz, T, Pana, A, Pandey, A, Pant, S, Pardhan, S, Park, E-K, Park, S, Patel, J, Pati, S, Paudel, R, Paudel, U, Paun, M, Toroudi, HP, Peng, M, Pereira, J, Pereira, RB, Perna, S, Perumalsamy, N, Pestell, RG, Pezzani, R, Piccinelli, C, Pillay, JD, Piracha, ZZ, Pischon, T, Postma, MJ, Langroudi, AP, Pourshams, A, Pourtaheri, N, Prashant, A, Qadir, MMF, Syed, ZQ, Rabiee, M, Rabiee, N, Radfar, A, Radhakrishnan, RA, Radhakrishnan, V, Raeisi, M, Rafiee, A, Rafiei, A, Raheem, N, Rahim, F, Rahman, MO, Rahman, M, Rahman, MA, Rahmani, AM, Rahmani, S, Rahmanian, V, Rajai, N, Rajesh, A, Ram, P, Ramezanzadeh, K, Rana, J, Ranabhat, K, Ranasinghe, P, Rao, CR, Rao, SJ, Rashedi, S, Rashidi, A, Rashidi, M-M, Ratan, ZA, Rawaf, DL, Rawaf, S, Rawal, L, Rawassizadeh, R, Razeghinia, MS, Rehman, AU, Rehman, IU, Reitsma, MB, Renzaho, AMN, Rezaei, M, Rezaei, N, Rezaei, S, Rezaeian, M, Rezapour, A, Riad, A, Rikhtegar, R, Rios-Blancas, M, Roberts, TJ, Rohloff, P, Romero-Rodriguez, E, Roshandel, G, Rwegerera, GM, Manjula, S, Saber-Ayad, MM, Saberzadeh-Ardestani, B, Sabour, S, Saddik, B, Sadeghi, E, Saeb, MR, Saeed, U, Safaei, M, Safary, A, Sahebazzamani, M, Sahebkar, A, Sahoo, H, Sajid, MR, Salari, H, Salehi, S, Salem, MR, Salimzadeh, H, Samodra, YL, Samy, AM, Sanabria, J, Sankararaman, S, Sanmarchi, F, Santric-Milicevic, MM, Saqib, MAN, Sarveazad, A, Sarvi, F, Sathian, B, Satpathy, M, Sayegh, N, Schneider, IJC, Schwarzinger, M, Sekerija, M, Senthilkumaran, S, Sepanlou, SG, Seylani, A, Seyoum, K, Sha, F, Shafaat, O, Shah, PA, Shahabi, S, Shahid, I, Shahrbaf, MA, Shahsavari, HR, Shaikh, MA, Shaka, MF, Shaker, E, Shannawaz, M, Sharew, MMS, Sharifi, A, Sharifi-Rad, J, Sharma, P, Shashamo, BB, Sheikh, A, Sheikh, M, Sheikhbahaei, S, Sheikhi, RA, Sheikhy, A, Shepherd, PR, Shetty, A, Shetty, JK, Shetty, RS, Shibuya, K, Shirkoohi, R, Shirzad-Aski, H, Shivakumar, KM, Shivalli, S, Shivarov, V, Shobeiri, P, Varniab, ZS, Shorofi, SA, Shrestha, S, Sibhat, MM, Malleshappa, SS, Sidemo, NB, Silva, DAS, Silva, LMLR, Julian, GS, Silvestris, N, Simegn, W, Singh, AD, Singh, A, Singh, G, Singh, H, Singh, JA, Singh, JK, Singh, P, Singh, S, Sinha, DN, Sinke, AH, Siraj, MS, Sitas, F, Siwal, SS, Skryabin, VY, Skryabina, AA, Socea, B, Soeberg, MJ, Sofi-Mahmudi, A, Solomon, Y, Soltani-Zangbar, MS, Song, S, Song, Y, Sorensen, RJD, Soshnikov, S, Sotoudeh, H, Sowe, A, Sufiyan, MB, Suk, R, Suleman, M, Abdulkader, RS, Sultana, S, Sur, D, Szacska, M, Tabaeian, SP, Tabares-Seisdedos, R, Tabatabaei, SM, Tabuchi, T, Tadbiri, H, Taheri, E, Taheri, M, Soodejani, MT, Takahashi, K, Talaat, IM, Tampa, M, Tan, K-K, Tat, NY, Tat, VY, Tavakoli, A, Tehrani-Banihashemi, A, Tekalegn, Y, Tesfay, FH, Thapar, R, Thavamani, A, Chandrasekar, VT, Thomas, N, Thomas, NK, Ticoalu, JHV, Tiyuri, A, Tollosa, DN, Topor-Madry, R, Touvier, M, Tovani-Palone, MR, Traini, E, Mai, TNT, Tripathy, JP, Ukke, GG, Ullah, I, Ullah, S, Unnikrishnan, B, Vacante, M, Vaezi, M, Tahbaz, SV, Valdez, PR, Vardavas, C, Varthya, SB, Vaziri, S, Velazquez, DZ, Veroux, M, Villeneuve, PJ, Violante, FS, Vladimirov, SK, Vlassov, V, Vo, B, Vu, LG, Wadood, AW, Waheed, Y, Walde, MT, Wamai, RG, Wang, C, Wang, F, Wang, N, Wang, Y, Ward, P, Waris, A, Westerman, R, Wickramasinghe, ND, Woldemariam, M, Woldu, B, Xiao, H, Xu, S, Xu, X, Yadav, L, Jabbari, SHY, Yang, L, Yazdanpanah, F, Yeshaw, Y, Yismaw, Y, Yonemoto, N, Younis, MZ, Yousefi, Z, Yousefian, F, Yu, C, Yu, Y, Yunusa, I, Zahir, M, Zaki, N, Zaman, BA, Zangiabadian, M, Zare, F, Zare, I, Zareshahrabadi, Z, Zarrintan, A, Zastrozhin, MS, Zeineddine, MA, Zhang, D, Zhang, J, Zhang, Y, Zhang, Z-J, Zhou, L, Zodpey, S, Zoladl, M, Vos, T, Hay, S, Force, LM, and Murray, CJL
- Abstract
BACKGROUND: Understanding the magnitude of cancer burden attributable to potentially modifiable risk factors is crucial for development of effective prevention and mitigation strategies. We analysed results from the Global Burden of Diseases, Injuries, and Risk Factors Study (GBD) 2019 to inform cancer control planning efforts globally. METHODS: The GBD 2019 comparative risk assessment framework was used to estimate cancer burden attributable to behavioural, environmental and occupational, and metabolic risk factors. A total of 82 risk-outcome pairs were included on the basis of the World Cancer Research Fund criteria. Estimated cancer deaths and disability-adjusted life-years (DALYs) in 2019 and change in these measures between 2010 and 2019 are presented. FINDINGS: Globally, in 2019, the risk factors included in this analysis accounted for 4·45 million (95% uncertainty interval 4·01-4·94) deaths and 105 million (95·0-116) DALYs for both sexes combined, representing 44·4% (41·3-48·4) of all cancer deaths and 42·0% (39·1-45·6) of all DALYs. There were 2·88 million (2·60-3·18) risk-attributable cancer deaths in males (50·6% [47·8-54·1] of all male cancer deaths) and 1·58 million (1·36-1·84) risk-attributable cancer deaths in females (36·3% [32·5-41·3] of all female cancer deaths). The leading risk factors at the most detailed level globally for risk-attributable cancer deaths and DALYs in 2019 for both sexes combined were smoking, followed by alcohol use and high BMI. Risk-attributable cancer burden varied by world region and Socio-demographic Index (SDI), with smoking, unsafe sex, and alcohol use being the three leading risk factors for risk-attributable cancer DALYs in low SDI locations in 2019, whereas DALYs in high SDI locations mirrored the top three global risk factor rankings. From 2010 to 2019, global risk-attributable cancer deaths increased by 20·4% (12·6-28·4) and DALYs by 16·8% (8·8-25·0), with the greatest percentage increase in metabolic risks (34·7% [2
- Published
- 2022
6. Cancer Incidence, Mortality, Years of Life Lost, Years Lived With Disability, and Disability-Adjusted Life Years for 29 Cancer Groups From 2010 to 2019: A Systematic Analysis for the Global Burden of Disease Study 2019.
- Author
-
Global Burden of Disease 2019 Cancer Collaboration, Kocarnik, JM, Compton, K, Dean, FE, Fu, W, Gaw, BL, Harvey, JD, Henrikson, HJ, Lu, D, Pennini, A, Xu, R, Bhojaraja, VS, Bibi, S, Bijani, A, Biondi, A, Bisignano, C, Bjørge, T, Bleyer, A, Blyuss, O, Bolarinwa, OA, Bolla, SR, Ababneh, E, Braithwaite, D, Brar, A, Brenner, H, Bustamante-Teixeira, MT, Butt, NS, Butt, ZA, Caetano Dos Santos, FL, Cao, Y, Carreras, G, Catalá-López, F, Abbasi-Kangevari, M, Cembranel, F, Cerin, E, Cernigliaro, A, Chakinala, RC, Chattu, SK, Chattu, VK, Chaturvedi, P, Chimed-Ochir, O, Cho, DY, Christopher, DJ, Abbastabar, H, Chu, D-T, Chung, MT, Conde, J, Cortés, S, Cortesi, PA, Costa, VM, Cunha, AR, Dadras, O, Dagnew, AB, Dahlawi, SMA, Abd-Elsalam, SM, Dai, X, Dandona, L, Dandona, R, Darwesh, AM, das Neves, J, De la Hoz, FP, Demis, AB, Denova-Gutiérrez, E, Dhamnetiya, D, Dhimal, ML, Abdoli, A, Dhimal, M, Dianatinasab, M, Diaz, D, Djalalinia, S, Do, HP, Doaei, S, Dorostkar, F, Dos Santos Figueiredo, FW, Driscoll, TR, Ebrahimi, H, Abedi, A, Eftekharzadeh, S, El Tantawi, M, El-Abid, H, Elbarazi, I, Elhabashy, HR, Elhadi, M, El-Jaafary, SI, Eshrati, B, Eskandarieh, S, Esmaeilzadeh, F, Abidi, H, Etemadi, A, Ezzikouri, S, Faisaluddin, M, Faraon, EJA, Fares, J, Farzadfar, F, Feroze, AH, Ferrero, S, Ferro Desideri, L, Filip, I, Abolhassani, H, Fischer, F, Fisher, JL, Foroutan, M, Fukumoto, T, Gaal, PA, Gad, MM, Gadanya, MA, Gallus, S, Gaspar Fonseca, M, Getachew Obsa, A, Adedeji, IA, Ghafourifard, M, Ghashghaee, A, Ghith, N, Gholamalizadeh, M, Gilani, SA, Ginindza, TG, Gizaw, ATT, Glasbey, JC, Golechha, M, Goleij, P, Adnani, QES, Gomez, RS, Gopalani, SV, Gorini, G, Goudarzi, H, Grosso, G, Gubari, MIM, Guerra, MR, Guha, A, Gunasekera, DS, Gupta, B, Advani, SM, Gupta, VB, Gupta, VK, Gutiérrez, RA, Hafezi-Nejad, N, Haider, MR, Haj-Mirzaian, A, Halwani, R, Hamadeh, RR, Hameed, S, Hamidi, S, Afzal, MS, Hanif, A, Haque, S, Harlianto, NI, Haro, JM, Hasaballah, AI, Hassanipour, S, Hay, RJ, Hay, SI, Hayat, K, Heidari, G, Aghaali, M, Heidari, M, Herrera-Serna, BY, Herteliu, C, Hezam, K, Holla, R, Hossain, MM, Hossain, MBH, Hosseini, M-S, Hosseini, M, Hosseinzadeh, M, Ahinkorah, BO, Hostiuc, M, Hostiuc, S, Househ, M, Hsairi, M, Huang, J, Hugo, FN, Hussain, R, Hussein, NR, Hwang, B-F, Iavicoli, I, Ahmad, S, Ibitoye, SE, Ida, F, Ikuta, KS, Ilesanmi, OS, Ilic, IM, Ilic, MD, Irham, LM, Islam, JY, Islam, RM, Islam, SMS, Ahmad, T, Ismail, NE, Isola, G, Iwagami, M, Jacob, L, Jain, V, Jakovljevic, MB, Javaheri, T, Jayaram, S, Jazayeri, SB, Jha, RP, Ahmadi, A, Jonas, JB, Joo, T, Joseph, N, Joukar, F, Jürisson, M, Kabir, A, Kahrizi, D, Kalankesh, LR, Kalhor, R, Kaliyadan, F, Ahmadi, S, Kalkonde, Y, Kamath, A, Kameran Al-Salihi, N, Kandel, H, Kapoor, N, Karch, A, Kasa, AS, Katikireddi, SV, Kauppila, JH, Kavetskyy, T, Ahmed Rashid, T, Kebede, SA, Keshavarz, P, Keykhaei, M, Khader, YS, Khalilov, R, Khan, G, Khan, M, Khan, MN, Khan, MAB, Khang, Y-H, Ahmed Salih, Y, Khater, AM, Khayamzadeh, M, Kim, GR, Kim, YJ, Kisa, A, Kisa, S, Kissimova-Skarbek, K, Kopec, JA, Koteeswaran, R, Koul, PA, Akalu, GT, Koulmane Laxminarayana, SL, Koyanagi, A, Kucuk Bicer, B, Kugbey, N, Kumar, GA, Kumar, N, Kurmi, OP, Kutluk, T, La Vecchia, C, Aklilu, A, Lami, FH, Landires, I, Lauriola, P, Lee, S-W, Lee, SWH, Lee, W-C, Lee, YH, Leigh, J, Leong, E, Li, J, Akram, T, Li, M-C, Liu, X, Loureiro, JA, Lunevicius, R, Magdy Abd El Razek, M, Majeed, A, Makki, A, Male, S, Malik, AA, Mansournia, MA, Akunna, CJ, Martini, S, Masoumi, SZ, Mathur, P, McKee, M, Mehrotra, R, Mendoza, W, Menezes, RG, Mengesha, EW, Mesregah, MK, Mestrovic, T, Al Hamad, H, Miao Jonasson, J, Miazgowski, B, Miazgowski, T, Michalek, IM, Miller, TR, Mirzaei, H, Mirzaei, HR, Misra, S, Mithra, P, Moghadaszadeh, M, Alahdab, F, Mohammad, KA, Mohammad, Y, Mohammadi, M, Mohammadi, SM, Mohammadian-Hafshejani, A, Mohammed, S, Moka, N, Mokdad, AH, Molokhia, M, Monasta, L, Al-Aly, Z, Moni, MA, Moosavi, MA, Moradi, Y, Moraga, P, Morgado-da-Costa, J, Morrison, SD, Mosapour, A, Mubarik, S, Mwanri, L, Nagarajan, AJ, Ali, S, Nagaraju, SP, Nagata, C, Naimzada, MD, Nangia, V, Naqvi, AA, Narasimha Swamy, S, Ndejjo, R, Nduaguba, SO, Negoi, I, Negru, SM, Alimohamadi, Y, Neupane Kandel, S, Nguyen, CT, Nguyen, HLT, Niazi, RK, Nnaji, CA, Noor, NM, Nuñez-Samudio, V, Nzoputam, CI, Oancea, B, Ochir, C, Alipour, V, Odukoya, OO, Ogbo, FA, Olagunju, AT, Olakunde, BO, Omar, E, Omar Bali, A, Omonisi, AEE, Ong, S, Onwujekwe, OE, Orru, H, Aljunid, SM, Ortega-Altamirano, DV, Otstavnov, N, Otstavnov, SS, Owolabi, MO, P A, M, Padubidri, JR, Pakshir, K, Pana, A, Panagiotakos, D, Panda-Jonas, S, Alkhayyat, M, Pardhan, S, Park, E-C, Park, E-K, Pashazadeh Kan, F, Patel, HK, Patel, JR, Pati, S, Pattanshetty, SM, Paudel, U, Pereira, DM, Almasi-Hashiani, A, Pereira, RB, Perianayagam, A, Pillay, JD, Pirouzpanah, S, Pishgar, F, Podder, I, Postma, MJ, Pourjafar, H, Prashant, A, Preotescu, L, Almasri, NA, Rabiee, M, Rabiee, N, Radfar, A, Radhakrishnan, RA, Radhakrishnan, V, Rafiee, A, Rahim, F, Rahimzadeh, S, Rahman, M, Rahman, MA, Al-Maweri, SAA, Rahmani, AM, Rajai, N, Rajesh, A, Rakovac, I, Ram, P, Ramezanzadeh, K, Ranabhat, K, Ranasinghe, P, Rao, CR, Rao, SJ, Almustanyir, S, Rawassizadeh, R, Razeghinia, MS, Renzaho, AMN, Rezaei, N, Rezapour, A, Roberts, TJ, Rodriguez, JAB, Rohloff, P, Romoli, M, Alonso, N, Ronfani, L, Roshandel, G, Rwegerera, GM, S, M, Sabour, S, Saddik, B, Saeed, U, Sahebkar, A, Sahoo, H, Salehi, S, Alvis-Guzman, N, Salem, MR, Salimzadeh, H, Samaei, M, Samy, AM, Sanabria, J, Sankararaman, S, Santric-Milicevic, MM, Sardiwalla, Y, Sarveazad, A, Sathian, B, Amu, H, Sawhney, M, Saylan, M, Schneider, IJC, Sekerija, M, Seylani, A, Shafaat, O, Shaghaghi, Z, Shaikh, MA, Shamsoddin, E, Shannawaz, M, Anbesu, EW, Sharma, R, Sheikh, A, Sheikhbahaei, S, Shetty, A, Shetty, JK, Shetty, PH, Shibuya, K, Shirkoohi, R, Shivakumar, KM, Shivarov, V, Ancuceanu, R, Siabani, S, Siddappa Malleshappa, SK, Silva, DAS, Singh, JA, Sintayehu, Y, Skryabin, VY, Skryabina, AA, Soeberg, MJ, Sofi-Mahmudi, A, Sotoudeh, H, Ansari, F, Steiropoulos, P, Straif, K, Subedi, R, Sufiyan, MB, Sultan, I, Sultana, S, Sur, D, Szerencsés, V, Szócska, M, Tabarés-Seisdedos, R, Ansari-Moghaddam, A, Tabuchi, T, Tadbiri, H, Taherkhani, A, Takahashi, K, Talaat, IM, Tan, K-K, Tat, VY, Tedla, BAA, Tefera, YG, Tehrani-Banihashemi, A, Antwi, MH, Temsah, M-H, Tesfay, FH, Tessema, GA, Thapar, R, Thavamani, A, Thoguluva Chandrasekar, V, Thomas, N, Tohidinik, HR, Touvier, M, Tovani-Palone, MR, Anvari, D, Traini, E, Tran, BX, Tran, KB, Tran, MTN, Tripathy, JP, Tusa, BS, Ullah, I, Ullah, S, Umapathi, KK, Unnikrishnan, B, Anyasodor, AE, Upadhyay, E, Vacante, M, Vaezi, M, Valadan Tahbaz, S, Velazquez, DZ, Veroux, M, Violante, FS, Vlassov, V, Vo, B, Volovici, V, Aqeel, M, Vu, GT, Waheed, Y, Wamai, RG, Ward, P, Wen, YF, Westerman, R, Winkler, AS, Yadav, L, Yahyazadeh Jabbari, SH, Yang, L, Arabloo, J, Yaya, S, Yazie, TSY, Yeshaw, Y, Yonemoto, N, Younis, MZ, Yousefi, Z, Yu, C, Yuce, D, Yunusa, I, Zadnik, V, Arab-Zozani, M, Zare, F, Zastrozhin, MS, Zastrozhina, A, Zhang, J, Zhong, C, Zhou, L, Zhu, C, Ziapour, A, Zimmermann, IR, Fitzmaurice, C, Aremu, O, Murray, CJL, Force, LM, Ariffin, H, Aripov, T, Arshad, M, Artaman, A, Arulappan, J, Asemi, Z, Asghari Jafarabadi, M, Ashraf, T, Atorkey, P, Aujayeb, A, Ausloos, M, Awedew, AF, Ayala Quintanilla, BP, Ayenew, T, Azab, MA, Azadnajafabad, S, Azari Jafari, A, Azarian, G, Azzam, AY, Badiye, AD, Bahadory, S, Baig, AA, Baker, JL, Balakrishnan, S, Banach, M, Bärnighausen, TW, Barone-Adesi, F, Barra, F, Barrow, A, Behzadifar, M, Belgaumi, UI, Bezabhe, WMM, Bezabih, YM, Bhagat, DS, Bhagavathula, AS, Bhardwaj, N, Bhardwaj, P, Bhaskar, S, Bhattacharyya, K, Global Burden of Disease 2019 Cancer Collaboration, Kocarnik, JM, Compton, K, Dean, FE, Fu, W, Gaw, BL, Harvey, JD, Henrikson, HJ, Lu, D, Pennini, A, Xu, R, Bhojaraja, VS, Bibi, S, Bijani, A, Biondi, A, Bisignano, C, Bjørge, T, Bleyer, A, Blyuss, O, Bolarinwa, OA, Bolla, SR, Ababneh, E, Braithwaite, D, Brar, A, Brenner, H, Bustamante-Teixeira, MT, Butt, NS, Butt, ZA, Caetano Dos Santos, FL, Cao, Y, Carreras, G, Catalá-López, F, Abbasi-Kangevari, M, Cembranel, F, Cerin, E, Cernigliaro, A, Chakinala, RC, Chattu, SK, Chattu, VK, Chaturvedi, P, Chimed-Ochir, O, Cho, DY, Christopher, DJ, Abbastabar, H, Chu, D-T, Chung, MT, Conde, J, Cortés, S, Cortesi, PA, Costa, VM, Cunha, AR, Dadras, O, Dagnew, AB, Dahlawi, SMA, Abd-Elsalam, SM, Dai, X, Dandona, L, Dandona, R, Darwesh, AM, das Neves, J, De la Hoz, FP, Demis, AB, Denova-Gutiérrez, E, Dhamnetiya, D, Dhimal, ML, Abdoli, A, Dhimal, M, Dianatinasab, M, Diaz, D, Djalalinia, S, Do, HP, Doaei, S, Dorostkar, F, Dos Santos Figueiredo, FW, Driscoll, TR, Ebrahimi, H, Abedi, A, Eftekharzadeh, S, El Tantawi, M, El-Abid, H, Elbarazi, I, Elhabashy, HR, Elhadi, M, El-Jaafary, SI, Eshrati, B, Eskandarieh, S, Esmaeilzadeh, F, Abidi, H, Etemadi, A, Ezzikouri, S, Faisaluddin, M, Faraon, EJA, Fares, J, Farzadfar, F, Feroze, AH, Ferrero, S, Ferro Desideri, L, Filip, I, Abolhassani, H, Fischer, F, Fisher, JL, Foroutan, M, Fukumoto, T, Gaal, PA, Gad, MM, Gadanya, MA, Gallus, S, Gaspar Fonseca, M, Getachew Obsa, A, Adedeji, IA, Ghafourifard, M, Ghashghaee, A, Ghith, N, Gholamalizadeh, M, Gilani, SA, Ginindza, TG, Gizaw, ATT, Glasbey, JC, Golechha, M, Goleij, P, Adnani, QES, Gomez, RS, Gopalani, SV, Gorini, G, Goudarzi, H, Grosso, G, Gubari, MIM, Guerra, MR, Guha, A, Gunasekera, DS, Gupta, B, Advani, SM, Gupta, VB, Gupta, VK, Gutiérrez, RA, Hafezi-Nejad, N, Haider, MR, Haj-Mirzaian, A, Halwani, R, Hamadeh, RR, Hameed, S, Hamidi, S, Afzal, MS, Hanif, A, Haque, S, Harlianto, NI, Haro, JM, Hasaballah, AI, Hassanipour, S, Hay, RJ, Hay, SI, Hayat, K, Heidari, G, Aghaali, M, Heidari, M, Herrera-Serna, BY, Herteliu, C, Hezam, K, Holla, R, Hossain, MM, Hossain, MBH, Hosseini, M-S, Hosseini, M, Hosseinzadeh, M, Ahinkorah, BO, Hostiuc, M, Hostiuc, S, Househ, M, Hsairi, M, Huang, J, Hugo, FN, Hussain, R, Hussein, NR, Hwang, B-F, Iavicoli, I, Ahmad, S, Ibitoye, SE, Ida, F, Ikuta, KS, Ilesanmi, OS, Ilic, IM, Ilic, MD, Irham, LM, Islam, JY, Islam, RM, Islam, SMS, Ahmad, T, Ismail, NE, Isola, G, Iwagami, M, Jacob, L, Jain, V, Jakovljevic, MB, Javaheri, T, Jayaram, S, Jazayeri, SB, Jha, RP, Ahmadi, A, Jonas, JB, Joo, T, Joseph, N, Joukar, F, Jürisson, M, Kabir, A, Kahrizi, D, Kalankesh, LR, Kalhor, R, Kaliyadan, F, Ahmadi, S, Kalkonde, Y, Kamath, A, Kameran Al-Salihi, N, Kandel, H, Kapoor, N, Karch, A, Kasa, AS, Katikireddi, SV, Kauppila, JH, Kavetskyy, T, Ahmed Rashid, T, Kebede, SA, Keshavarz, P, Keykhaei, M, Khader, YS, Khalilov, R, Khan, G, Khan, M, Khan, MN, Khan, MAB, Khang, Y-H, Ahmed Salih, Y, Khater, AM, Khayamzadeh, M, Kim, GR, Kim, YJ, Kisa, A, Kisa, S, Kissimova-Skarbek, K, Kopec, JA, Koteeswaran, R, Koul, PA, Akalu, GT, Koulmane Laxminarayana, SL, Koyanagi, A, Kucuk Bicer, B, Kugbey, N, Kumar, GA, Kumar, N, Kurmi, OP, Kutluk, T, La Vecchia, C, Aklilu, A, Lami, FH, Landires, I, Lauriola, P, Lee, S-W, Lee, SWH, Lee, W-C, Lee, YH, Leigh, J, Leong, E, Li, J, Akram, T, Li, M-C, Liu, X, Loureiro, JA, Lunevicius, R, Magdy Abd El Razek, M, Majeed, A, Makki, A, Male, S, Malik, AA, Mansournia, MA, Akunna, CJ, Martini, S, Masoumi, SZ, Mathur, P, McKee, M, Mehrotra, R, Mendoza, W, Menezes, RG, Mengesha, EW, Mesregah, MK, Mestrovic, T, Al Hamad, H, Miao Jonasson, J, Miazgowski, B, Miazgowski, T, Michalek, IM, Miller, TR, Mirzaei, H, Mirzaei, HR, Misra, S, Mithra, P, Moghadaszadeh, M, Alahdab, F, Mohammad, KA, Mohammad, Y, Mohammadi, M, Mohammadi, SM, Mohammadian-Hafshejani, A, Mohammed, S, Moka, N, Mokdad, AH, Molokhia, M, Monasta, L, Al-Aly, Z, Moni, MA, Moosavi, MA, Moradi, Y, Moraga, P, Morgado-da-Costa, J, Morrison, SD, Mosapour, A, Mubarik, S, Mwanri, L, Nagarajan, AJ, Ali, S, Nagaraju, SP, Nagata, C, Naimzada, MD, Nangia, V, Naqvi, AA, Narasimha Swamy, S, Ndejjo, R, Nduaguba, SO, Negoi, I, Negru, SM, Alimohamadi, Y, Neupane Kandel, S, Nguyen, CT, Nguyen, HLT, Niazi, RK, Nnaji, CA, Noor, NM, Nuñez-Samudio, V, Nzoputam, CI, Oancea, B, Ochir, C, Alipour, V, Odukoya, OO, Ogbo, FA, Olagunju, AT, Olakunde, BO, Omar, E, Omar Bali, A, Omonisi, AEE, Ong, S, Onwujekwe, OE, Orru, H, Aljunid, SM, Ortega-Altamirano, DV, Otstavnov, N, Otstavnov, SS, Owolabi, MO, P A, M, Padubidri, JR, Pakshir, K, Pana, A, Panagiotakos, D, Panda-Jonas, S, Alkhayyat, M, Pardhan, S, Park, E-C, Park, E-K, Pashazadeh Kan, F, Patel, HK, Patel, JR, Pati, S, Pattanshetty, SM, Paudel, U, Pereira, DM, Almasi-Hashiani, A, Pereira, RB, Perianayagam, A, Pillay, JD, Pirouzpanah, S, Pishgar, F, Podder, I, Postma, MJ, Pourjafar, H, Prashant, A, Preotescu, L, Almasri, NA, Rabiee, M, Rabiee, N, Radfar, A, Radhakrishnan, RA, Radhakrishnan, V, Rafiee, A, Rahim, F, Rahimzadeh, S, Rahman, M, Rahman, MA, Al-Maweri, SAA, Rahmani, AM, Rajai, N, Rajesh, A, Rakovac, I, Ram, P, Ramezanzadeh, K, Ranabhat, K, Ranasinghe, P, Rao, CR, Rao, SJ, Almustanyir, S, Rawassizadeh, R, Razeghinia, MS, Renzaho, AMN, Rezaei, N, Rezapour, A, Roberts, TJ, Rodriguez, JAB, Rohloff, P, Romoli, M, Alonso, N, Ronfani, L, Roshandel, G, Rwegerera, GM, S, M, Sabour, S, Saddik, B, Saeed, U, Sahebkar, A, Sahoo, H, Salehi, S, Alvis-Guzman, N, Salem, MR, Salimzadeh, H, Samaei, M, Samy, AM, Sanabria, J, Sankararaman, S, Santric-Milicevic, MM, Sardiwalla, Y, Sarveazad, A, Sathian, B, Amu, H, Sawhney, M, Saylan, M, Schneider, IJC, Sekerija, M, Seylani, A, Shafaat, O, Shaghaghi, Z, Shaikh, MA, Shamsoddin, E, Shannawaz, M, Anbesu, EW, Sharma, R, Sheikh, A, Sheikhbahaei, S, Shetty, A, Shetty, JK, Shetty, PH, Shibuya, K, Shirkoohi, R, Shivakumar, KM, Shivarov, V, Ancuceanu, R, Siabani, S, Siddappa Malleshappa, SK, Silva, DAS, Singh, JA, Sintayehu, Y, Skryabin, VY, Skryabina, AA, Soeberg, MJ, Sofi-Mahmudi, A, Sotoudeh, H, Ansari, F, Steiropoulos, P, Straif, K, Subedi, R, Sufiyan, MB, Sultan, I, Sultana, S, Sur, D, Szerencsés, V, Szócska, M, Tabarés-Seisdedos, R, Ansari-Moghaddam, A, Tabuchi, T, Tadbiri, H, Taherkhani, A, Takahashi, K, Talaat, IM, Tan, K-K, Tat, VY, Tedla, BAA, Tefera, YG, Tehrani-Banihashemi, A, Antwi, MH, Temsah, M-H, Tesfay, FH, Tessema, GA, Thapar, R, Thavamani, A, Thoguluva Chandrasekar, V, Thomas, N, Tohidinik, HR, Touvier, M, Tovani-Palone, MR, Anvari, D, Traini, E, Tran, BX, Tran, KB, Tran, MTN, Tripathy, JP, Tusa, BS, Ullah, I, Ullah, S, Umapathi, KK, Unnikrishnan, B, Anyasodor, AE, Upadhyay, E, Vacante, M, Vaezi, M, Valadan Tahbaz, S, Velazquez, DZ, Veroux, M, Violante, FS, Vlassov, V, Vo, B, Volovici, V, Aqeel, M, Vu, GT, Waheed, Y, Wamai, RG, Ward, P, Wen, YF, Westerman, R, Winkler, AS, Yadav, L, Yahyazadeh Jabbari, SH, Yang, L, Arabloo, J, Yaya, S, Yazie, TSY, Yeshaw, Y, Yonemoto, N, Younis, MZ, Yousefi, Z, Yu, C, Yuce, D, Yunusa, I, Zadnik, V, Arab-Zozani, M, Zare, F, Zastrozhin, MS, Zastrozhina, A, Zhang, J, Zhong, C, Zhou, L, Zhu, C, Ziapour, A, Zimmermann, IR, Fitzmaurice, C, Aremu, O, Murray, CJL, Force, LM, Ariffin, H, Aripov, T, Arshad, M, Artaman, A, Arulappan, J, Asemi, Z, Asghari Jafarabadi, M, Ashraf, T, Atorkey, P, Aujayeb, A, Ausloos, M, Awedew, AF, Ayala Quintanilla, BP, Ayenew, T, Azab, MA, Azadnajafabad, S, Azari Jafari, A, Azarian, G, Azzam, AY, Badiye, AD, Bahadory, S, Baig, AA, Baker, JL, Balakrishnan, S, Banach, M, Bärnighausen, TW, Barone-Adesi, F, Barra, F, Barrow, A, Behzadifar, M, Belgaumi, UI, Bezabhe, WMM, Bezabih, YM, Bhagat, DS, Bhagavathula, AS, Bhardwaj, N, Bhardwaj, P, Bhaskar, S, and Bhattacharyya, K
- Abstract
Importance: The Global Burden of Diseases, Injuries, and Risk Factors Study 2019 (GBD 2019) provided systematic estimates of incidence, morbidity, and mortality to inform local and international efforts toward reducing cancer burden. Objective: To estimate cancer burden and trends globally for 204 countries and territories and by Sociodemographic Index (SDI) quintiles from 2010 to 2019. Evidence Review: The GBD 2019 estimation methods were used to describe cancer incidence, mortality, years lived with disability, years of life lost, and disability-adjusted life years (DALYs) in 2019 and over the past decade. Estimates are also provided by quintiles of the SDI, a composite measure of educational attainment, income per capita, and total fertility rate for those younger than 25 years. Estimates include 95% uncertainty intervals (UIs). Findings: In 2019, there were an estimated 23.6 million (95% UI, 22.2-24.9 million) new cancer cases (17.2 million when excluding nonmelanoma skin cancer) and 10.0 million (95% UI, 9.36-10.6 million) cancer deaths globally, with an estimated 250 million (235-264 million) DALYs due to cancer. Since 2010, these represented a 26.3% (95% UI, 20.3%-32.3%) increase in new cases, a 20.9% (95% UI, 14.2%-27.6%) increase in deaths, and a 16.0% (95% UI, 9.3%-22.8%) increase in DALYs. Among 22 groups of diseases and injuries in the GBD 2019 study, cancer was second only to cardiovascular diseases for the number of deaths, years of life lost, and DALYs globally in 2019. Cancer burden differed across SDI quintiles. The proportion of years lived with disability that contributed to DALYs increased with SDI, ranging from 1.4% (1.1%-1.8%) in the low SDI quintile to 5.7% (4.2%-7.1%) in the high SDI quintile. While the high SDI quintile had the highest number of new cases in 2019, the middle SDI quintile had the highest number of cancer deaths and DALYs. From 2010 to 2019, the largest percentage increase in the numbers of cases and deaths occurred in the low
- Published
- 2022
7. Cancer Incidence, Mortality, Years of Life Lost, Years Lived With Disability, and Disability-Adjusted Life Years for 29 Cancer Groups From 2010 to 2019:A Systematic Analysis for the Global Burden of Disease Study 2019
- Author
-
Global Burden of Disease 2019 Cancer Collaboration, Kocarnik, JM, Compton, K, Dean, FE, Fu, W, Gaw, BL, Harvey, JD, Henrikson, HJ, Lu, D, Pennini, A, Xu, R, Ababneh, E, Abbasi-Kangevari, M, Abbastabar, H, Abd-Elsalam, SM, Abdoli, A, Abedi, A, Abidi, H, Abolhassani, H, Adedeji, IA, Adnani, QES, Advani, SM, Afzal, MS, Aghaali, M, Ahinkorah, BO, Ahmad, S, Ahmad, T, Ahmadi, A, Ahmadi, S, Ahmed Rashid, T, Ahmed Salih, Y, Akalu, GT, Aklilu, A, Akram, T, Akunna, CJ, Al Hamad, H, Alahdab, F, Al-Aly, Z, Ali, S, Alimohamadi, Y, Alipour, V, Aljunid, SM, Alkhayyat, M, Almasi-Hashiani, A, Almasri, NA, Al-Maweri, SAA, Almustanyir, S, Alonso, N, Alvis-Guzman, N, Amu, H, Anbesu, EW, Ancuceanu, R, Ansari, F, Ansari-Moghaddam, A, Antwi, MH, Anvari, D, Anyasodor, AE, Aqeel, M, Arabloo, J, Arab-Zozani, M, Aremu, O, Ariffin, H, Aripov, T, Arshad, M, Artaman, A, Arulappan, J, Asemi, Z, Asghari Jafarabadi, M, Ashraf, T, Atorkey, P, Aujayeb, A, Ausloos, M, Awedew, AF, Ayala Quintanilla, BP, Ayenew, T, Azab, MA, Azadnajafabad, S, Azari Jafari, A, Azarian, G, Azzam, AY, Badiye, AD, Bahadory, S, Baig, AA, Baker, JL, Balakrishnan, S, Banach, M, Bärnighausen, TW, Barone-Adesi, F, Barra, F, Barrow, A, Behzadifar, M, Belgaumi, UI, Bezabhe, WMM, Bezabih, YM, Bhagat, DS, Bhagavathula, AS, Bhardwaj, N, Bhardwaj, P, Bhaskar, S, Bhattacharyya, K, Bhojaraja, VS, Bibi, S, Bijani, A, Biondi, A, Bisignano, C, Bjørge, T, Bleyer, A, Blyuss, O, Bolarinwa, OA, Bolla, SR, Braithwaite, D, Brar, A, Brenner, H, Bustamante-Teixeira, MT, Butt, NS, Butt, ZA, Caetano Dos Santos, FL, Cao, Y, Carreras, G, Catalá-López, F, Cembranel, F, Cerin, E, Cernigliaro, A, Chakinala, RC, Chattu, SK, Chattu, VK, Chaturvedi, P, Chimed-Ochir, O, Cho, DY, Christopher, DJ, Chu, D-T, Chung, MT, Conde, J, Cortés, S, Cortesi, PA, Costa, VM, Cunha, AR, Dadras, O, Dagnew, AB, Dahlawi, SMA, Dai, X, Dandona, L, Dandona, R, Darwesh, AM, Das Neves, J, De la Hoz, FP, Demis, AB, Denova-Gutiérrez, E, Dhamnetiya, D, Dhimal, ML, Dhimal, M, Dianatinasab, M, Diaz, D, Djalalinia, S, Do, HP, Doaei, S, Dorostkar, F, Dos Santos Figueiredo, FW, Driscoll, TR, Ebrahimi, H, Eftekharzadeh, S, El Tantawi, M, El-Abid, H, Elbarazi, I, Elhabashy, HR, Elhadi, M, El-Jaafary, SI, Eshrati, B, Eskandarieh, S, Esmaeilzadeh, F, Etemadi, A, Ezzikouri, S, Faisaluddin, M, Faraon, EJA, Fares, J, Farzadfar, F, Feroze, AH, Ferrero, S, Ferro Desideri, L, Filip, I, Fischer, F, Fisher, JL, Foroutan, M, Fukumoto, T, Gaal, PA, Gad, MM, Gadanya, MA, Gallus, S, Gaspar Fonseca, M, Getachew Obsa, A, Ghafourifard, M, Ghashghaee, A, Ghith, N, Gholamalizadeh, M, Gilani, SA, Ginindza, TG, Gizaw, ATT, Glasbey, JC, Golechha, M, Goleij, P, Gomez, RS, Gopalani, SV, Gorini, G, Goudarzi, H, Grosso, G, Gubari, MIM, Guerra, MR, Guha, A, Gunasekera, DS, Gupta, B, Gupta, VB, Gupta, VK, Gutiérrez, RA, Hafezi-Nejad, N, Haider, MR, Haj-Mirzaian, A, Halwani, R, Hamadeh, RR, Hameed, S, Hamidi, S, Hanif, A, Haque, S, Harlianto, NI, Haro, JM, Hasaballah, AI, Hassanipour, S, Hay, RJ, Hay, SI, Hayat, K, Heidari, G, Heidari, M, Herrera-Serna, BY, Herteliu, C, Hezam, K, Holla, R, Hossain, MM, Hossain, MBH, Hosseini, M-S, Hosseini, M, Hosseinzadeh, M, Hostiuc, M, Hostiuc, S, Househ, M, Hsairi, M, Huang, J, Hugo, FN, Hussain, R, Hussein, NR, Hwang, B-F, Iavicoli, I, Ibitoye, SE, Ida, F, Ikuta, KS, Ilesanmi, OS, Ilic, IM, Ilic, MD, Irham, LM, Islam, JY, Islam, RM, Islam, SMS, Ismail, NE, Isola, G, Iwagami, M, Jacob, L, Jain, V, Jakovljevic, MB, Javaheri, T, Jayaram, S, Jazayeri, SB, Jha, RP, Jonas, JB, Joo, T, Joseph, N, Joukar, F, Jürisson, M, Kabir, A, Kahrizi, D, Kalankesh, LR, Kalhor, R, Kaliyadan, F, Kalkonde, Y, Kamath, A, Kameran Al-Salihi, N, Kandel, H, Kapoor, N, Karch, A, Kasa, AS, Katikireddi, SV, Kauppila, JH, Kavetskyy, T, Kebede, SA, Keshavarz, P, Keykhaei, M, Khader, YS, Khalilov, R, Khan, G, Khan, M, Khan, MN, Khan, MAB, Khang, Y-H, Khater, AM, Khayamzadeh, M, Kim, GR, Kim, YJ, Kisa, A, Kisa, S, Kissimova-Skarbek, K, Kopec, JA, Koteeswaran, R, Koul, PA, Koulmane Laxminarayana, SL, Koyanagi, A, Kucuk Bicer, B, Kugbey, N, Kumar, GA, Kumar, N, Kurmi, OP, Kutluk, T, La Vecchia, C, Lami, FH, Landires, I, Lauriola, P, Lee, S-W, Lee, SWH, Lee, W-C, Lee, YH, Leigh, J, Leong, E, Li, J, Li, M-C, Liu, X, Loureiro, JA, Lunevicius, R, Magdy Abd El Razek, M, Majeed, A, Makki, A, Male, S, Malik, AA, Mansournia, MA, Martini, S, Masoumi, SZ, Mathur, P, McKee, M, Mehrotra, R, Mendoza, W, Menezes, RG, Mengesha, EW, Mesregah, MK, Mestrovic, T, Miao Jonasson, J, Miazgowski, B, Miazgowski, T, Michalek, IM, Miller, TR, Mirzaei, H, Mirzaei, HR, Misra, S, Mithra, P, Moghadaszadeh, M, Mohammad, KA, Mohammad, Y, Mohammadi, M, Mohammadi, SM, Mohammadian-Hafshejani, A, Mohammed, S, Moka, N, Mokdad, AH, Molokhia, M, Monasta, L, Moni, MA, Moosavi, MA, Moradi, Y, Moraga, P, Morgado-da-Costa, J, Morrison, SD, Mosapour, A, Mubarik, S, Mwanri, L, Nagarajan, AJ, Nagaraju, SP, Nagata, C, Naimzada, MD, Nangia, V, Naqvi, AA, Narasimha Swamy, S, Ndejjo, R, Nduaguba, SO, Negoi, I, Negru, SM, Neupane Kandel, S, Nguyen, CT, Nguyen, HLT, Niazi, RK, Nnaji, CA, Noor, NM, Nuñez-Samudio, V, Nzoputam, CI, Oancea, B, Ochir, C, Odukoya, OO, Ogbo, FA, Olagunju, AT, Olakunde, BO, Omar, E, Omar Bali, A, Omonisi, AEE, Ong, S, Onwujekwe, OE, Orru, H, Ortega-Altamirano, DV, Otstavnov, N, Otstavnov, SS, Owolabi, MO, P A, M, Padubidri, JR, Pakshir, K, Pana, A, Panagiotakos, D, Panda-Jonas, S, Pardhan, S, Park, E-C, Park, E-K, Pashazadeh Kan, F, Patel, HK, Patel, JR, Pati, S, Pattanshetty, SM, Paudel, U, Pereira, DM, Pereira, RB, Perianayagam, A, Pillay, JD, Pirouzpanah, S, Pishgar, F, Podder, I, Postma, MJ, Pourjafar, H, Prashant, A, Preotescu, L, Rabiee, M, Rabiee, N, Radfar, A, Radhakrishnan, RA, Radhakrishnan, V, Rafiee, A, Rahim, F, Rahimzadeh, S, Rahman, M, Rahman, MA, Rahmani, AM, Rajai, N, Rajesh, A, Rakovac, I, Ram, P, Ramezanzadeh, K, Ranabhat, K, Ranasinghe, P, Rao, CR, Rao, SJ, Rawassizadeh, R, Razeghinia, MS, Renzaho, AMN, Rezaei, N, Rezapour, A, Roberts, TJ, Rodriguez, JAB, Rohloff, P, Romoli, M, Ronfani, L, Roshandel, G, Rwegerera, GM, S, M, Sabour, S, Saddik, B, Saeed, U, Sahebkar, A, Sahoo, H, Salehi, S, Salem, MR, Salimzadeh, H, Samaei, M, Samy, AM, Sanabria, J, Sankararaman, S, Santric-Milicevic, MM, Sardiwalla, Y, Sarveazad, A, Sathian, B, Sawhney, M, Saylan, M, Schneider, IJC, Sekerija, M, Seylani, A, Shafaat, O, Shaghaghi, Z, Shaikh, MA, Shamsoddin, E, Shannawaz, M, Sharma, R, Sheikh, A, Sheikhbahaei, S, Shetty, A, Shetty, JK, Shetty, PH, Shibuya, K, Shirkoohi, R, Shivakumar, KM, Shivarov, V, Siabani, S, Siddappa Malleshappa, SK, Silva, DAS, Singh, JA, Sintayehu, Y, Skryabin, VY, Skryabina, AA, Soeberg, MJ, Sofi-Mahmudi, A, Sotoudeh, H, Steiropoulos, P, Straif, K, Subedi, R, Sufiyan, MB, Sultan, I, Sultana, S, Sur, D, Szerencsés, V, Szócska, M, Tabarés-Seisdedos, R, Tabuchi, T, Tadbiri, H, Taherkhani, A, Takahashi, K, Talaat, IM, Tan, K-K, Tat, VY, Tedla, BAA, Tefera, YG, Tehrani-Banihashemi, A, Temsah, M-H, Tesfay, FH, Tessema, GA, Thapar, R, Thavamani, A, Thoguluva Chandrasekar, V, Thomas, N, Tohidinik, HR, Touvier, M, Tovani-Palone, MR, Traini, E, Tran, BX, Tran, KB, Tran, MTN, Tripathy, JP, Tusa, BS, Ullah, I, Ullah, S, Umapathi, KK, Unnikrishnan, B, Upadhyay, E, Vacante, M, Vaezi, M, Valadan Tahbaz, S, Velazquez, DZ, Veroux, M, Violante, FS, Vlassov, V, Vo, B, Volovici, V, Vu, GT, Waheed, Y, Wamai, RG, Ward, P, Wen, YF, Westerman, R, Winkler, AS, Yadav, L, Yahyazadeh Jabbari, SH, Yang, L, Yaya, S, Yazie, TSY, Yeshaw, Y, Yonemoto, N, Younis, MZ, Yousefi, Z, Yu, C, Yuce, D, Yunusa, I, Zadnik, V, Zare, F, Zastrozhin, MS, Zastrozhina, A, Zhang, J, Zhong, C, Zhou, L, Zhu, C, Ziapour, A, Zimmermann, IR, Fitzmaurice, C, Murray, CJL, Force, LM, Value, Affordability and Sustainability (VALUE), Real World Studies in PharmacoEpidemiology, -Genetics, -Economics and -Therapy (PEGET), Microbes in Health and Disease (MHD), Kocarnik, J, Compton, K, Dean, F, Fu, W, Gaw, B, Harvey, J, Henrikson, H, Lu, D, Pennini, A, Xu, R, Ababneh, E, Abbasi-Kangevari, M, Abbastabar, H, Abd-Elsalam, S, Abdoli, A, Abedi, A, Abidi, H, Abolhassani, H, Adedeji, I, Adnani, Q, Advani, S, Afzal, M, Aghaali, M, Ahinkorah, B, Ahmad, S, Ahmad, T, Ahmadi, A, Ahmadi, S, Ahmed Rashid, T, Ahmed Salih, Y, Akalu, G, Aklilu, A, Akram, T, Akunna, C, Al Hamad, H, Alahdab, F, Al-Aly, Z, Ali, S, Alimohamadi, Y, Alipour, V, Aljunid, S, Alkhayyat, M, Almasi-Hashiani, A, Almasri, N, Al-Maweri, S, Almustanyir, S, Alonso, N, Alvis-Guzman, N, Amu, H, Anbesu, E, Ancuceanu, R, Ansari, F, Ansari-Moghaddam, A, Antwi, M, Anvari, D, Anyasodor, A, Aqeel, M, Arabloo, J, Arab-Zozani, M, Aremu, O, Ariffin, H, Aripov, T, Arshad, M, Artaman, A, Arulappan, J, Asemi, Z, Asghari Jafarabadi, M, Ashraf, T, Atorkey, P, Aujayeb, A, Ausloos, M, Awedew, A, Ayala Quintanilla, B, Ayenew, T, Azab, M, Azadnajafabad, S, Azari Jafari, A, Azarian, G, Azzam, A, Badiye, A, Bahadory, S, Baig, A, Baker, J, Balakrishnan, S, Banach, M, Barnighausen, T, Barone-Adesi, F, Barra, F, Barrow, A, Behzadifar, M, Belgaumi, U, Bezabhe, W, Bezabih, Y, Bhagat, D, Bhagavathula, A, Bhardwaj, N, Bhardwaj, P, Bhaskar, S, Bhattacharyya, K, Bhojaraja, V, Bibi, S, Bijani, A, Biondi, A, Bisignano, C, Bjorge, T, Bleyer, A, Blyuss, O, Bolarinwa, O, Bolla, S, Braithwaite, D, Brar, A, Brenner, H, Bustamante-Teixeira, M, Butt, N, Butt, Z, Caetano Dos Santos, F, Cao, Y, Carreras, G, Catala-Lopez, F, Cembranel, F, Cerin, E, Cernigliaro, A, Chakinala, R, Chattu, S, Chattu, V, Chaturvedi, P, Chimed-Ochir, O, Cho, D, Christopher, D, Chu, D, Chung, M, Conde, J, Cortes, S, Cortesi, P, Costa, V, Cunha, A, Dadras, O, Dagnew, A, Dahlawi, S, Dai, X, Dandona, L, Dandona, R, Darwesh, A, Das Neves, J, De La Hoz, F, Demis, A, Denova-Gutierrez, E, Dhamnetiya, D, Dhimal, M, Dianatinasab, M, Diaz, D, Djalalinia, S, Do, H, Doaei, S, Dorostkar, F, Dos Santos Figueiredo, F, Driscoll, T, Ebrahimi, H, Eftekharzadeh, S, El Tantawi, M, El-Abid, H, Elbarazi, I, Elhabashy, H, Elhadi, M, El-Jaafary, S, Eshrati, B, Eskandarieh, S, Esmaeilzadeh, F, Etemadi, A, Ezzikouri, S, Faisaluddin, M, Faraon, E, Fares, J, Farzadfar, F, Feroze, A, Ferrero, S, Ferro Desideri, L, Filip, I, Fischer, F, Fisher, J, Foroutan, M, Fukumoto, T, Gaal, P, Gad, M, Gadanya, M, Gallus, S, Gaspar Fonseca, M, Getachew Obsa, A, Ghafourifard, M, Ghashghaee, A, Ghith, N, Gholamalizadeh, M, Gilani, S, Ginindza, T, Gizaw, A, Glasbey, J, Golechha, M, Goleij, P, Gomez, R, Gopalani, S, Gorini, G, Goudarzi, H, Grosso, G, Gubari, M, Guerra, M, Guha, A, Gunasekera, D, Gupta, B, Gupta, V, Gutierrez, R, Hafezi-Nejad, N, Haider, M, Haj-Mirzaian, A, Halwani, R, Hamadeh, R, Hameed, S, Hamidi, S, Hanif, A, Haque, S, Harlianto, N, Haro, J, Hasaballah, A, Hassanipour, S, Hay, R, Hay, S, Hayat, K, Heidari, G, Heidari, M, Herrera-Serna, B, Herteliu, C, Hezam, K, Holla, R, Hossain, M, Hosseini, M, Hosseinzadeh, M, Hostiuc, M, Hostiuc, S, Househ, M, Hsairi, M, Huang, J, Hugo, F, Hussain, R, Hussein, N, Hwang, B, Iavicoli, I, Ibitoye, S, Ida, F, Ikuta, K, Ilesanmi, O, Ilic, I, Ilic, M, Irham, L, Islam, J, Islam, R, Islam, S, Ismail, N, Isola, G, Iwagami, M, Jacob, L, Jain, V, Jakovljevic, M, Javaheri, T, Jayaram, S, Jazayeri, S, Jha, R, Jonas, J, Joo, T, Joseph, N, Joukar, F, Jurisson, M, Kabir, A, Kahrizi, D, Kalankesh, L, Kalhor, R, Kaliyadan, F, Kalkonde, Y, Kamath, A, Kameran Al-Salihi, N, Kandel, H, Kapoor, N, Karch, A, Kasa, A, Katikireddi, S, Kauppila, J, Kavetskyy, T, Kebede, S, Keshavarz, P, Keykhaei, M, Khader, Y, Khalilov, R, Khan, G, Khan, M, Khang, Y, Khater, A, Khayamzadeh, M, Kim, G, Kim, Y, Kisa, A, Kisa, S, Kissimova-Skarbek, K, Kopec, J, Koteeswaran, R, Koul, P, Koulmane Laxminarayana, S, Koyanagi, A, Kucuk Bicer, B, Kugbey, N, Kumar, G, Kumar, N, Kurmi, O, Kutluk, T, La Vecchia, C, Lami, F, Landires, I, Lauriola, P, Lee, S, Lee, W, Lee, Y, Leigh, J, Leong, E, Li, J, Li, M, Liu, X, Loureiro, J, Lunevicius, R, Magdy Abd El Razek, M, Majeed, A, Makki, A, Male, S, Malik, A, Mansournia, M, Martini, S, Masoumi, S, Mathur, P, Mckee, M, Mehrotra, R, Mendoza, W, Menezes, R, Mengesha, E, Mesregah, M, Mestrovic, T, Miao Jonasson, J, Miazgowski, B, Miazgowski, T, Michalek, I, Miller, T, Mirzaei, H, Misra, S, Mithra, P, Moghadaszadeh, M, Mohammad, K, Mohammad, Y, Mohammadi, M, Mohammadi, S, Mohammadian-Hafshejani, A, Mohammed, S, Moka, N, Mokdad, A, Molokhia, M, Monasta, L, Moni, M, Moosavi, M, Moradi, Y, Moraga, P, Morgado-Da-Costa, J, Morrison, S, Mosapour, A, Mubarik, S, Mwanri, L, Nagarajan, A, Nagaraju, S, Nagata, C, Naimzada, M, Nangia, V, Naqvi, A, Narasimha Swamy, S, Ndejjo, R, Nduaguba, S, Negoi, I, Negru, S, Neupane Kandel, S, Nguyen, C, Nguyen, H, Niazi, R, Nnaji, C, Noor, N, Nunez-Samudio, V, Nzoputam, C, Oancea, B, Ochir, C, Odukoya, O, Ogbo, F, Olagunju, A, Olakunde, B, Omar, E, Omar Bali, A, Omonisi, A, Ong, S, Onwujekwe, O, Orru, H, Ortega-Altamirano, D, Otstavnov, N, Otstavnov, S, Owolabi, M, P A, M, Padubidri, J, Pakshir, K, Pana, A, Panagiotakos, D, Panda-Jonas, S, Pardhan, S, Park, E, Pashazadeh Kan, F, Patel, H, Patel, J, Pati, S, Pattanshetty, S, Paudel, U, Pereira, D, Pereira, R, Perianayagam, A, Pillay, J, Pirouzpanah, S, Pishgar, F, Podder, I, Postma, M, Pourjafar, H, Prashant, A, Preotescu, L, Rabiee, M, Rabiee, N, Radfar, A, Radhakrishnan, R, Radhakrishnan, V, Rafiee, A, Rahim, F, Rahimzadeh, S, Rahman, M, Rahmani, A, Rajai, N, Rajesh, A, Rakovac, I, Ram, P, Ramezanzadeh, K, Ranabhat, K, Ranasinghe, P, Rao, C, Rao, S, Rawassizadeh, R, Razeghinia, M, Renzaho, A, Rezaei, N, Rezapour, A, Roberts, T, Rodriguez, J, Rohloff, P, Romoli, M, Ronfani, L, Roshandel, G, Rwegerera, G, Manjula, S, Sabour, S, Saddik, B, Saeed, U, Sahebkar, A, Sahoo, H, Salehi, S, Salem, M, Salimzadeh, H, Samaei, M, Samy, A, Sanabria, J, Sankararaman, S, Santric-Milicevic, M, Sardiwalla, Y, Sarveazad, A, Sathian, B, Sawhney, M, Saylan, M, Schneider, I, Sekerija, M, Seylani, A, Shafaat, O, Shaghaghi, Z, Shaikh, M, Shamsoddin, E, Shannawaz, M, Sharma, R, Sheikh, A, Sheikhbahaei, S, Shetty, A, Shetty, J, Shetty, P, Shibuya, K, Shirkoohi, R, Shivakumar, K, Shivarov, V, Siabani, S, Siddappa Malleshappa, S, Silva, D, Singh, J, Sintayehu, Y, Skryabin, V, Skryabina, A, Soeberg, M, Sofi-Mahmudi, A, Sotoudeh, H, Steiropoulos, P, Straif, K, Subedi, R, Sufiyan, M, Sultan, I, Sultana, S, Sur, D, Szerencses, V, Szocska, M, Tabares-Seisdedos, R, Tabuchi, T, Tadbiri, H, Taherkhani, A, Takahashi, K, Talaat, I, Tan, K, Tat, V, Tedla, B, Tefera, Y, Tehrani-Banihashemi, A, Temsah, M, Tesfay, F, Tessema, G, Thapar, R, Thavamani, A, Thoguluva Chandrasekar, V, Thomas, N, Tohidinik, H, Touvier, M, Tovani-Palone, M, Traini, E, Tran, B, Tran, K, Tran, M, Tripathy, J, Tusa, B, Ullah, I, Ullah, S, Umapathi, K, Unnikrishnan, B, Upadhyay, E, Vacante, M, Vaezi, M, Valadan Tahbaz, S, Velazquez, D, Veroux, M, Violante, F, Vlassov, V, Vo, B, Volovici, V, Vu, G, Waheed, Y, Wamai, R, Ward, P, Wen, Y, Westerman, R, Winkler, A, Yadav, L, Yahyazadeh Jabbari, S, Yang, L, Yaya, S, Yazie, T, Yeshaw, Y, Yonemoto, N, Younis, M, Yousefi, Z, Yu, C, Yuce, D, Yunusa, I, Zadnik, V, Zare, F, Zastrozhin, M, Zastrozhina, A, Zhang, J, Zhong, C, Zhou, L, Zhu, C, Ziapour, A, Zimmermann, I, Fitzmaurice, C, Murray, C, Force, L, Kocarnik J.M., Compton K., Dean F.E., Fu W., Gaw B.L., Harvey J.D., Henrikson H.J., Lu D., Pennini A., Xu R., Ababneh E., Abbasi-Kangevari M., Abbastabar H., Abd-Elsalam S.M., Abdoli A., Abedi A., Abidi H., Abolhassani H., Adedeji I.A., Adnani Q.E.S., Advani S.M., Afzal M.S., Aghaali M., Ahinkorah B.O., Ahmad S., Ahmad T., Ahmadi A., Ahmadi S., Ahmed Rashid T., Ahmed Salih Y., Akalu G.T., Aklilu A., Akram T., Akunna C.J., Al Hamad H., Alahdab F., Al-Aly Z., Ali S., Alimohamadi Y., Alipour V., Aljunid S.M., Alkhayyat M., Almasi-Hashiani A., Almasri N.A., Al-Maweri S.A.A., Almustanyir S., Alonso N., Alvis-Guzman N., Amu H., Anbesu E.W., Ancuceanu R., Ansari F., Ansari-Moghaddam A., Antwi M.H., Anvari D., Anyasodor A.E., Aqeel M., Arabloo J., Arab-Zozani M., Aremu O., Ariffin H., Aripov T., Arshad M., Artaman A., Arulappan J., Asemi Z., Asghari Jafarabadi M., Ashraf T., Atorkey P., Aujayeb A., Ausloos M., Awedew A.F., Ayala Quintanilla B.P., Ayenew T., Azab M.A., Azadnajafabad S., Azari Jafari A., Azarian G., Azzam A.Y., Badiye A.D., Bahadory S., Baig A.A., Baker J.L., Balakrishnan S., Banach M., Barnighausen T.W., Barone-Adesi F., Barra F., Barrow A., Behzadifar M., Belgaumi U.I., Bezabhe W.M.M., Bezabih Y.M., Bhagat D.S., Bhagavathula A.S., Bhardwaj N., Bhardwaj P., Bhaskar S., Bhattacharyya K., Bhojaraja V.S., Bibi S., Bijani A., Biondi A., Bisignano C., Bjorge T., Bleyer A., Blyuss O., Bolarinwa O.A., Bolla S.R., Braithwaite D., Brar A., Brenner H., Bustamante-Teixeira M.T., Butt N.S., Butt Z.A., Caetano dos Santos F.L., Cao Y., Carreras G., Catala-Lopez F., Cembranel F., Cerin E., Cernigliaro A., Chakinala R.C., Chattu S.K., Chattu V.K., Chaturvedi P., Chimed-Ochir O., Cho D.Y., Christopher D.J., Chu D.-T., Chung M.T., Conde J., Cortes S., Cortesi P.A., Costa V.M., Cunha A.R., Dadras O., Dagnew A.B., Dahlawi S.M.A., Dai X., Dandona L., Dandona R., Darwesh A.M., das Neves J., De la Hoz F.P., Demis A.B., Denova-Gutierrez E., Dhamnetiya D., Dhimal M.L., Dhimal M., Dianatinasab M., Diaz D., Djalalinia S., Do H.P., Doaei S., Dorostkar F., dos Santos Figueiredo F.W., Driscoll T.R., Ebrahimi H., Eftekharzadeh S., El Tantawi M., El-Abid H., Elbarazi I., Elhabashy H.R., Elhadi M., El-Jaafary S.I., Eshrati B., Eskandarieh S., Esmaeilzadeh F., Etemadi A., Ezzikouri S., Faisaluddin M., Faraon E.J.A., Fares J., Farzadfar F., Feroze A.H., Ferrero S., Ferro Desideri L., Filip I., Fischer F., Fisher J.L., Foroutan M., Fukumoto T., Gaal P.A., Gad M.M., Gadanya M.A., Gallus S., Gaspar Fonseca M., Getachew Obsa A., Ghafourifard M., Ghashghaee A., Ghith N., Gholamalizadeh M., Gilani S.A., Ginindza T.G., Gizaw A.T.T., Glasbey J.C., Golechha M., Goleij P., Gomez R.S., Gopalani S.V., Gorini G., Goudarzi H., Grosso G., Gubari M.I.M., Guerra M.R., Guha A., Gunasekera D.S., Gupta B., Gupta V.B., Gupta V.K., Gutierrez R.A., Hafezi-Nejad N., Haider M.R., Haj-Mirzaian A., Halwani R., Hamadeh R.R., Hameed S., Hamidi S., Hanif A., Haque S., Harlianto N.I., Haro J.M., Hasaballah A.I., Hassanipour S., Hay R.J., Hay S.I., Hayat K., Heidari G., Heidari M., Herrera-Serna B.Y., Herteliu C., Hezam K., Holla R., Hossain M.M., Hossain M.B.H., Hosseini M.-S., Hosseini M., Hosseinzadeh M., Hostiuc M., Hostiuc S., Househ M., Hsairi M., Huang J., Hugo F.N., Hussain R., Hussein N.R., Hwang B.-F., Iavicoli I., Ibitoye S.E., Ida F., Ikuta K.S., Ilesanmi O.S., Ilic I.M., Ilic M.D., Irham L.M., Islam J.Y., Islam R.M., Islam S.M.S., Ismail N.E., Isola G., Iwagami M., Jacob L., Jain V., Jakovljevic M.B., Javaheri T., Jayaram S., Jazayeri S.B., Jha R.P., Jonas J.B., Joo T., Joseph N., Joukar F., Jurisson M., Kabir A., Kahrizi D., Kalankesh L.R., Kalhor R., Kaliyadan F., Kalkonde Y., Kamath A., Kameran Al-Salihi N., Kandel H., Kapoor N., Karch A., Kasa A.S., Katikireddi S.V., Kauppila J.H., Kavetskyy T., Kebede S.A., Keshavarz P., Keykhaei M., Khader Y.S., Khalilov R., Khan G., Khan M., Khan M.N., Khan M.A.B., Khang Y.-H., Khater A.M., Khayamzadeh M., Kim G.R., Kim Y.J., Kisa A., Kisa S., Kissimova-Skarbek K., Kopec J.A., Koteeswaran R., Koul P.A., Koulmane Laxminarayana S.L., Koyanagi A., Kucuk Bicer B., Kugbey N., Kumar G.A., Kumar N., Kurmi O.P., Kutluk T., La Vecchia C., Lami F.H., Landires I., Lauriola P., Lee S.-W., Lee S.W.H., Lee W.-C., Lee Y.H., Leigh J., Leong E., Li J., Li M.-C., Liu X., Loureiro J.A., Lunevicius R., Magdy Abd El Razek M., Majeed A., Makki A., Male S., Malik A.A., Mansournia M.A., Martini S., Masoumi S.Z., Mathur P., McKee M., Mehrotra R., Mendoza W., Menezes R.G., Mengesha E.W., Mesregah M.K., Mestrovic T., Miao Jonasson J., Miazgowski B., Miazgowski T., Michalek I.M., Miller T.R., Mirzaei H., Mirzaei H.R., Misra S., Mithra P., Moghadaszadeh M., Mohammad K.A., Mohammad Y., Mohammadi M., Mohammadi S.M., Mohammadian-Hafshejani A., Mohammed S., Moka N., Mokdad A.H., Molokhia M., Monasta L., Moni M.A., Moosavi M.A., Moradi Y., Moraga P., Morgado-Da-Costa J., Morrison S.D., Mosapour A., Mubarik S., Mwanri L., Nagarajan A.J., Nagaraju S.P., Nagata C., Naimzada M.D., Nangia V., Naqvi A.A., Narasimha Swamy S., Ndejjo R., Nduaguba S.O., Negoi I., Negru S.M., Neupane Kandel S., Nguyen C.T., Nguyen H.L.T., Niazi R.K., Nnaji C.A., Noor N.M., Nunez-Samudio V., Nzoputam C.I., Oancea B., Ochir C., Odukoya O.O., Ogbo F.A., Olagunju A.T., Olakunde B.O., Omar E., Omar Bali A.O., Omonisi A.E.E., Ong S., Onwujekwe O.E., Orru H., Ortega-Altamirano D.V., Otstavnov N., Otstavnov S.S., Owolabi M.O., P A M., Padubidri J.R., Pakshir K., Pana A., Panagiotakos D., Panda-Jonas S., Pardhan S., Park E.-C., Park E.-K., Pashazadeh Kan F., Patel H.K., Patel J.R., Pati S., Pattanshetty S.M., Paudel U., Pereira D.M., Pereira R.B., Perianayagam A., Pillay J.D., Pirouzpanah S., Pishgar F., Podder I., Postma M.J., Pourjafar H., Prashant A., Preotescu L., Rabiee M., Rabiee N., Radfar A., Radhakrishnan R.A., Radhakrishnan V., Rafiee A., Rahim F., Rahimzadeh S., Rahman M., Rahman M.A., Rahmani A.M., Rajai N., Rajesh A., Rakovac I., Ram P., Ramezanzadeh K., Ranabhat K., Ranasinghe P., Rao C.R., Rao S.J., Rawassizadeh R., Razeghinia M.S., Renzaho A.M.N., Rezaei N., Rezapour A., Roberts T.J., Rodriguez J.A.B., Rohloff P., Romoli M., Ronfani L., Roshandel G., Rwegerera G.M., Manjula S., Sabour S., Saddik B., Saeed U., Sahebkar A., Sahoo H., Salehi S., Salem M.R., Salimzadeh H., Samaei M., Samy A.M., Sanabria J., Sankararaman S., Santric-Milicevic M.M., Sardiwalla Y., Sarveazad A., Sathian B., Sawhney M., Saylan M., Schneider I.J.J., Sekerija M., Seylani A., Shafaat O., Shaghaghi Z., Shaikh M.A., Shamsoddin E., Shannawaz M., Sharma R., Sheikh A., Sheikhbahaei S., Shetty A., Shetty J.K., Shetty P.H., Shibuya K., Shirkoohi R., Shivakumar K.M., Shivarov V., Siabani S., Siddappa Malleshappa S.K., Silva D.A.S., Singh J.A., Sintayehu Y., Skryabin V.Y., Skryabina A.A., Soeberg M.J., Sofi-Mahmudi A., Sotoudeh H., Steiropoulos P., Straif K., Subedi R., Sufiyan M.B., Sultan I., Sultana S., Sur D., Szerencses V., Szocska M., Tabares-Seisdedos R., Tabuchi T., Tadbiri H., Taherkhani A., Takahashi K., Talaat I.M., Tan K.-K., Tat V.Y., Tedla B.A.A., Tefera Y.G., Tehrani-Banihashemi A., Temsah M., Tesfay F.H., Tessema G.A., Thapar R., Thavamani A., Thoguluva Chandrasekar V., Thomas N., Tohidinik H.R., Touvier M., Tovani-Palone M.R., Traini E., Tran B.X., Tran K.B., Tran M.T.N., Tripathy J.P., Tusa B.S., Ullah I., Ullah S., Umapathi K.K., Unnikrishnan B., Upadhyay E., Vacante M., Vaezi M., Valadan Tahbaz S., Velazquez D.Z., Veroux M., Violante F.S., Vlassov V., Vo B., Volovici V., Vu G.T., Waheed Y., Wamai R.G., Ward P., Wen Y.F., Westerman R., Winkler A.S., Yadav L., Yahyazadeh Jabbari S.H., Yang L., Yaya S., Yazie T.S.Y., Yeshaw Y., Yonemoto N., Younis M.Z., Yousefi Z., Yu C., Yuce D., Yunusa I., Zadnik V., Zare F., Zastrozhin M.S., Zastrozhina A., Zhang J., Zhong C., Zhou L., Zhu C., Ziapour A., Zimmermann I.R., Fitzmaurice C., Murray C.J.L., Force L.M., Bill & Melinda Gates Foundation, American Lebanese Syrian Associated Charities, Kuwait University (Kuwait), National University of Malaysia (Malasia), Alexander von Humboldt Foundation, Federal Ministry of Education & Research (Alemania), NIH - National Cancer Institute (NCI) (Estados Unidos), Unión Europea. Comisión Europea. European Research Council (ERC), Unión Europea. Comisión Europea. H2020, Novo Nordisk Foundation, National Health and Medical Research Council (Australia), Jazan University (Arabia Saudí), Romanian National Authority for Scientific Research and Innovation, Ministry of Education (Brasil), National Heart Foundation of Australia, Ministry of Education, Science and Technological Development (Serbia), NHS - Research Scotland (Reino Unido), Medical Research Council (Reino Unido), Scottish Government (Reino Unido), Jatiya Kabi Kazi Nazrul Islam University (Bangladesh), Xiamen University (Malasia), Manipal Academy of Higher Education (India), Sistema Nacional de Investigación (Panamá), Secretaría Nacional de Ciencia, Tecnología e Innovación (Panamá), King College London, National Health Service (Reino Unido), Government of the Russian Federation, Coordenação de Aperfeiçoamento de Pessoal de Nível Superior (Brasil), National Council for Scientific and Technological Development (Brasil), Cancer Prevention and Research Institute of Texas (Estados Unidos), Fundação para a Ciência e Tecnologia (Portugal), Neurosurgery, Kocarnik, J. M., Compton, K., Dean, F. E., Fu, W., Gaw, B. L., Harvey, J. D., Henrikson, H. J., Lu, D., Pennini, A., Xu, R., Ababneh, E., Abbasi-Kangevari, M., Abbastabar, H., Abd-Elsalam, S. M., Abdoli, A., Abedi, A., Abidi, H., Abolhassani, H., Adedeji, I. A., Adnani, Q. E. S., Advani, S. M., Afzal, M. S., Aghaali, M., Ahinkorah, B. O., Ahmad, S., Ahmad, T., Ahmadi, A., Ahmadi, S., Ahmed Rashid, T., Ahmed Salih, Y., Akalu, G. T., Aklilu, A., Akram, T., Akunna, C. J., Al Hamad, H., Alahdab, F., Al-Aly, Z., Ali, S., Alimohamadi, Y., Alipour, V., Aljunid, S. M., Alkhayyat, M., Almasi-Hashiani, A., Almasri, N. A., Al-Maweri, S. A. A., Almustanyir, S., Alonso, N., Alvis-Guzman, N., Amu, H., Anbesu, E. W., Ancuceanu, R., Ansari, F., Ansari-Moghaddam, A., Antwi, M. H., Anvari, D., Anyasodor, A. E., Aqeel, M., Arabloo, J., Arab-Zozani, M., Aremu, O., Ariffin, H., Aripov, T., Arshad, M., Artaman, A., Arulappan, J., Asemi, Z., Asghari Jafarabadi, M., Ashraf, T., Atorkey, P., Aujayeb, A., Ausloos, M., Awedew, A. F., Ayala Quintanilla, B. P., Ayenew, T., Azab, M. A., Azadnajafabad, S., Azari Jafari, A., Azarian, G., Azzam, A. Y., Badiye, A. D., Bahadory, S., Baig, A. A., Baker, J. L., Balakrishnan, S., Banach, M., Barnighausen, T. W., Barone-Adesi, F., Barra, F., Barrow, A., Behzadifar, M., Belgaumi, U. I., Bezabhe, W. M. M., Bezabih, Y. M., Bhagat, D. S., Bhagavathula, A. S., Bhardwaj, N., Bhardwaj, P., Bhaskar, S., Bhattacharyya, K., Bhojaraja, V. S., Bibi, S., Bijani, A., Biondi, A., Bisignano, C., Bjorge, T., Bleyer, A., Blyuss, O., Bolarinwa, O. A., Bolla, S. R., Braithwaite, D., Brar, A., Brenner, H., Bustamante-Teixeira, M. T., Butt, N. S., Butt, Z. A., Caetano Dos Santos, F. L., Cao, Y., Carreras, G., Catala-Lopez, F., Cembranel, F., Cerin, E., Cernigliaro, A., Chakinala, R. C., Chattu, S. K., Chattu, V. K., Chaturvedi, P., Chimed-Ochir, O., Cho, D. Y., Christopher, D. J., Chu, D. -T., Chung, M. T., Conde, J., Cortes, S., Cortesi, P. A., Costa, V. M., Cunha, A. R., Dadras, O., Dagnew, A. B., Dahlawi, S. M. A., Dai, X., Dandona, L., Dandona, R., Darwesh, A. M., Das Neves, J., De La Hoz, F. P., Demis, A. B., Denova-Gutierrez, E., Dhamnetiya, D., Dhimal, M. L., Dhimal, M., Dianatinasab, M., Diaz, D., Djalalinia, S., Do, H. P., Doaei, S., Dorostkar, F., Dos Santos Figueiredo, F. W., Driscoll, T. R., Ebrahimi, H., Eftekharzadeh, S., El Tantawi, M., El-Abid, H., Elbarazi, I., Elhabashy, H. R., Elhadi, M., El-Jaafary, S. I., Eshrati, B., Eskandarieh, S., Esmaeilzadeh, F., Etemadi, A., Ezzikouri, S., Faisaluddin, M., Faraon, E. J. A., Fares, J., Farzadfar, F., Feroze, A. H., Ferrero, S., Ferro Desideri, L., Filip, I., Fischer, F., Fisher, J. L., Foroutan, M., Fukumoto, T., Gaal, P. A., Gad, M. M., Gadanya, M. A., Gallus, S., Gaspar Fonseca, M., Getachew Obsa, A., Ghafourifard, M., Ghashghaee, A., Ghith, N., Gholamalizadeh, M., Gilani, S. A., Ginindza, T. G., Gizaw, A. T. T., Glasbey, J. C., Golechha, M., Goleij, P., Gomez, R. S., Gopalani, S. V., Gorini, G., Goudarzi, H., Grosso, G., Gubari, M. I. M., Guerra, M. R., Guha, A., Gunasekera, D. S., Gupta, B., Gupta, V. B., Gupta, V. K., Gutierrez, R. A., Hafezi-Nejad, N., Haider, M. R., Haj-Mirzaian, A., Halwani, R., Hamadeh, R. R., Hameed, S., Hamidi, S., Hanif, A., Haque, S., Harlianto, N. I., Haro, J. M., Hasaballah, A. I., Hassanipour, S., Hay, R. J., Hay, S. I., Hayat, K., Heidari, G., Heidari, M., Herrera-Serna, B. Y., Herteliu, C., Hezam, K., Holla, R., Hossain, M. M., Hossain, M. B. H., Hosseini, M. -S., Hosseini, M., Hosseinzadeh, M., Hostiuc, M., Hostiuc, S., Househ, M., Hsairi, M., Huang, J., Hugo, F. N., Hussain, R., Hussein, N. R., Hwang, B. -F., Iavicoli, I., Ibitoye, S. E., Ida, F., Ikuta, K. S., Ilesanmi, O. S., Ilic, I. M., Ilic, M. D., Irham, L. M., Islam, J. Y., Islam, R. M., Islam, S. M. S., Ismail, N. E., Isola, G., Iwagami, M., Jacob, L., Jain, V., Jakovljevic, M. B., Javaheri, T., Jayaram, S., Jazayeri, S. B., Jha, R. P., Jonas, J. B., Joo, T., Joseph, N., Joukar, F., Jurisson, M., Kabir, A., Kahrizi, D., Kalankesh, L. R., Kalhor, R., Kaliyadan, F., Kalkonde, Y., Kamath, A., Kameran Al-Salihi, N., Kandel, H., Kapoor, N., Karch, A., Kasa, A. S., Katikireddi, S. V., Kauppila, J. H., Kavetskyy, T., Kebede, S. A., Keshavarz, P., Keykhaei, M., Khader, Y. S., Khalilov, R., Khan, G., Khan, M., Khan, M. N., Khan, M. A. B., Khang, Y. -H., Khater, A. M., Khayamzadeh, M., Kim, G. R., Kim, Y. J., Kisa, A., Kisa, S., Kissimova-Skarbek, K., Kopec, J. A., Koteeswaran, R., Koul, P. A., Koulmane Laxminarayana, S. L., Koyanagi, A., Kucuk Bicer, B., Kugbey, N., Kumar, G. A., Kumar, N., Kurmi, O. P., Kutluk, T., La Vecchia, C., Lami, F. H., Landires, I., Lauriola, P., Lee, S. -W., Lee, S. W. H., Lee, W. -C., Lee, Y. H., Leigh, J., Leong, E., Li, J., Li, M. -C., Liu, X., Loureiro, J. A., Lunevicius, R., Magdy Abd El Razek, M., Majeed, A., Makki, A., Male, S., Malik, A. A., Mansournia, M. A., Martini, S., Masoumi, S. Z., Mathur, P., Mckee, M., Mehrotra, R., Mendoza, W., Menezes, R. G., Mengesha, E. W., Mesregah, M. K., Mestrovic, T., Miao Jonasson, J., Miazgowski, B., Miazgowski, T., Michalek, I. M., Miller, T. R., Mirzaei, H., Mirzaei, H. R., Misra, S., Mithra, P., Moghadaszadeh, M., Mohammad, K. A., Mohammad, Y., Mohammadi, M., Mohammadi, S. M., Mohammadian-Hafshejani, A., Mohammed, S., Moka, N., Mokdad, A. H., Molokhia, M., Monasta, L., Moni, M. A., Moosavi, M. A., Moradi, Y., Moraga, P., Morgado-Da-Costa, J., Morrison, S. D., Mosapour, A., Mubarik, S., Mwanri, L., Nagarajan, A. J., Nagaraju, S. P., Nagata, C., Naimzada, M. D., Nangia, V., Naqvi, A. A., Narasimha Swamy, S., Ndejjo, R., Nduaguba, S. O., Negoi, I., Negru, S. M., Neupane Kandel, S., Nguyen, C. T., Nguyen, H. L. T., Niazi, R. K., Nnaji, C. A., Noor, N. M., Nunez-Samudio, V., Nzoputam, C. I., Oancea, B., Ochir, C., Odukoya, O. O., Ogbo, F. A., Olagunju, A. T., Olakunde, B. O., Omar, E., Omar Bali, A., Omonisi, A. E. E., Ong, S., Onwujekwe, O. E., Orru, H., Ortega-Altamirano, D. V., Otstavnov, N., Otstavnov, S. S., Owolabi, M. O., P A, M., Padubidri, J. R., Pakshir, K., Pana, A., Panagiotakos, D., Panda-Jonas, S., Pardhan, S., Park, E. -C., Park, E. -K., Pashazadeh Kan, F., Patel, H. K., Patel, J. R., Pati, S., Pattanshetty, S. M., Paudel, U., Pereira, D. M., Pereira, R. B., Perianayagam, A., Pillay, J. D., Pirouzpanah, S., Pishgar, F., Podder, I., Postma, M. J., Pourjafar, H., Prashant, A., Preotescu, L., Rabiee, M., Rabiee, N., Radfar, A., Radhakrishnan, R. A., Radhakrishnan, V., Rafiee, A., Rahim, F., Rahimzadeh, S., Rahman, M., Rahman, M. A., Rahmani, A. M., Rajai, N., Rajesh, A., Rakovac, I., Ram, P., Ramezanzadeh, K., Ranabhat, K., Ranasinghe, P., Rao, C. R., Rao, S. J., Rawassizadeh, R., Razeghinia, M. S., Renzaho, A. M. N., Rezaei, N., Rezapour, A., Roberts, T. J., Rodriguez, J. A. B., Rohloff, P., Romoli, M., Ronfani, L., Roshandel, G., Rwegerera, G. M., Manjula, S., Sabour, S., Saddik, B., Saeed, U., Sahebkar, A., Sahoo, H., Salehi, S., Salem, M. R., Salimzadeh, H., Samaei, M., Samy, A. M., Sanabria, J., Sankararaman, S., Santric-Milicevic, M. M., Sardiwalla, Y., Sarveazad, A., Sathian, B., Sawhney, M., Saylan, M., Schneider, I. J. C., Sekerija, M., Seylani, A., Shafaat, O., Shaghaghi, Z., Shaikh, M. A., Shamsoddin, E., Shannawaz, M., Sharma, R., Sheikh, A., Sheikhbahaei, S., Shetty, A., Shetty, J. K., Shetty, P. H., Shibuya, K., Shirkoohi, R., Shivakumar, K. M., Shivarov, V., Siabani, S., Siddappa Malleshappa, S. K., Silva, D. A. S., Singh, J. A., Sintayehu, Y., Skryabin, V. Y., Skryabina, A. A., Soeberg, M. J., Sofi-Mahmudi, A., Sotoudeh, H., Steiropoulos, P., Straif, K., Subedi, R., Sufiyan, M. B., Sultan, I., Sultana, S., Sur, D., Szerencses, V., Szocska, M., Tabares-Seisdedos, R., Tabuchi, T., Tadbiri, H., Taherkhani, A., Takahashi, K., Talaat, I. M., Tan, K. -K., Tat, V. Y., Tedla, B. A. A., Tefera, Y. G., Tehrani-Banihashemi, A., Temsah, M. -H., Tesfay, F. H., Tessema, G. A., Thapar, R., Thavamani, A., Thoguluva Chandrasekar, V., Thomas, N., Tohidinik, H. R., Touvier, M., Tovani-Palone, M. R., Traini, E., Tran, B. X., Tran, K. B., Tran, M. T. N., Tripathy, J. P., Tusa, B. S., Ullah, I., Ullah, S., Umapathi, K. K., Unnikrishnan, B., Upadhyay, E., Vacante, M., Vaezi, M., Valadan Tahbaz, S., Velazquez, D. Z., Veroux, M., Violante, F. S., Vlassov, V., Vo, B., Volovici, V., Vu, G. T., Waheed, Y., Wamai, R. G., Ward, P., Wen, Y. F., Westerman, R., Winkler, A. S., Yadav, L., Yahyazadeh Jabbari, S. H., Yang, L., Yaya, S., Yazie, T. S. Y., Yeshaw, Y., Yonemoto, N., Younis, M. Z., Yousefi, Z., Yu, C., Yuce, D., Yunusa, I., Zadnik, V., Zare, F., Zastrozhin, M. S., Zastrozhina, A., Zhang, J., Zhong, C., Zhou, L., Zhu, C., Ziapour, A., Zimmermann, I. R., Fitzmaurice, C., Murray, C. J. L., and Force, L. M.
- Subjects
Cancer Research ,GBD ,195 COUNTRIES ,Global Health ,1117 Public Health and Health Services ,Global Burden of Disease ,SDG 3 - Good Health and Well-being ,WORLDWIDE ,Risk Factors ,Neoplasms ,SURVEILLANCE ,SUPPORT ,Global Burden of Disease 2019 Cancer Collaboration ,Prevalence ,Online First ,cancer ,Humans ,1112 Oncology and Carcinogenesis ,public health, cancer, burden of diseases ,PROGRESS ,Original Investigation ,Global burden ,Science & Technology ,CHALLENGES ,Research ,Incidence ,Medisinske Fag: 700::Klinisk medisinske fag: 750::Onkologi: 762 [VDP] ,COVID-19 ,1112 Oncology and Carcinogenesis, 1117 Public Health and Health Services ,Disability-Adjusted Life Years ,mortality ,STATISTICS ,Oncology ,Cancer Incidence, Mortality, Years of Life Lost, Years Lived With Disability, and Disability-Adjusted Life Years for 29 Cancer Groups From 2010 to 2019 A Systematic Analysis for the Global Burden of Disease Study 2019 ,HEALTH-CARE ,TERRITORIES ,Quality-Adjusted Life Years ,Life Sciences & Biomedicine ,Comments - Abstract
Key Points Question What was the burden of cancer globally and across Sociodemographic Index (SDI) groupings in 2019, and how has incidence, morbidity, and mortality changed since 2010? Findings In this systematic analysis, there were 23.6 million new global cancer cases in 2019 (17.2 million when excluding those with nonmelanoma skin cancer), 10.0 million cancer deaths, and an estimated 250 million disability-adjusted life years estimated to be due to cancer; since 2010, these represent increases of 26.3%, 20.9%, and 16.0%, respectively. Absolute cancer burden increased in all SDI quintiles since 2010, but the largest percentage increases occurred in the low and low-middle SDI quintiles. Meanings The study results suggest that increased cancer prevention and control efforts are needed to equitably address the evolving and increasing burden of cancer across the SDI spectrum., Importance The Global Burden of Diseases, Injuries, and Risk Factors Study 2019 (GBD 2019) provided systematic estimates of incidence, morbidity, and mortality to inform local and international efforts toward reducing cancer burden. Objective To estimate cancer burden and trends globally for 204 countries and territories and by Sociodemographic Index (SDI) quintiles from 2010 to 2019. Evidence Review The GBD 2019 estimation methods were used to describe cancer incidence, mortality, years lived with disability, years of life lost, and disability-adjusted life years (DALYs) in 2019 and over the past decade. Estimates are also provided by quintiles of the SDI, a composite measure of educational attainment, income per capita, and total fertility rate for those younger than 25 years. Estimates include 95% uncertainty intervals (UIs). Findings In 2019, there were an estimated 23.6 million (95% UI, 22.2-24.9 million) new cancer cases (17.2 million when excluding nonmelanoma skin cancer) and 10.0 million (95% UI, 9.36-10.6 million) cancer deaths globally, with an estimated 250 million (235-264 million) DALYs due to cancer. Since 2010, these represented a 26.3% (95% UI, 20.3%-32.3%) increase in new cases, a 20.9% (95% UI, 14.2%-27.6%) increase in deaths, and a 16.0% (95% UI, 9.3%-22.8%) increase in DALYs. Among 22 groups of diseases and injuries in the GBD 2019 study, cancer was second only to cardiovascular diseases for the number of deaths, years of life lost, and DALYs globally in 2019. Cancer burden differed across SDI quintiles. The proportion of years lived with disability that contributed to DALYs increased with SDI, ranging from 1.4% (1.1%-1.8%) in the low SDI quintile to 5.7% (4.2%-7.1%) in the high SDI quintile. While the high SDI quintile had the highest number of new cases in 2019, the middle SDI quintile had the highest number of cancer deaths and DALYs. From 2010 to 2019, the largest percentage increase in the numbers of cases and deaths occurred in the low and low-middle SDI quintiles. Conclusions and Relevance The results of this systematic analysis suggest that the global burden of cancer is substantial and growing, with burden differing by SDI. These results provide comprehensive and comparable estimates that can potentially inform efforts toward equitable cancer control around the world., The Global Burden of Diseases, Injuries, and Risk Factors Study 2019 examines cancer burden and trends globally for 204 countries and territories and by Socio-demographic Index quintiles from 2010 to 2019.
- Published
- 2022
- Full Text
- View/download PDF
8. Results of the Seventh Scientific Workshop of ECCO: Precision Medicine in IBD—Disease Outcome and Response to Therapy
- Author
-
Verstockt, B, Noor, NM, Marigorta, UM, Pavlidis, P, Deepak, P, Ungaro, RC, and Scientific Workshop Steering Committee
- Subjects
Precision medicine ,personalised medicine ,inflammatory bowel diseases ,disease prognosis ,disease outcome ,response to therapy ,digestive system diseases - Abstract
Inflammatory bowel diseases [IBD] are a heterogeneous spectrum with two extreme phenotypes, Crohn’s disease [CD] and ulcerative colitis [UC], which both represent numerous phenotypical variations. Hence, we should no longer approach all IBD patients similarly, but rather aim to rethink clinical classifications and modify treatment algorithms to usher in a new era of precision medicine in IBD. This scientific ECCO workshop aims to provide a state-of-the-art overview on prognostic and predictive markers, shed light on key questions in biomarker development, propose best practices in IBD biomarker development [including trial design], and discuss the potential for multi-omic data integration to help drive further advances to make precision medicine a reality in IBD.
- Published
- 2021
9. Cancer Incidence, Mortality, Years of Life Lost, Years Lived With Disability, and Disability-Adjusted Life Years for 29 Cancer Groups From 2010 to 2019: A Systematic Analysis for the Global Burden of Disease Study 2019.
- Author
-
Global Burden of Disease 2019 Cancer Collaboration, Kocarnik, JM, Compton, K, Dean, FE, Fu, W, Gaw, BL, Harvey, JD, Henrikson, HJ, Lu, D, Pennini, A, Xu, R, Ababneh, E, Abbasi-Kangevari, M, Abbastabar, H, Abd-Elsalam, SM, Abdoli, A, Abedi, A, Abidi, H, Abolhassani, H, Adedeji, IA, Adnani, QES, Advani, SM, Afzal, MS, Aghaali, M, Ahinkorah, BO, Ahmad, S, Ahmad, T, Ahmadi, A, Ahmadi, S, Ahmed Rashid, T, Ahmed Salih, Y, Akalu, GT, Aklilu, A, Akram, T, Akunna, CJ, Al Hamad, H, Alahdab, F, Al-Aly, Z, Ali, S, Alimohamadi, Y, Alipour, V, Aljunid, SM, Alkhayyat, M, Almasi-Hashiani, A, Almasri, NA, Al-Maweri, SAA, Almustanyir, S, Alonso, N, Alvis-Guzman, N, Amu, H, Anbesu, EW, Ancuceanu, R, Ansari, F, Ansari-Moghaddam, A, Antwi, MH, Anvari, D, Anyasodor, AE, Aqeel, M, Arabloo, J, Arab-Zozani, M, Aremu, O, Ariffin, H, Aripov, T, Arshad, M, Artaman, A, Arulappan, J, Asemi, Z, Asghari Jafarabadi, M, Ashraf, T, Atorkey, P, Aujayeb, A, Ausloos, M, Awedew, AF, Ayala Quintanilla, BP, Ayenew, T, Azab, MA, Azadnajafabad, S, Azari Jafari, A, Azarian, G, Azzam, AY, Badiye, AD, Bahadory, S, Baig, AA, Baker, JL, Balakrishnan, S, Banach, M, Bärnighausen, TW, Barone-Adesi, F, Barra, F, Barrow, A, Behzadifar, M, Belgaumi, UI, Bezabhe, WMM, Bezabih, YM, Bhagat, DS, Bhagavathula, AS, Bhardwaj, N, Bhardwaj, P, Bhaskar, S, Bhattacharyya, K, Bhojaraja, VS, Bibi, S, Bijani, A, Biondi, A, Bisignano, C, Bjørge, T, Bleyer, A, Blyuss, O, Bolarinwa, OA, Bolla, SR, Braithwaite, D, Brar, A, Brenner, H, Bustamante-Teixeira, MT, Butt, NS, Butt, ZA, Caetano Dos Santos, FL, Cao, Y, Carreras, G, Catalá-López, F, Cembranel, F, Cerin, E, Cernigliaro, A, Chakinala, RC, Chattu, SK, Chattu, VK, Chaturvedi, P, Chimed-Ochir, O, Cho, DY, Christopher, DJ, Chu, D-T, Chung, MT, Conde, J, Cortés, S, Cortesi, PA, Costa, VM, Cunha, AR, Dadras, O, Dagnew, AB, Dahlawi, SMA, Dai, X, Dandona, L, Dandona, R, Darwesh, AM, das Neves, J, De la Hoz, FP, Demis, AB, Denova-Gutiérrez, E, Dhamnetiya, D, Dhimal, ML, Dhimal, M, Dianatinasab, M, Diaz, D, Djalalinia, S, Do, HP, Doaei, S, Dorostkar, F, Dos Santos Figueiredo, FW, Driscoll, TR, Ebrahimi, H, Eftekharzadeh, S, El Tantawi, M, El-Abid, H, Elbarazi, I, Elhabashy, HR, Elhadi, M, El-Jaafary, SI, Eshrati, B, Eskandarieh, S, Esmaeilzadeh, F, Etemadi, A, Ezzikouri, S, Faisaluddin, M, Faraon, EJA, Fares, J, Farzadfar, F, Feroze, AH, Ferrero, S, Ferro Desideri, L, Filip, I, Fischer, F, Fisher, JL, Foroutan, M, Fukumoto, T, Gaal, PA, Gad, MM, Gadanya, MA, Gallus, S, Gaspar Fonseca, M, Getachew Obsa, A, Ghafourifard, M, Ghashghaee, A, Ghith, N, Gholamalizadeh, M, Gilani, SA, Ginindza, TG, Gizaw, ATT, Glasbey, JC, Golechha, M, Goleij, P, Gomez, RS, Gopalani, SV, Gorini, G, Goudarzi, H, Grosso, G, Gubari, MIM, Guerra, MR, Guha, A, Gunasekera, DS, Gupta, B, Gupta, VB, Gupta, VK, Gutiérrez, RA, Hafezi-Nejad, N, Haider, MR, Haj-Mirzaian, A, Halwani, R, Hamadeh, RR, Hameed, S, Hamidi, S, Hanif, A, Haque, S, Harlianto, NI, Haro, JM, Hasaballah, AI, Hassanipour, S, Hay, RJ, Hay, SI, Hayat, K, Heidari, G, Heidari, M, Herrera-Serna, BY, Herteliu, C, Hezam, K, Holla, R, Hossain, MM, Hossain, MBH, Hosseini, M-S, Hosseini, M, Hosseinzadeh, M, Hostiuc, M, Hostiuc, S, Househ, M, Hsairi, M, Huang, J, Hugo, FN, Hussain, R, Hussein, NR, Hwang, B-F, Iavicoli, I, Ibitoye, SE, Ida, F, Ikuta, KS, Ilesanmi, OS, Ilic, IM, Ilic, MD, Irham, LM, Islam, JY, Islam, RM, Islam, Shariful, Ismail, NE, Isola, G, Iwagami, M, Jacob, L, Jain, V, Jakovljevic, MB, Javaheri, T, Jayaram, S, Jazayeri, SB, Jha, RP, Jonas, JB, Joo, T, Joseph, N, Joukar, F, Jürisson, M, Kabir, A, Kahrizi, D, Kalankesh, LR, Kalhor, R, Kaliyadan, F, Kalkonde, Y, Kamath, A, Kameran Al-Salihi, N, Kandel, H, Kapoor, N, Karch, A, Kasa, AS, Katikireddi, SV, Kauppila, JH, Kavetskyy, T, Kebede, SA, Keshavarz, P, Keykhaei, M, Khader, YS, Khalilov, R, Khan, G, Khan, M, Khan, MN, Khan, MAB, Khang, Y-H, Khater, AM, Khayamzadeh, M, Kim, GR, Kim, YJ, Kisa, A, Kisa, S, Kissimova-Skarbek, K, Kopec, JA, Koteeswaran, R, Koul, PA, Koulmane Laxminarayana, SL, Koyanagi, A, Kucuk Bicer, B, Kugbey, N, Kumar, GA, Kumar, N, Kurmi, OP, Kutluk, T, La Vecchia, C, Lami, FH, Landires, I, Lauriola, P, Lee, S-W, Lee, SWH, Lee, W-C, Lee, YH, Leigh, J, Leong, E, Li, J, Li, M-C, Liu, X, Loureiro, JA, Lunevicius, R, Magdy Abd El Razek, M, Majeed, A, Makki, A, Male, S, Malik, AA, Mansournia, MA, Martini, S, Masoumi, SZ, Mathur, P, McKee, M, Mehrotra, R, Mendoza, W, Menezes, RG, Mengesha, EW, Mesregah, MK, Mestrovic, T, Miao Jonasson, J, Miazgowski, B, Miazgowski, T, Michalek, IM, Miller, TR, Mirzaei, H, Mirzaei, HR, Misra, S, Mithra, P, Moghadaszadeh, M, Mohammad, KA, Mohammad, Y, Mohammadi, M, Mohammadi, SM, Mohammadian-Hafshejani, A, Mohammed, S, Moka, N, Mokdad, AH, Molokhia, M, Monasta, L, Moni, MA, Moosavi, MA, Moradi, Y, Moraga, P, Morgado-da-Costa, J, Morrison, SD, Mosapour, A, Mubarik, S, Mwanri, L, Nagarajan, AJ, Nagaraju, SP, Nagata, C, Naimzada, MD, Nangia, V, Naqvi, AA, Narasimha Swamy, S, Ndejjo, R, Nduaguba, SO, Negoi, I, Negru, SM, Neupane Kandel, S, Nguyen, CT, Nguyen, HLT, Niazi, RK, Nnaji, CA, Noor, NM, Nuñez-Samudio, V, Nzoputam, CI, Oancea, B, Ochir, C, Odukoya, OO, Ogbo, FA, Olagunju, AT, Olakunde, BO, Omar, E, Omar Bali, A, Omonisi, AEE, Ong, S, Onwujekwe, OE, Orru, H, Ortega-Altamirano, DV, Otstavnov, N, Otstavnov, SS, Owolabi, MO, P A, M, Padubidri, JR, Pakshir, K, Pana, A, Panagiotakos, D, Panda-Jonas, S, Pardhan, S, Park, E-C, Park, E-K, Pashazadeh Kan, F, Patel, HK, Patel, JR, Pati, S, Pattanshetty, SM, Paudel, U, Pereira, DM, Pereira, RB, Perianayagam, A, Pillay, JD, Pirouzpanah, S, Pishgar, F, Podder, I, Postma, MJ, Pourjafar, H, Prashant, A, Preotescu, L, Rabiee, M, Rabiee, N, Radfar, A, Radhakrishnan, RA, Radhakrishnan, V, Rafiee, A, Rahim, F, Rahimzadeh, S, Rahman, M, Rahman, MA, Rahmani, AM, Rajai, N, Rajesh, A, Rakovac, I, Ram, P, Ramezanzadeh, K, Ranabhat, K, Ranasinghe, P, Rao, CR, Rao, SJ, Rawassizadeh, R, Razeghinia, MS, Renzaho, AMN, Rezaei, N, Rezapour, A, Roberts, TJ, Rodriguez, JAB, Rohloff, P, Romoli, M, Ronfani, L, Roshandel, G, Rwegerera, GM, S, M, Sabour, S, Saddik, B, Saeed, U, Sahebkar, A, Sahoo, H, Salehi, S, Salem, MR, Salimzadeh, H, Samaei, M, Samy, AM, Sanabria, J, Sankararaman, S, Santric-Milicevic, MM, Sardiwalla, Y, Sarveazad, A, Sathian, B, Sawhney, M, Saylan, M, Schneider, IJC, Sekerija, M, Seylani, A, Shafaat, O, Shaghaghi, Z, Shaikh, MA, Shamsoddin, E, Shannawaz, M, Sharma, R, Sheikh, A, Sheikhbahaei, S, Shetty, A, Shetty, JK, Shetty, PH, Shibuya, K, Shirkoohi, R, Shivakumar, KM, Shivarov, V, Siabani, S, Siddappa Malleshappa, SK, Silva, DAS, Singh, JA, Sintayehu, Y, Skryabin, VY, Skryabina, AA, Soeberg, MJ, Sofi-Mahmudi, A, Sotoudeh, H, Steiropoulos, P, Straif, K, Subedi, R, Sufiyan, MB, Sultan, I, Sultana, S, Sur, D, Szerencsés, V, Szócska, M, Tabarés-Seisdedos, R, Tabuchi, T, Tadbiri, H, Taherkhani, A, Takahashi, K, Talaat, IM, Tan, K-K, Tat, VY, Tedla, BAA, Tefera, YG, Tehrani-Banihashemi, A, Temsah, M-H, Tesfay, FH, Tessema, GA, Thapar, R, Thavamani, A, Thoguluva Chandrasekar, V, Thomas, N, Tohidinik, HR, Touvier, M, Tovani-Palone, MR, Traini, E, Tran, BX, Tran, KB, Tran, MTN, Tripathy, JP, Tusa, BS, Ullah, I, Ullah, S, Umapathi, KK, Unnikrishnan, B, Upadhyay, E, Vacante, M, Vaezi, M, Valadan Tahbaz, S, Velazquez, DZ, Veroux, M, Violante, FS, Vlassov, V, Vo, B, Volovici, V, Vu, GT, Waheed, Y, Wamai, RG, Ward, P, Wen, YF, Westerman, R, Winkler, AS, Yadav, L, Yahyazadeh Jabbari, SH, Yang, L, Yaya, S, Yazie, TSY, Yeshaw, Y, Yonemoto, N, Younis, MZ, Yousefi, Z, Yu, C, Yuce, D, Yunusa, I, Zadnik, V, Zare, F, Zastrozhin, MS, Zastrozhina, A, Zhang, J, Zhong, C, Zhou, L, Zhu, C, Ziapour, A, Zimmermann, IR, Fitzmaurice, C, Murray, CJL, Force, LM, Global Burden of Disease 2019 Cancer Collaboration, Kocarnik, JM, Compton, K, Dean, FE, Fu, W, Gaw, BL, Harvey, JD, Henrikson, HJ, Lu, D, Pennini, A, Xu, R, Ababneh, E, Abbasi-Kangevari, M, Abbastabar, H, Abd-Elsalam, SM, Abdoli, A, Abedi, A, Abidi, H, Abolhassani, H, Adedeji, IA, Adnani, QES, Advani, SM, Afzal, MS, Aghaali, M, Ahinkorah, BO, Ahmad, S, Ahmad, T, Ahmadi, A, Ahmadi, S, Ahmed Rashid, T, Ahmed Salih, Y, Akalu, GT, Aklilu, A, Akram, T, Akunna, CJ, Al Hamad, H, Alahdab, F, Al-Aly, Z, Ali, S, Alimohamadi, Y, Alipour, V, Aljunid, SM, Alkhayyat, M, Almasi-Hashiani, A, Almasri, NA, Al-Maweri, SAA, Almustanyir, S, Alonso, N, Alvis-Guzman, N, Amu, H, Anbesu, EW, Ancuceanu, R, Ansari, F, Ansari-Moghaddam, A, Antwi, MH, Anvari, D, Anyasodor, AE, Aqeel, M, Arabloo, J, Arab-Zozani, M, Aremu, O, Ariffin, H, Aripov, T, Arshad, M, Artaman, A, Arulappan, J, Asemi, Z, Asghari Jafarabadi, M, Ashraf, T, Atorkey, P, Aujayeb, A, Ausloos, M, Awedew, AF, Ayala Quintanilla, BP, Ayenew, T, Azab, MA, Azadnajafabad, S, Azari Jafari, A, Azarian, G, Azzam, AY, Badiye, AD, Bahadory, S, Baig, AA, Baker, JL, Balakrishnan, S, Banach, M, Bärnighausen, TW, Barone-Adesi, F, Barra, F, Barrow, A, Behzadifar, M, Belgaumi, UI, Bezabhe, WMM, Bezabih, YM, Bhagat, DS, Bhagavathula, AS, Bhardwaj, N, Bhardwaj, P, Bhaskar, S, Bhattacharyya, K, Bhojaraja, VS, Bibi, S, Bijani, A, Biondi, A, Bisignano, C, Bjørge, T, Bleyer, A, Blyuss, O, Bolarinwa, OA, Bolla, SR, Braithwaite, D, Brar, A, Brenner, H, Bustamante-Teixeira, MT, Butt, NS, Butt, ZA, Caetano Dos Santos, FL, Cao, Y, Carreras, G, Catalá-López, F, Cembranel, F, Cerin, E, Cernigliaro, A, Chakinala, RC, Chattu, SK, Chattu, VK, Chaturvedi, P, Chimed-Ochir, O, Cho, DY, Christopher, DJ, Chu, D-T, Chung, MT, Conde, J, Cortés, S, Cortesi, PA, Costa, VM, Cunha, AR, Dadras, O, Dagnew, AB, Dahlawi, SMA, Dai, X, Dandona, L, Dandona, R, Darwesh, AM, das Neves, J, De la Hoz, FP, Demis, AB, Denova-Gutiérrez, E, Dhamnetiya, D, Dhimal, ML, Dhimal, M, Dianatinasab, M, Diaz, D, Djalalinia, S, Do, HP, Doaei, S, Dorostkar, F, Dos Santos Figueiredo, FW, Driscoll, TR, Ebrahimi, H, Eftekharzadeh, S, El Tantawi, M, El-Abid, H, Elbarazi, I, Elhabashy, HR, Elhadi, M, El-Jaafary, SI, Eshrati, B, Eskandarieh, S, Esmaeilzadeh, F, Etemadi, A, Ezzikouri, S, Faisaluddin, M, Faraon, EJA, Fares, J, Farzadfar, F, Feroze, AH, Ferrero, S, Ferro Desideri, L, Filip, I, Fischer, F, Fisher, JL, Foroutan, M, Fukumoto, T, Gaal, PA, Gad, MM, Gadanya, MA, Gallus, S, Gaspar Fonseca, M, Getachew Obsa, A, Ghafourifard, M, Ghashghaee, A, Ghith, N, Gholamalizadeh, M, Gilani, SA, Ginindza, TG, Gizaw, ATT, Glasbey, JC, Golechha, M, Goleij, P, Gomez, RS, Gopalani, SV, Gorini, G, Goudarzi, H, Grosso, G, Gubari, MIM, Guerra, MR, Guha, A, Gunasekera, DS, Gupta, B, Gupta, VB, Gupta, VK, Gutiérrez, RA, Hafezi-Nejad, N, Haider, MR, Haj-Mirzaian, A, Halwani, R, Hamadeh, RR, Hameed, S, Hamidi, S, Hanif, A, Haque, S, Harlianto, NI, Haro, JM, Hasaballah, AI, Hassanipour, S, Hay, RJ, Hay, SI, Hayat, K, Heidari, G, Heidari, M, Herrera-Serna, BY, Herteliu, C, Hezam, K, Holla, R, Hossain, MM, Hossain, MBH, Hosseini, M-S, Hosseini, M, Hosseinzadeh, M, Hostiuc, M, Hostiuc, S, Househ, M, Hsairi, M, Huang, J, Hugo, FN, Hussain, R, Hussein, NR, Hwang, B-F, Iavicoli, I, Ibitoye, SE, Ida, F, Ikuta, KS, Ilesanmi, OS, Ilic, IM, Ilic, MD, Irham, LM, Islam, JY, Islam, RM, Islam, Shariful, Ismail, NE, Isola, G, Iwagami, M, Jacob, L, Jain, V, Jakovljevic, MB, Javaheri, T, Jayaram, S, Jazayeri, SB, Jha, RP, Jonas, JB, Joo, T, Joseph, N, Joukar, F, Jürisson, M, Kabir, A, Kahrizi, D, Kalankesh, LR, Kalhor, R, Kaliyadan, F, Kalkonde, Y, Kamath, A, Kameran Al-Salihi, N, Kandel, H, Kapoor, N, Karch, A, Kasa, AS, Katikireddi, SV, Kauppila, JH, Kavetskyy, T, Kebede, SA, Keshavarz, P, Keykhaei, M, Khader, YS, Khalilov, R, Khan, G, Khan, M, Khan, MN, Khan, MAB, Khang, Y-H, Khater, AM, Khayamzadeh, M, Kim, GR, Kim, YJ, Kisa, A, Kisa, S, Kissimova-Skarbek, K, Kopec, JA, Koteeswaran, R, Koul, PA, Koulmane Laxminarayana, SL, Koyanagi, A, Kucuk Bicer, B, Kugbey, N, Kumar, GA, Kumar, N, Kurmi, OP, Kutluk, T, La Vecchia, C, Lami, FH, Landires, I, Lauriola, P, Lee, S-W, Lee, SWH, Lee, W-C, Lee, YH, Leigh, J, Leong, E, Li, J, Li, M-C, Liu, X, Loureiro, JA, Lunevicius, R, Magdy Abd El Razek, M, Majeed, A, Makki, A, Male, S, Malik, AA, Mansournia, MA, Martini, S, Masoumi, SZ, Mathur, P, McKee, M, Mehrotra, R, Mendoza, W, Menezes, RG, Mengesha, EW, Mesregah, MK, Mestrovic, T, Miao Jonasson, J, Miazgowski, B, Miazgowski, T, Michalek, IM, Miller, TR, Mirzaei, H, Mirzaei, HR, Misra, S, Mithra, P, Moghadaszadeh, M, Mohammad, KA, Mohammad, Y, Mohammadi, M, Mohammadi, SM, Mohammadian-Hafshejani, A, Mohammed, S, Moka, N, Mokdad, AH, Molokhia, M, Monasta, L, Moni, MA, Moosavi, MA, Moradi, Y, Moraga, P, Morgado-da-Costa, J, Morrison, SD, Mosapour, A, Mubarik, S, Mwanri, L, Nagarajan, AJ, Nagaraju, SP, Nagata, C, Naimzada, MD, Nangia, V, Naqvi, AA, Narasimha Swamy, S, Ndejjo, R, Nduaguba, SO, Negoi, I, Negru, SM, Neupane Kandel, S, Nguyen, CT, Nguyen, HLT, Niazi, RK, Nnaji, CA, Noor, NM, Nuñez-Samudio, V, Nzoputam, CI, Oancea, B, Ochir, C, Odukoya, OO, Ogbo, FA, Olagunju, AT, Olakunde, BO, Omar, E, Omar Bali, A, Omonisi, AEE, Ong, S, Onwujekwe, OE, Orru, H, Ortega-Altamirano, DV, Otstavnov, N, Otstavnov, SS, Owolabi, MO, P A, M, Padubidri, JR, Pakshir, K, Pana, A, Panagiotakos, D, Panda-Jonas, S, Pardhan, S, Park, E-C, Park, E-K, Pashazadeh Kan, F, Patel, HK, Patel, JR, Pati, S, Pattanshetty, SM, Paudel, U, Pereira, DM, Pereira, RB, Perianayagam, A, Pillay, JD, Pirouzpanah, S, Pishgar, F, Podder, I, Postma, MJ, Pourjafar, H, Prashant, A, Preotescu, L, Rabiee, M, Rabiee, N, Radfar, A, Radhakrishnan, RA, Radhakrishnan, V, Rafiee, A, Rahim, F, Rahimzadeh, S, Rahman, M, Rahman, MA, Rahmani, AM, Rajai, N, Rajesh, A, Rakovac, I, Ram, P, Ramezanzadeh, K, Ranabhat, K, Ranasinghe, P, Rao, CR, Rao, SJ, Rawassizadeh, R, Razeghinia, MS, Renzaho, AMN, Rezaei, N, Rezapour, A, Roberts, TJ, Rodriguez, JAB, Rohloff, P, Romoli, M, Ronfani, L, Roshandel, G, Rwegerera, GM, S, M, Sabour, S, Saddik, B, Saeed, U, Sahebkar, A, Sahoo, H, Salehi, S, Salem, MR, Salimzadeh, H, Samaei, M, Samy, AM, Sanabria, J, Sankararaman, S, Santric-Milicevic, MM, Sardiwalla, Y, Sarveazad, A, Sathian, B, Sawhney, M, Saylan, M, Schneider, IJC, Sekerija, M, Seylani, A, Shafaat, O, Shaghaghi, Z, Shaikh, MA, Shamsoddin, E, Shannawaz, M, Sharma, R, Sheikh, A, Sheikhbahaei, S, Shetty, A, Shetty, JK, Shetty, PH, Shibuya, K, Shirkoohi, R, Shivakumar, KM, Shivarov, V, Siabani, S, Siddappa Malleshappa, SK, Silva, DAS, Singh, JA, Sintayehu, Y, Skryabin, VY, Skryabina, AA, Soeberg, MJ, Sofi-Mahmudi, A, Sotoudeh, H, Steiropoulos, P, Straif, K, Subedi, R, Sufiyan, MB, Sultan, I, Sultana, S, Sur, D, Szerencsés, V, Szócska, M, Tabarés-Seisdedos, R, Tabuchi, T, Tadbiri, H, Taherkhani, A, Takahashi, K, Talaat, IM, Tan, K-K, Tat, VY, Tedla, BAA, Tefera, YG, Tehrani-Banihashemi, A, Temsah, M-H, Tesfay, FH, Tessema, GA, Thapar, R, Thavamani, A, Thoguluva Chandrasekar, V, Thomas, N, Tohidinik, HR, Touvier, M, Tovani-Palone, MR, Traini, E, Tran, BX, Tran, KB, Tran, MTN, Tripathy, JP, Tusa, BS, Ullah, I, Ullah, S, Umapathi, KK, Unnikrishnan, B, Upadhyay, E, Vacante, M, Vaezi, M, Valadan Tahbaz, S, Velazquez, DZ, Veroux, M, Violante, FS, Vlassov, V, Vo, B, Volovici, V, Vu, GT, Waheed, Y, Wamai, RG, Ward, P, Wen, YF, Westerman, R, Winkler, AS, Yadav, L, Yahyazadeh Jabbari, SH, Yang, L, Yaya, S, Yazie, TSY, Yeshaw, Y, Yonemoto, N, Younis, MZ, Yousefi, Z, Yu, C, Yuce, D, Yunusa, I, Zadnik, V, Zare, F, Zastrozhin, MS, Zastrozhina, A, Zhang, J, Zhong, C, Zhou, L, Zhu, C, Ziapour, A, Zimmermann, IR, Fitzmaurice, C, Murray, CJL, and Force, LM
- Abstract
Importance: The Global Burden of Diseases, Injuries, and Risk Factors Study 2019 (GBD 2019) provided systematic estimates of incidence, morbidity, and mortality to inform local and international efforts toward reducing cancer burden. Objective: To estimate cancer burden and trends globally for 204 countries and territories and by Sociodemographic Index (SDI) quintiles from 2010 to 2019. Evidence Review: The GBD 2019 estimation methods were used to describe cancer incidence, mortality, years lived with disability, years of life lost, and disability-adjusted life years (DALYs) in 2019 and over the past decade. Estimates are also provided by quintiles of the SDI, a composite measure of educational attainment, income per capita, and total fertility rate for those younger than 25 years. Estimates include 95% uncertainty intervals (UIs). Findings: In 2019, there were an estimated 23.6 million (95% UI, 22.2-24.9 million) new cancer cases (17.2 million when excluding nonmelanoma skin cancer) and 10.0 million (95% UI, 9.36-10.6 million) cancer deaths globally, with an estimated 250 million (235-264 million) DALYs due to cancer. Since 2010, these represented a 26.3% (95% UI, 20.3%-32.3%) increase in new cases, a 20.9% (95% UI, 14.2%-27.6%) increase in deaths, and a 16.0% (95% UI, 9.3%-22.8%) increase in DALYs. Among 22 groups of diseases and injuries in the GBD 2019 study, cancer was second only to cardiovascular diseases for the number of deaths, years of life lost, and DALYs globally in 2019. Cancer burden differed across SDI quintiles. The proportion of years lived with disability that contributed to DALYs increased with SDI, ranging from 1.4% (1.1%-1.8%) in the low SDI quintile to 5.7% (4.2%-7.1%) in the high SDI quintile. While the high SDI quintile had the highest number of new cases in 2019, the middle SDI quintile had the highest number of cancer deaths and DALYs. From 2010 to 2019, the largest percentage increase in the numbers of cases and deaths occurred in the low
- Published
- 2021
10. Global, regional, and national progress towards Sustainable Development Goal 3.2 for neonatal and child health: all-cause and cause-specific mortality findings from the Global Burden of Disease Study 2019
- Author
-
Paulson, KR, Kamath, AM, Alam, T, Bienhoff, K, Abady, GG, Abbas, J, Abbasi-Kangevari, M, Abbastabar, H, Abd-Allah, F, Abd-Elsalam, SM, Abdoli, A, Abedi, A, Abolhassani, H, Abreu, LG, Abu-Gharbieh, E, Abu-Rmeileh, NME, Abushouk, A, Adamu, AL, Adebayo, OM, Adegbosin, AE, Adekanmbi, V, Adetokunboh, OO, Adeyinka, DA, Adsuar, JC, Afshari, K, Aghaali, M, Agudelo-Botero, M, Ahinkorah, BO, Ahmad, T, Ahmadi, K, Ahmed, MB, Aji, B, Akalu, Y, Akinyemi, OO, Aklilu, A, Al-Aly, Z, Alam, K, Alanezi, FM, Alanzi, TM, Alcalde-Rabanal, JE, Al-Eyadhy, A, Ali, T, Alicandro, G, Alif, SM, Alipour, V, Alizade, H, Aljunid, SM, Almasi-Hashiani, A, Almasri, NA, Al-Mekhlafi, HM, Alonso, J, Al-Raddadi, RM, Altirkawi, KA, Alumran, AK, Alvis-Guzman, N, Alvis-Zakzuk, NJ, Ameyaw, EK, Amini, S, Amini-Rarani, M, Amit, AML, Amugsi, DA, Ancuceanu, R, Anderlini, D, Andrei, CL, Ansari, F, Ansari-Moghaddam, A, Antonio, CAT, Antriyandarti, E, Anvari, D, Anwer, R, Aqeel, M, Arabloo, J, Arab-Zozani, M, Aripov, T, Arnlov, J, Artanti, KD, Arzani, A, Asaad, M, Asadi-Aliabadi, M, Asadi-Pooya, AA, Jafarabadi, MA, Athari, SS, Athari, SM, Atnafu, DD, Atreya, A, Atteraya, MS, Ausloos, M, Awan, AT, Quintanilla, BPA, Ayano, G, Ayanore, MA, Aynalem, YA, Azari, S, Azarian, G, Azene, ZN, Darshan, BB, Babaee, E, Badiye, AD, Baig, AA, Banach, M, Banik, PC, Barker-Collo, SL, Barqawi, HJ, Bassat, Q, Basu, S, Baune, BT, Bayati, M, Bedi, N, Beghi, E, Beghi, M, Bell, ML, Bendak, S, Bennett, DA, Bensenor, IM, Berhe, K, Berman, AE, Bezabih, YM, Bhagavathula, AS, Bhandari, D, Bhardwaj, N, Bhardwaj, P, Bhattacharyya, K, Bhattarai, S, Bhutta, ZA, Bikbov, B, Biondi, A, Birihane, BM, Biswas, RK, Bohlouli, S, Bragazzi, NL, Breusov, A, Brunoni, AR, Burkart, K, Nagaraja, SB, Busse, R, Butt, ZA, dos Santos, FLC, Cahuana-Hurtado, L, Camargos, P, Camera, LA, Cardenas, R, Carreras, G, Carrero, JJ, Carvalho, F, Castaldelli-Maia, JM, Castaneda-Orjuela, CA, Castelpietra, G, Cerin, E, Chang, J-C, Chanie, WF, Charan, J, Chatterjee, S, Chattu, SK, Chattu, VK, Chaturvedi, S, Chen, S, Cho, DY, Choi, J-YJ, Chu, D-T, Ciobanu, LG, Cirillo, M, Conde, J, Costa, VM, Couto, RAS, Dachew, BA, Dahlawi, SMA, Dai, H, Dai, X, Dandona, L, Dandona, R, Daneshpajouhnejad, P, Darmstadt, GL, Das, JK, Davila-Cervantes, CA, Davis, AC, Davletov, K, De la Hoz, FP, De Leo, D, Deeba, F, Denova-Gutierrez, E, Dervenis, N, Desalew, A, Deuba, K, Dey, S, Dharmaratne, SD, Dhingra, S, Dhungana, GP, da Silva, DD, Diaz, D, Dorostkar, F, Doshmangir, L, Dubljanin, E, Duraes, AR, Eagan, AW, Edinur, HA, Efendi, F, Eftekharzadeh, S, El Sayed, I, El Tantawi, M, Elbarazi, I, Elgendy, IY, El-Jaafary, S, Emami, A, Enany, S, Eyawo, O, Ezzikouri, S, Faris, PS, Farzadfar, F, Fattahi, N, Fauk, NK, Fazlzadeh, M, Feigin, VL, Ferede, TY, Fereshtehnejad, S-M, Fernandes, E, Ferrara, P, Filip, I, Fischer, F, Fisher, JL, Foigt, NA, Folayan, MO, Foroutan, M, Franklin, RC, Freitas, M, Friedman, SD, Fukumoto, T, Gad, MM, Gaidhane, AM, Gaidhane, S, Gaihre, S, Gallus, S, Garcia-Basteiro, AL, Garcia-Gordillo, M, Gardner, WM, Fonseca, MG, Gebremedhin, KB, Getacher, L, Ghashghaee, A, Gholamian, A, Gilani, SA, Gill, TK, Giussani, G, Gnedovskaya, E, Godinho, MA, Goel, A, Golechha, M, Gona, PN, Gopalani, SV, Goudarzi, H, Grivna, M, Gugnani, HC, Guido, D, Guimaraes, RA, Das Gupta, R, Gupta, R, Hafezi-Nejad, N, Haider, MR, Haj-Mirzaian, A, Hamidi, S, Hanif, A, Hankey, GJ, Hargono, A, Hasaballah, A, Hasan, MM, Hasan, SS, Hassan, A, Hassanipour, S, Hassankhani, H, Havmoeller, RJ, Hayat, K, Heidari-Soureshjani, R, Henry, NJ, Herteliu, C, Hole, MK, Holla, R, Hossain, N, Hosseini, M, Hosseinzadeh, M, Hostiuc, M, Hostiuc, S, Househ, M, Huang, J, Humayun, A, Hwang, B-F, Iavicoli, I, Ibitoye, SE, Ikuta, KS, Ilesanmi, OS, Ilic, IM, Ilic, MD, Inamdar, S, Inbaraj, LR, Iqbal, K, Iqbal, U, Islam, MM, Shariful Islam, Sheikh, Iso, H, Iwagami, M, Iwu, CCD, Jaafari, J, Jacobsen, KH, Jagnoor, J, Jain, V, Janodia, MD, Javaheri, T, Javanmardi, F, Jayaram, S, Jayatilleke, AU, Jenabi, E, Jha, RP, Ji, JS, John, O, Jonas, JB, Joo, T, Joseph, N, Joukar, F, Jozwiak, JJ, Jurisson, M, Kabir, A, Kabir, Z, Kalankesh, LR, Kamyari, N, Kanchan, T, Kapoor, N, Matin, BK, Karch, A, Karimi, SE, Kassahun, G, Kayode, GA, Karyani, AK, Kemmer, L, Khalid, N, Khalilov, R, Khammarnia, M, Khan, EA, Khan, G, Khan, M, Khan, MN, Khang, Y-H, Khatab, K, Khater, AM, Khater, MM, Khayamzadeh, M, Khosravi, A, Kim, D, Kim, Y-E, Kim, YJ, Kimokoti, RW, Kisa, A, Kisa, S, Kissoon, N, Kopec, JA, Kosen, S, Koul, PA, Laxminarayana, SLK, Koyanagi, A, Krishan, K, Krishnamoorthy, V, Defo, BK, Bicer, BK, Kulkarni, V, Kumar, GA, Kumar, M, Kumar, N, Kurmi, OP, Kusuma, D, La Vecchia, C, Lacey, B, Lalloo, R, Lami, FH, Landires, I, Larsson, AO, Lasrado, S, Lassi, ZS, Lauriola, P, Lee, PH, Lee, SWH, Lee, YH, Leigh, J, Leonardi, M, Lewycka, S, Li, B, Li, S, Liang, J, Lim, L-L, Limenih, MA, Lin, R-T, Liu, X, Lodha, R, Lopez, AD, Lozano, R, Lugo, A, Lunevicius, R, Mackay, MT, Kunjathur, SM, Magnani, FG, Prasad, DRM, Maheri, M, Mahmoudi, M, Majeed, A, Maled, V, Maleki, A, Maleki, S, Malekzadeh, R, Malik, AA, Malta, DC, Mamun, AA, Mansouri, B, Mansournia, MA, Martinez, G, Martini, S, Martins-Melo, FR, Masoumi, SZ, Maulik, PK, McAlinden, C, McGrath, JJ, Medina-Solis, CE, Nasab, EM, Mejia-Rodriguez, F, Memish, ZA, Mendoza, W, Menezes, RG, Mengesha, EW, Mensah, GA, Meretoja, A, Meretoja, TJ, Mersha, AM, Mestrovic, T, Miazgowski, B, Miazgowski, T, Michalek, IM, Miller, TR, Mini, GK, Miri, M, Mirica, A, Mirrakhimov, EM, Mirzaei, H, Mirzaei, M, Moazen, B, Moghadaszadeh, M, Mohajer, B, Mohamad, O, Mohammad, Y, Mohammadi, SM, Mohammadian-Hafshejani, A, Mohammed, S, Mokdad, AH, Molokhia, M, Monasta, L, Mondello, S, Moni, MA, Moore, CE, Moradi, G, Moradi, M, Moradzadeh, R, Moraga, P, Morawska, L, Morrison, SD, Mosser, JF, Khaneghah, AM, Mustafa, G, Naderi, M, Nagarajan, AJ, Nagaraju, SP, Naghavi, M, Naghshtabrizi, B, Naimzada, MD, Nangia, V, Swamy, SN, Nascimento, BR, Naveed, M, Nazari, J, Ndejjo, R, Negoi, I, Negoi, RI, Nena, E, Nepal, S, Netsere, HB, Nguefack-Tsague, G, Ngunjiri, JW, Chi, TYN, Cuong, TN, Huong, LTN, Nigatu, YT, Nigussie, SN, Nixon, MR, Nnaji, CA, Nomura, S, Noor, NM, Noubiap, JJ, Nunez-Samudio, V, Nwatah, VE, Oancea, B, Odukoya, OO, Ogbo, FA, Olusanya, BO, Olusanya, JO, Bali, AO, Onwujekwe, OE, Ortiz, A, Otoiu, A, Otstavnov, N, Otstavnov, SS, Owolabi, MO, Mahesh, PA, Padubidri, JR, Pakhale, S, Pakshir, K, Pal, PK, Palladino, R, Pana, A, Panda-Jonas, S, Pandey, A, Pandi-Perumal, SR, Pangaribuan, HU, Pardo-Montano, AM, Park, E-K, Patel, SK, Patton, GC, Pawar, S, Toroudi, HP, Peden, AE, Pepito, VCF, Peprah, EK, Pereira, J, Perez-Gomez, J, Perico, N, Pesudovs, K, Pilgrim, T, Pinheiro, M, Piradov, MA, Pirsaheb, M, Platts-Mills, JA, Pokhrel, KN, Postma, MJ, Pourjafar, H, Prada, S, Prakash, S, Pupillo, E, Syed, ZQ, Rabiee, N, Radfar, A, Rafiee, A, Rafiei, A, Raggi, A, Rahimzadeh, S, Rahman, MHU, Rahmani, AM, Ramezanzadeh, K, Rana, J, Ranabhat, CL, Rao, SJ, Rasella, D, Rastogi, P, Rathi, P, Rawaf, DL, Rawaf, S, Rawasia, WF, Rawassizadeh, R, Jr, RCR, Remuzzi, G, Renzaho, AMN, Reshmi, B, Resnikoff, S, Rezaei, N, Rezapour, A, Riahi, SM, Ribeiro, D, Rickard, J, Roever, L, Ronfani, L, Rothenbacher, D, Rubagotti, E, Rumisha, SF, Ryan, PM, Saddik, B, Sadeghi, E, Moghaddam, SS, Sagar, R, Sahebkar, A, Salahshoor, MR, Salehi, S, Salem, MR, Salimzadeh, H, Salomon, JA, Samodra, YL, Samy, AM, Sanabria, J, Santric-Milicevic, MM, Saraswathy, SYI, Sarker, AR, Sarrafzadegan, N, Sarveazad, A, Sathian, B, Sathish, T, Sattin, D, Saxena, S, Saya, GK, Saylan, M, Schiavolin, S, Schlaich, MP, Schwebel, DC, Schwendicke, F, Senthilkumaran, S, Sepanlou, SG, Servan-Mori, E, Sha, F, Shafaat, O, Shahabi, S, Shahbaz, M, Shaheen, AA, Shahid, I, Shaikh, MA, Shakiba, S, Shalash, AS, Shams-Beyranvand, M, Shannawaz, M, Sharafi, K, Sheikh, A, Sheikhbahaei, S, Shiferaw, WS, Shigematsu, M, Shin, JI, Shiri, R, Shiue, I, Shuval, K, Siddiqi, TJ, Sidemo, NB, Sigfusdottir, ID, Sigurvinsdottir, R, Silva, JP, Silverberg, JIS, Simonetti, B, Singh, BB, Singh, JA, Singhal, D, Sinha, DN, Skiadaresi, E, Skryabin, VY, Skryabina, AA, Sleet, DA, Sobaih, BH, Sobhiyeh, MR, Soltani, S, Soriano, JB, Spurlock, EE, Sreeramareddy, CT, Steiropoulos, P, Stokes, Mark, Stortecky, S, Sufiyan, MB, Abdulkader, RS, Sulo, G, Swope, CB, Sykes, BL, Szeto, MD, Szocska, M, Tabares-Seisdedos, R, Tadesse, EG, Taherkhani, A, Tamiru, AT, Tareque, MI, Tehrani-Banihashemi, A, Temsah, M-H, Tesfay, FH, Tessema, GA, Tessema, ZT, Thankappan, KR, Thapar, R, Tolani, MA, Tovani-Palone, MR, Traini, E, Bach, XT, Tripathy, JP, Tsapparellas, G, Tsatsakis, A, Car, LT, Uddin, Riaz, Ullah, A, Umeokonkwo, CD, Unim, B, Unnikrishnan, B, Upadhyay, E, Usman, MS, Vacante, M, Vaezi, M, Tahbaz, SV, Valdez, PR, Vasankari, TJ, Venketasubramanian, N, Verma, M, Violante, FS, Vlassov, V, Vo, B, Giang, TV, Wado, YD, Waheed, Y, Wamai, RG, Wang, Y, Wang, Y-P, Ward, P, Werdecker, A, Westerman, R, Wickramasinghe, ND, Wilner, LB, Wiysonge, CS, Wu, A-M, Wu, C, Xie, Y, Jabbari, SHY, Yamagishi, K, Yandrapalli, S, Yaya, S, Yazdi-Feyzabadi, V, Yip, P, Yonemoto, N, Yoon, S-J, Younis, MZ, Yousefi, Z, Yousefinezhadi, T, Yu, C, Yusuf, SS, Zaidi, SS, Bin Zaman, S, Zamani, M, Zamanian, M, Zastrozhin, MS, Zastrozhina, A, Zhang, Y, Zhang, Z-J, Zhao, X-JG, Ziapour, A, Hay, S, Murray, CJL, Wang, H, Kassebaum, NJ, Paulson, KR, Kamath, AM, Alam, T, Bienhoff, K, Abady, GG, Abbas, J, Abbasi-Kangevari, M, Abbastabar, H, Abd-Allah, F, Abd-Elsalam, SM, Abdoli, A, Abedi, A, Abolhassani, H, Abreu, LG, Abu-Gharbieh, E, Abu-Rmeileh, NME, Abushouk, A, Adamu, AL, Adebayo, OM, Adegbosin, AE, Adekanmbi, V, Adetokunboh, OO, Adeyinka, DA, Adsuar, JC, Afshari, K, Aghaali, M, Agudelo-Botero, M, Ahinkorah, BO, Ahmad, T, Ahmadi, K, Ahmed, MB, Aji, B, Akalu, Y, Akinyemi, OO, Aklilu, A, Al-Aly, Z, Alam, K, Alanezi, FM, Alanzi, TM, Alcalde-Rabanal, JE, Al-Eyadhy, A, Ali, T, Alicandro, G, Alif, SM, Alipour, V, Alizade, H, Aljunid, SM, Almasi-Hashiani, A, Almasri, NA, Al-Mekhlafi, HM, Alonso, J, Al-Raddadi, RM, Altirkawi, KA, Alumran, AK, Alvis-Guzman, N, Alvis-Zakzuk, NJ, Ameyaw, EK, Amini, S, Amini-Rarani, M, Amit, AML, Amugsi, DA, Ancuceanu, R, Anderlini, D, Andrei, CL, Ansari, F, Ansari-Moghaddam, A, Antonio, CAT, Antriyandarti, E, Anvari, D, Anwer, R, Aqeel, M, Arabloo, J, Arab-Zozani, M, Aripov, T, Arnlov, J, Artanti, KD, Arzani, A, Asaad, M, Asadi-Aliabadi, M, Asadi-Pooya, AA, Jafarabadi, MA, Athari, SS, Athari, SM, Atnafu, DD, Atreya, A, Atteraya, MS, Ausloos, M, Awan, AT, Quintanilla, BPA, Ayano, G, Ayanore, MA, Aynalem, YA, Azari, S, Azarian, G, Azene, ZN, Darshan, BB, Babaee, E, Badiye, AD, Baig, AA, Banach, M, Banik, PC, Barker-Collo, SL, Barqawi, HJ, Bassat, Q, Basu, S, Baune, BT, Bayati, M, Bedi, N, Beghi, E, Beghi, M, Bell, ML, Bendak, S, Bennett, DA, Bensenor, IM, Berhe, K, Berman, AE, Bezabih, YM, Bhagavathula, AS, Bhandari, D, Bhardwaj, N, Bhardwaj, P, Bhattacharyya, K, Bhattarai, S, Bhutta, ZA, Bikbov, B, Biondi, A, Birihane, BM, Biswas, RK, Bohlouli, S, Bragazzi, NL, Breusov, A, Brunoni, AR, Burkart, K, Nagaraja, SB, Busse, R, Butt, ZA, dos Santos, FLC, Cahuana-Hurtado, L, Camargos, P, Camera, LA, Cardenas, R, Carreras, G, Carrero, JJ, Carvalho, F, Castaldelli-Maia, JM, Castaneda-Orjuela, CA, Castelpietra, G, Cerin, E, Chang, J-C, Chanie, WF, Charan, J, Chatterjee, S, Chattu, SK, Chattu, VK, Chaturvedi, S, Chen, S, Cho, DY, Choi, J-YJ, Chu, D-T, Ciobanu, LG, Cirillo, M, Conde, J, Costa, VM, Couto, RAS, Dachew, BA, Dahlawi, SMA, Dai, H, Dai, X, Dandona, L, Dandona, R, Daneshpajouhnejad, P, Darmstadt, GL, Das, JK, Davila-Cervantes, CA, Davis, AC, Davletov, K, De la Hoz, FP, De Leo, D, Deeba, F, Denova-Gutierrez, E, Dervenis, N, Desalew, A, Deuba, K, Dey, S, Dharmaratne, SD, Dhingra, S, Dhungana, GP, da Silva, DD, Diaz, D, Dorostkar, F, Doshmangir, L, Dubljanin, E, Duraes, AR, Eagan, AW, Edinur, HA, Efendi, F, Eftekharzadeh, S, El Sayed, I, El Tantawi, M, Elbarazi, I, Elgendy, IY, El-Jaafary, S, Emami, A, Enany, S, Eyawo, O, Ezzikouri, S, Faris, PS, Farzadfar, F, Fattahi, N, Fauk, NK, Fazlzadeh, M, Feigin, VL, Ferede, TY, Fereshtehnejad, S-M, Fernandes, E, Ferrara, P, Filip, I, Fischer, F, Fisher, JL, Foigt, NA, Folayan, MO, Foroutan, M, Franklin, RC, Freitas, M, Friedman, SD, Fukumoto, T, Gad, MM, Gaidhane, AM, Gaidhane, S, Gaihre, S, Gallus, S, Garcia-Basteiro, AL, Garcia-Gordillo, M, Gardner, WM, Fonseca, MG, Gebremedhin, KB, Getacher, L, Ghashghaee, A, Gholamian, A, Gilani, SA, Gill, TK, Giussani, G, Gnedovskaya, E, Godinho, MA, Goel, A, Golechha, M, Gona, PN, Gopalani, SV, Goudarzi, H, Grivna, M, Gugnani, HC, Guido, D, Guimaraes, RA, Das Gupta, R, Gupta, R, Hafezi-Nejad, N, Haider, MR, Haj-Mirzaian, A, Hamidi, S, Hanif, A, Hankey, GJ, Hargono, A, Hasaballah, A, Hasan, MM, Hasan, SS, Hassan, A, Hassanipour, S, Hassankhani, H, Havmoeller, RJ, Hayat, K, Heidari-Soureshjani, R, Henry, NJ, Herteliu, C, Hole, MK, Holla, R, Hossain, N, Hosseini, M, Hosseinzadeh, M, Hostiuc, M, Hostiuc, S, Househ, M, Huang, J, Humayun, A, Hwang, B-F, Iavicoli, I, Ibitoye, SE, Ikuta, KS, Ilesanmi, OS, Ilic, IM, Ilic, MD, Inamdar, S, Inbaraj, LR, Iqbal, K, Iqbal, U, Islam, MM, Shariful Islam, Sheikh, Iso, H, Iwagami, M, Iwu, CCD, Jaafari, J, Jacobsen, KH, Jagnoor, J, Jain, V, Janodia, MD, Javaheri, T, Javanmardi, F, Jayaram, S, Jayatilleke, AU, Jenabi, E, Jha, RP, Ji, JS, John, O, Jonas, JB, Joo, T, Joseph, N, Joukar, F, Jozwiak, JJ, Jurisson, M, Kabir, A, Kabir, Z, Kalankesh, LR, Kamyari, N, Kanchan, T, Kapoor, N, Matin, BK, Karch, A, Karimi, SE, Kassahun, G, Kayode, GA, Karyani, AK, Kemmer, L, Khalid, N, Khalilov, R, Khammarnia, M, Khan, EA, Khan, G, Khan, M, Khan, MN, Khang, Y-H, Khatab, K, Khater, AM, Khater, MM, Khayamzadeh, M, Khosravi, A, Kim, D, Kim, Y-E, Kim, YJ, Kimokoti, RW, Kisa, A, Kisa, S, Kissoon, N, Kopec, JA, Kosen, S, Koul, PA, Laxminarayana, SLK, Koyanagi, A, Krishan, K, Krishnamoorthy, V, Defo, BK, Bicer, BK, Kulkarni, V, Kumar, GA, Kumar, M, Kumar, N, Kurmi, OP, Kusuma, D, La Vecchia, C, Lacey, B, Lalloo, R, Lami, FH, Landires, I, Larsson, AO, Lasrado, S, Lassi, ZS, Lauriola, P, Lee, PH, Lee, SWH, Lee, YH, Leigh, J, Leonardi, M, Lewycka, S, Li, B, Li, S, Liang, J, Lim, L-L, Limenih, MA, Lin, R-T, Liu, X, Lodha, R, Lopez, AD, Lozano, R, Lugo, A, Lunevicius, R, Mackay, MT, Kunjathur, SM, Magnani, FG, Prasad, DRM, Maheri, M, Mahmoudi, M, Majeed, A, Maled, V, Maleki, A, Maleki, S, Malekzadeh, R, Malik, AA, Malta, DC, Mamun, AA, Mansouri, B, Mansournia, MA, Martinez, G, Martini, S, Martins-Melo, FR, Masoumi, SZ, Maulik, PK, McAlinden, C, McGrath, JJ, Medina-Solis, CE, Nasab, EM, Mejia-Rodriguez, F, Memish, ZA, Mendoza, W, Menezes, RG, Mengesha, EW, Mensah, GA, Meretoja, A, Meretoja, TJ, Mersha, AM, Mestrovic, T, Miazgowski, B, Miazgowski, T, Michalek, IM, Miller, TR, Mini, GK, Miri, M, Mirica, A, Mirrakhimov, EM, Mirzaei, H, Mirzaei, M, Moazen, B, Moghadaszadeh, M, Mohajer, B, Mohamad, O, Mohammad, Y, Mohammadi, SM, Mohammadian-Hafshejani, A, Mohammed, S, Mokdad, AH, Molokhia, M, Monasta, L, Mondello, S, Moni, MA, Moore, CE, Moradi, G, Moradi, M, Moradzadeh, R, Moraga, P, Morawska, L, Morrison, SD, Mosser, JF, Khaneghah, AM, Mustafa, G, Naderi, M, Nagarajan, AJ, Nagaraju, SP, Naghavi, M, Naghshtabrizi, B, Naimzada, MD, Nangia, V, Swamy, SN, Nascimento, BR, Naveed, M, Nazari, J, Ndejjo, R, Negoi, I, Negoi, RI, Nena, E, Nepal, S, Netsere, HB, Nguefack-Tsague, G, Ngunjiri, JW, Chi, TYN, Cuong, TN, Huong, LTN, Nigatu, YT, Nigussie, SN, Nixon, MR, Nnaji, CA, Nomura, S, Noor, NM, Noubiap, JJ, Nunez-Samudio, V, Nwatah, VE, Oancea, B, Odukoya, OO, Ogbo, FA, Olusanya, BO, Olusanya, JO, Bali, AO, Onwujekwe, OE, Ortiz, A, Otoiu, A, Otstavnov, N, Otstavnov, SS, Owolabi, MO, Mahesh, PA, Padubidri, JR, Pakhale, S, Pakshir, K, Pal, PK, Palladino, R, Pana, A, Panda-Jonas, S, Pandey, A, Pandi-Perumal, SR, Pangaribuan, HU, Pardo-Montano, AM, Park, E-K, Patel, SK, Patton, GC, Pawar, S, Toroudi, HP, Peden, AE, Pepito, VCF, Peprah, EK, Pereira, J, Perez-Gomez, J, Perico, N, Pesudovs, K, Pilgrim, T, Pinheiro, M, Piradov, MA, Pirsaheb, M, Platts-Mills, JA, Pokhrel, KN, Postma, MJ, Pourjafar, H, Prada, S, Prakash, S, Pupillo, E, Syed, ZQ, Rabiee, N, Radfar, A, Rafiee, A, Rafiei, A, Raggi, A, Rahimzadeh, S, Rahman, MHU, Rahmani, AM, Ramezanzadeh, K, Rana, J, Ranabhat, CL, Rao, SJ, Rasella, D, Rastogi, P, Rathi, P, Rawaf, DL, Rawaf, S, Rawasia, WF, Rawassizadeh, R, Jr, RCR, Remuzzi, G, Renzaho, AMN, Reshmi, B, Resnikoff, S, Rezaei, N, Rezapour, A, Riahi, SM, Ribeiro, D, Rickard, J, Roever, L, Ronfani, L, Rothenbacher, D, Rubagotti, E, Rumisha, SF, Ryan, PM, Saddik, B, Sadeghi, E, Moghaddam, SS, Sagar, R, Sahebkar, A, Salahshoor, MR, Salehi, S, Salem, MR, Salimzadeh, H, Salomon, JA, Samodra, YL, Samy, AM, Sanabria, J, Santric-Milicevic, MM, Saraswathy, SYI, Sarker, AR, Sarrafzadegan, N, Sarveazad, A, Sathian, B, Sathish, T, Sattin, D, Saxena, S, Saya, GK, Saylan, M, Schiavolin, S, Schlaich, MP, Schwebel, DC, Schwendicke, F, Senthilkumaran, S, Sepanlou, SG, Servan-Mori, E, Sha, F, Shafaat, O, Shahabi, S, Shahbaz, M, Shaheen, AA, Shahid, I, Shaikh, MA, Shakiba, S, Shalash, AS, Shams-Beyranvand, M, Shannawaz, M, Sharafi, K, Sheikh, A, Sheikhbahaei, S, Shiferaw, WS, Shigematsu, M, Shin, JI, Shiri, R, Shiue, I, Shuval, K, Siddiqi, TJ, Sidemo, NB, Sigfusdottir, ID, Sigurvinsdottir, R, Silva, JP, Silverberg, JIS, Simonetti, B, Singh, BB, Singh, JA, Singhal, D, Sinha, DN, Skiadaresi, E, Skryabin, VY, Skryabina, AA, Sleet, DA, Sobaih, BH, Sobhiyeh, MR, Soltani, S, Soriano, JB, Spurlock, EE, Sreeramareddy, CT, Steiropoulos, P, Stokes, Mark, Stortecky, S, Sufiyan, MB, Abdulkader, RS, Sulo, G, Swope, CB, Sykes, BL, Szeto, MD, Szocska, M, Tabares-Seisdedos, R, Tadesse, EG, Taherkhani, A, Tamiru, AT, Tareque, MI, Tehrani-Banihashemi, A, Temsah, M-H, Tesfay, FH, Tessema, GA, Tessema, ZT, Thankappan, KR, Thapar, R, Tolani, MA, Tovani-Palone, MR, Traini, E, Bach, XT, Tripathy, JP, Tsapparellas, G, Tsatsakis, A, Car, LT, Uddin, Riaz, Ullah, A, Umeokonkwo, CD, Unim, B, Unnikrishnan, B, Upadhyay, E, Usman, MS, Vacante, M, Vaezi, M, Tahbaz, SV, Valdez, PR, Vasankari, TJ, Venketasubramanian, N, Verma, M, Violante, FS, Vlassov, V, Vo, B, Giang, TV, Wado, YD, Waheed, Y, Wamai, RG, Wang, Y, Wang, Y-P, Ward, P, Werdecker, A, Westerman, R, Wickramasinghe, ND, Wilner, LB, Wiysonge, CS, Wu, A-M, Wu, C, Xie, Y, Jabbari, SHY, Yamagishi, K, Yandrapalli, S, Yaya, S, Yazdi-Feyzabadi, V, Yip, P, Yonemoto, N, Yoon, S-J, Younis, MZ, Yousefi, Z, Yousefinezhadi, T, Yu, C, Yusuf, SS, Zaidi, SS, Bin Zaman, S, Zamani, M, Zamanian, M, Zastrozhin, MS, Zastrozhina, A, Zhang, Y, Zhang, Z-J, Zhao, X-JG, Ziapour, A, Hay, S, Murray, CJL, Wang, H, and Kassebaum, NJ
- Published
- 2021
11. An automatic zone detection system for safe landing of UAVs
- Author
-
Kaljahi, MA, Shivakumara, P, Idris, MYI, Anisi, MH, Lu, T, Blumenstein, M, and Noor, NM
- Subjects
Artificial Intelligence & Image Processing - Abstract
© 2019 Elsevier Ltd As the demand increases for the use Unmanned Aerial Vehicles (UAVs) to monitor natural disasters, protecting territories, spraying, vigilance in urban areas, etc., detecting safe landing zones becomes a new area that has gained interest. This paper presents an intelligent system for detecting regions to navigate a UAV when it requires an emergency landing due to technical causes. The proposed system explores the fact that safe regions in images have flat surfaces, which are extracted using the Gabor Transform. This results in images of different orientations. The proposed system then performs histogram operations on different Gabor-oriented images to select pixels that contribute to the highest peak, as Candidate Pixels (CP), for the respective Gabor-oriented images. Next, to group candidate pixels as one region, we explore Markov Chain Codes (MCCs), which estimate the probability of pixels being classified as candidates with neighboring pixels. This process results in Candidate Regions (CRs) detection. For each image of the respective Gabor orientation, including CRs, the proposed system finds a candidate region that has the highest area and considers it as a reference. We then estimate the degree of similarity between the reference CR with corresponding CRs in the respective Gabor-oriented images using a Chi square distance measure. Furthermore, the proposed system chooses the CR which gives the highest similarity to the reference CR to fuse with that reference, which results in the establishment of safe landing zones for the UAV. Experimental results on images from different situations for safe landing detection show that the proposed system outperforms the existing systems. Furthermore, experimental results on relative success rates for different emergency conditions of UAVs show that the proposed intelligent system is effective and useful compared to the existing UAV safe landing systems.
- Published
- 2019
12. Access to routinely collected health data for clinical trials - review of successful data requests to UK registries
- Author
-
Lensen, S, Macnair, A, Love, SB, Yorke-Edwards, V, Noor, NM, Martyn, M, Blenkinsop, A, Diaz-Montana, C, Powell, G, Williamson, E, Carpenter, J, Sydes, MR, Lensen, S, Macnair, A, Love, SB, Yorke-Edwards, V, Noor, NM, Martyn, M, Blenkinsop, A, Diaz-Montana, C, Powell, G, Williamson, E, Carpenter, J, and Sydes, MR
- Abstract
BACKGROUND: Clinical trials generally each collect their own data despite routinely collected health data (RCHD) increasing in quality and breadth. Our aim is to quantify UK-based randomised controlled trials (RCTs) accessing RCHD for participant data, characterise how these data are used and thereby recommend how more trials could use RCHD. METHODS: We conducted a systematic review of RCTs accessing RCHD from at least one registry in the UK between 2013 and 2018 for the purposes of informing or supplementing participant data. A list of all registries holding RCHD in the UK was compiled. In cases where registries published release registers, these were searched for RCTs accessing RCHD. Where no release register was available, registries were contacted to request a list of RCTs. For each identified RCT, information was collected from all publicly available sources (release registers, websites, protocol etc.). The search and data extraction were undertaken between January and May 2019. RESULTS: We identified 160 RCTs accessing RCHD between 2013 and 2018 from a total of 22 registries; this corresponds to only a very small proportion of all UK RCTs (about 3%). RCTs accessing RCHD were generally large (median sample size 1590), commonly evaluating treatments for cancer or cardiovascular disease. Most of the included RCTs accessed RCHD from NHS Digital (68%), and the most frequently accessed datasets were mortality (76%) and hospital visits (55%). RCHD was used to inform the primary trial (82%) and long-term follow-up (57%). There was substantial variation in how RCTs used RCHD to inform participant outcome measures. A limitation was the lack of information and transparency from registries and RCTs with respect to which datasets have been accessed and for what purposes. CONCLUSIONS: In the last five years, only a small minority of UK-based RCTs have accessed RCHD to inform participant data. We ask for improved accessibility, confirmed data quality and joined-up thinking b
- Published
- 2020
13. OC-044 Profile trial: predicting outcomes for crohn’s disease using a molecular biomarker
- Author
-
Lee, JC, primary, Biasci, D, additional, Noor, NM, additional, McKinney, EF, additional, Ahmad, T, additional, Lewis, NR, additional, Hart, AL, additional, Lyons, PA, additional, Parkes, M, additional, and Smith, KG, additional
- Published
- 2017
- Full Text
- View/download PDF
14. Selective inhibition of ASIC1a confers functional and morphological neuroprotection following traumatic spinal cord injury.
- Author
-
Koehn, LM, Noor, NM, Dong, Q, Er, S-Y, Rash, LD, King, GF, Dziegielewska, KM, Saunders, NR, Habgood, MD, Koehn, LM, Noor, NM, Dong, Q, Er, S-Y, Rash, LD, King, GF, Dziegielewska, KM, Saunders, NR, and Habgood, MD
- Abstract
Tissue loss after spinal trauma is biphasic, with initial mechanical/haemorrhagic damage at the time of impact being followed by gradual secondary expansion into adjacent, previously unaffected tissue. Limiting the extent of this secondary expansion of tissue damage has the potential to preserve greater residual spinal cord function in patients. The acute tissue hypoxia resulting from spinal cord injury (SCI) activates acid-sensing ion channel 1a (ASIC1a). We surmised that antagonism of this channel should provide neuroprotection and functional preservation after SCI. We show that systemic administration of the spider-venom peptide PcTx1, a selective inhibitor of ASIC1a, improves locomotor function in adult Sprague Dawley rats after thoracic SCI. The degree of functional improvement correlated with the degree of tissue preservation in descending white matter tracts involved in hind limb locomotor function. Transcriptomic analysis suggests that PcTx1-induced preservation of spinal cord tissue does not result from a reduction in apoptosis, with no evidence of down-regulation of key genes involved in either the intrinsic or extrinsic apoptotic pathways. We also demonstrate that trauma-induced disruption of blood-spinal cord barrier function persists for at least 4 days post-injury for compounds up to 10 kDa in size, whereas barrier function is restored for larger molecules within a few hours. This temporary loss of barrier function provides a " treatment window" through which systemically administered drugs have unrestricted access to spinal tissue in and around the sites of trauma. Taken together, our data provide evidence to support the use of ASIC1a inhibitors as a therapeutic treatment for SCI. This study also emphasizes the importance of objectively grading the functional severity of initial injuries (even when using standardized impacts) and we describe a simple scoring system based on hind limb function that could be adopted in future studies.
- Published
- 2016
15. Cellular Specificity of the Blood-CSF Barrier for Albumin Transfer across the Choroid Plexus Epithelium
- Author
-
Bisser, S, Liddelow, SA, Dziegielewska, KM, Mollgard, K, Whish, SC, Noor, NM, Wheaton, BJ, Gehwolf, R, Wagner, A, Traweger, A, Bauer, H, Bauer, H-C, Saunders, NR, Bisser, S, Liddelow, SA, Dziegielewska, KM, Mollgard, K, Whish, SC, Noor, NM, Wheaton, BJ, Gehwolf, R, Wagner, A, Traweger, A, Bauer, H, Bauer, H-C, and Saunders, NR
- Abstract
To maintain the precise internal milieu of the mammalian central nervous system, well-controlled transfer of molecules from periphery into brain is required. Recently the soluble and cell-surface albumin-binding glycoprotein SPARC (secreted protein acidic and rich in cysteine) has been implicated in albumin transport into developing brain, however the exact mechanism remains unknown. We postulate that SPARC is a docking site for albumin, mediating its uptake and transfer by choroid plexus epithelial cells from blood into cerebrospinal fluid (CSF). We used in vivo physiological measurements of transfer of endogenous (mouse) and exogenous (human) albumins, in situ Proximity Ligation Assay (in situ PLA), and qRT-PCR experiments to examine the cellular mechanism mediating protein transfer across the blood-CSF interface. We report that at all developmental stages mouse albumin and SPARC gave positive signals with in situ PLAs in plasma, CSF and within individual plexus cells suggesting a possible molecular interaction. In contrast, in situ PLA experiments in brain sections from mice injected with human albumin showed positive signals for human albumin in the vascular compartment that were only rarely identifiable within choroid plexus cells and only at older ages. Concentrations of both endogenous mouse albumin and exogenous (intraperitoneally injected) human albumin were estimated in plasma and CSF and expressed as CSF/plasma concentration ratios. Human albumin was not transferred through the mouse blood-CSF barrier to the same extent as endogenous mouse albumin, confirming results from in situ PLA. During postnatal development Sparc gene expression was higher in early postnatal ages than in the adult and changed in response to altered levels of albumin in blood plasma in a differential and developmentally regulated manner. Here we propose a possible cellular route and mechanism by which albumin is transferred from blood into CSF across a sub-population of specialised c
- Published
- 2014
16. Expression and Cellular Distribution of Ubiquitin in Response to Injury in the Developing Spinal Cord of Monodelphis domestica
- Author
-
Di Giovanni, S, Noor, NM, Mollgard, K, Wheaton, BJ, Steer, DL, Truettner, JS, Dziegielewska, KM, Dietrich, WD, Smith, AI, Saunders, NR, Di Giovanni, S, Noor, NM, Mollgard, K, Wheaton, BJ, Steer, DL, Truettner, JS, Dziegielewska, KM, Dietrich, WD, Smith, AI, and Saunders, NR
- Abstract
Ubiquitin, an 8.5 kDa protein associated with the proteasome degradation pathway has been recently identified as differentially expressed in segment of cord caudal to site of injury in developing spinal cord. Here we describe ubiquitin expression and cellular distribution in spinal cord up to postnatal day P35 in control opossums (Monodelphis domestica) and in response to complete spinal transection (T10) at P7, when axonal growth through site of injury occurs, and P28 when this is no longer possible. Cords were collected 1 or 7 days after injury, with age-matched controls and segments rostral to lesion were studied. Following spinal injury ubiquitin levels (western blotting) appeared reduced compared to controls especially one day after injury at P28. In contrast, after injury mRNA expression (qRT-PCR) was slightly increased at P7 but decreased at P28. Changes in isoelectric point of separated ubiquitin indicated possible post-translational modifications. Cellular distribution demonstrated a developmental shift between earliest (P8) and latest (P35) ages examined, from a predominantly cytoplasmic immunoreactivity to a nuclear expression; staining level and shift to nuclear staining was more pronounced following injury, except 7 days after transection at P28. After injury at P7 immunostaining increased in neurons and additionally in oligodendrocytes at P28. Mass spectrometry showed two ubiquitin bands; the heavier was identified as a fusion product, likely to be an ubiquitin precursor. Apparent changes in ubiquitin expression and cellular distribution in development and response to spinal injury suggest an intricate regulatory system that modulates these responses which, when better understood, may lead to potential therapeutic targets.
- Published
- 2013
17. Weight-Bearing Locomotion in the Developing Opossum, Monodelphis domestica following Spinal Transection: Remodeling of Neuronal Circuits Caudal to Lesion
- Author
-
Burgess, HA, Wheaton, BJ, Noor, NM, Whish, SC, Truettner, JS, Dietrich, WD, Zhang, M, Crack, PJ, Dziegielewska, KM, Saunders, NR, Burgess, HA, Wheaton, BJ, Noor, NM, Whish, SC, Truettner, JS, Dietrich, WD, Zhang, M, Crack, PJ, Dziegielewska, KM, and Saunders, NR
- Abstract
Complete spinal transection in the mature nervous system is typically followed by minimal axonal repair, extensive motor paralysis and loss of sensory functions caudal to the injury. In contrast, the immature nervous system has greater capacity for repair, a phenomenon sometimes called the infant lesion effect. This study investigates spinal injuries early in development using the marsupial opossum Monodelphis domestica whose young are born very immature, allowing access to developmental stages only accessible in utero in eutherian mammals. Spinal cords of Monodelphis pups were completely transected in the lower thoracic region, T10, on postnatal-day (P)7 or P28 and the animals grew to adulthood. In P7-injured animals regrown supraspinal and propriospinal axons through the injury site were demonstrated using retrograde axonal labelling. These animals recovered near-normal coordinated overground locomotion, but with altered gait characteristics including foot placement phase lags. In P28-injured animals no axonal regrowth through the injury site could be demonstrated yet they were able to perform weight-supporting hindlimb stepping overground and on the treadmill. When placed in an environment of reduced sensory feedback (swimming) P7-injured animals swam using their hindlimbs, suggesting that the axons that grew across the lesion made functional connections; P28-injured animals swam using their forelimbs only, suggesting that their overground hindlimb movements were reflex-dependent and thus likely to be generated locally in the lumbar spinal cord. Modifications to propriospinal circuitry in P7- and P28-injured opossums were demonstrated by changes in the number of fluorescently labelled neurons detected in the lumbar cord following tracer studies and changes in the balance of excitatory, inhibitory and neuromodulatory neurotransmitter receptors' gene expression shown by qRT-PCR. These results are discussed in the context of studies indicating that although followin
- Published
- 2013
18. Age-Dependent Changes in the Proteome Following Complete Spinal Cord Transection in a Postnatal South American Opossum (Monodelphis domestica)
- Author
-
Fenton, B, Noor, NM, Steer, DL, Wheaton, BJ, Ek, CJ, Truettner, JS, Dietrich, WD, Dziegielewska, KM, Richardson, SJ, Smith, AI, VandeBerg, JL, Saunders, NR, Fenton, B, Noor, NM, Steer, DL, Wheaton, BJ, Ek, CJ, Truettner, JS, Dietrich, WD, Dziegielewska, KM, Richardson, SJ, Smith, AI, VandeBerg, JL, and Saunders, NR
- Abstract
Recovery from severe spinal injury in adults is limited, compared to immature animals who demonstrate some capacity for repair. Using laboratory opossums (Monodelphis domestica), the aim was to compare proteomic responses to injury at two ages: one when there is axonal growth across the lesion and substantial behavioural recovery and one when no axonal growth occurs. Anaesthetized pups at postnatal day (P) 7 or P28 were subjected to complete transection of the spinal cord at thoracic level T10. Cords were collected 1 or 7 days after injury and from age-matched controls. Proteins were separated based on isoelectric point and subunit molecular weight; those whose expression levels changed following injury were identified by densitometry and analysed by mass spectrometry. Fifty-six unique proteins were identified as differentially regulated in response to spinal transection at both ages combined. More than 50% were cytoplasmic and 70% belonged to families of proteins with characteristic binding properties. Proteins were assigned to groups by biological function including regulation (40%), metabolism (26%), inflammation (19%) and structure (15%). More changes were detected at one than seven days after injury at both ages. Seven identified proteins: 14-3-3 epsilon, 14-3-3 gamma, cofilin, alpha enolase, heart fatty acid binding protein (FABP3), brain fatty acid binding protein (FABP7) and ubiquitin demonstrated age-related differential expression and were analysed by qRT-PCR. Changes in mRNA levels for FABP3 at P7+1day and ubiquitin at P28+1day were statistically significant. Immunocytochemical staining showed differences in ubiquitin localization in younger compared to older cords and an increase in oligodendrocyte and neuroglia immunostaining following injury at P28. Western blot analysis supported proteomic results for ubiquitin and 14-3-3 proteins. Data obtained at the two ages demonstrated changes in response to injury, compared to controls, that were different for d
- Published
- 2011
19. Optic cup and disc color channel multi-thresholding segmentation
- Author
-
Noor, NM, primary, Khalid, NEA, additional, and Ariff, NM, additional
- Published
- 2013
- Full Text
- View/download PDF
20. Internal medicine. Comparison of prevalence and female sexual dysfunction between diabetic and non-diabetic in kelantan.
- Author
-
Bau R, Ismail AH, Noor NM, and Sidi H
- Abstract
Objective: To determine the prevalence and compare the types of female sexual dysfunction between diabetics and non-diabetics. ' Design: Cross-sectional study Materials and Methods: The study was conducted on 178 diabetic women and 175 non-diabetic women in Out Patient Clinic and Diabetic Centre in Hospital Universiti Sains Malaysia using systematic random sampling. Malay Version of Female Sexual Function Index was used. Data was entered and analysed by SPSS 12 0 using descriptive and Simple Logistic Regression analyses. ' Results: The prevalence of sexual dysfunction among diabetics was 26.4% and among non-diabetics was 20.0%. Arousal disorder was reported in 28.7% diabetics and 17.1% non-diabetic (p value 0.040). Sexual satisfactions disorder among diabetics and non-diabetics was 15.2% and 8.0% respectively (p value 0.042). Conclusion: The prevalence of female sexual dysfunction among diabetics was 26.4% and among non-diabetics was 20.0%. Screening for sexual dysfunction should be part of general screening especially among diabetics and interventions were advice. [ABSTRACT FROM AUTHOR]
- Published
- 2010
21. Prevalence and associated factors of stress among assistant medical officers in Ministry of Health (MOH) hospitals in Kelantan and Terengganu, Malaysia.
- Author
-
Yacob MA, Daud A, Noor NM, and Mohammad WMZ
- Abstract
Objective: The study is aimed to determine the prevalence and associated factors of stress among assistant medical officers in Ministry of Health hospitals in Kelantan and Terengganu, Malaysia. Design: Cross-sectional study. Materials and Methods: A cross-sectional study was conducted on 194 randomly selected assistant medical officers in all Ministry of Health hospitals in Kelantan and Terengganu. The questionnaire was a self-administered questionnaire on socio-demographic data, Depression, Anxiety and Stress Scale-42 (DASS-42) and Job Content Questionnaires (JCQ). Results: The prevalence of stress was 13.7% (95% CI: 8.61, 18.79). General Linear Regression showed that decision latitude (P = 0.025), psychological job demand (P = 0.021), job insecurity (P = 0.009) and total physical hazards (P = 0.008) were significant associated factors. Conclusion: The prevalence of stress was 13.7%. Decision latitude, psychological job demand, job insecurity and total physical hazards were the significant associated factors of stress among assistant medical officers in Ministry of Health hospitals in Kelantan and Terengganu. [ABSTRACT FROM AUTHOR]
- Published
- 2010
22. Work and women's well-being: religion and age as moderators.
- Author
-
Noor NM
- Published
- 2008
- Full Text
- View/download PDF
23. Pap smear screening in Bachok, Kelantan from January to June 2005.
- Author
-
Noor NM and Sultan HM
- Abstract
Objectives: To describe the socio-demographic characteristics of women undergoing Pap smear screening and to evaluate the adequacy of specimen taken.Design: Cross sectional studyMaterials and Methods: A review of the Pap Smear Request and Report Form from January to June 2005 was conducted on all six health clinics in Bachok district, Kelantan. Data was entered using SPSS 12.0 and was transferred to Stata Intercooled 8.0 using Stat Transfer software.Result: The mean age of women who underwent Pap smear screening was 33.8 years. It was mainly done on women on hormonal contraceptives (46.7%) followed by those who were not on any contraceptives (30.4%) and those who were on IUCD (7.9%). Related to the methods of acquiring sample, 94.9% used spatula alone and 3.6% used endocervical brush. Only 63.5% of the specimens taken were 'satisfactory'. 'Satisfactory for evaluation but limited by' results (32.7%) were mainly due to lack of endocervical/transformation zone component. For 'unsatisfactory' smear, the main reason was scanty squamous epithelial component.Conclusion: The Pap smear screening was mainly utilized by younger women through opportunistic screening. The percentage of satisfactory smear which indicate the adequacy of specimen was low. [ABSTRACT FROM AUTHOR]
- Published
- 2008
24. Smoking and self-eeteem [sic] among Malay adolescents in Kota Bharu, Kelantan.
- Author
-
Noor NM, Ahmad Z, Sadiq LNM, Yaacob MJ, and Jalil RA
- Abstract
Objective: This study was to determine the association between self-esteem and smoking among Malay adolescents in Kota Bharu, Kelantan.Design: Cross-sectional studyMaterials and Methods: This study was conducted between January to June 2005 among 1364 students selected from ten co-educational government secondary schools in Kota Bharu using stratified multistage cluster sampling. Guided self-administered questionnaire and anthropometric measurement were taken. Data was entered using SPSS 12.0 and analysed using STATA 8.0 using General Linear Regression for survey data analysis.Results: The overall prevalence of smoking was 6.7%. The prevalence of smoking among boys was 13.8% and among girls was 1.1%. There was no association between self-esteem and smoking.Conclusion: There was no association between self-esteem and smoking among Malay Adolescents in Kota Bharu, Kelantan. [ABSTRACT FROM AUTHOR]
- Published
- 2008
25. Children and well-being: a comparison of employed and non-employed women.
- Author
-
Noor NM
- Published
- 1994
- Full Text
- View/download PDF
26. OC-044 Profile trial: predicting outcomes for crohn’s disease using a molecular biomarker
- Author
-
Lee, JC, Biasci, D, Noor, NM, McKinney, EF, Ahmad, T, Lewis, NR, Hart, AL, Lyons, PA, Parkes, M, and Smith, KG
- Abstract
IntroductionThe course of Crohn’s disease (CD) varies substantially between affected individuals, but reliable prognostic markers are not available in clinical practice. This hinders disease management because patients with aggressive disease will be undertreated by conventional “step-up” therapy, while those with indolent disease would be exposed to the risks of unnecessary immunosuppression of a “top-down” approach. Previously, we have described a transcriptional signature that is detectable within peripheral blood CD8 T cells at diagnosis and which correlates with subsequent disease course. To translate this work to the bedside and overcome the technical challenges of separating cell populations, we sought to develop a whole blood qPCR-based biomarker that can re-capitulate the CD8 subgroups without the need for cell separation. Here we describe the development and validation of this biomarker and the upcoming biomarker-stratified trial that will test whether it can deliver personalised medicine in CD.MethodFrom a training cohort of 69 newly diagnosed IBD patients, we simultaneously obtained a whole blood PAXgene RNA tube and peripheral blood CD8 T cell sample. Gene expression in both samples was measured by microarray. After confirming that the CD8 transcriptional signature was detectable and correlated with prognosis, we used machine learning to identify a transcriptional classifier in whole blood gene expression data that would re-capitulate the CD8 transcriptional subgroups. Model selection was performed using Bayesian Information Criterion and the genes identified were subsequently tested by qPCR and optimised to produce an 18 gene qPCR assay.ResultsIndependent validation of this biomarker was established using a second, independent cohort of 85 newly diagnosed patients with CD from 4 sites around the United Kingdom. This validated the biomarker and confirmed that the subgroups it identified had significantly different disease courses (analogous to those observed with the CD8 T cell subgroups). The hazard ratio for time to treatment escalation in this validation cohort was 3.52 (1.84–6.76, 95% confidence intervals, p=0.0002). We now propose to conduct the first ever biomarker-stratified trial in any inflammatory disease to determine whether this biomarker can deliver personalised medicine in CD.ConclusionWe have developed, optimised and validated a whole blood qPCR classifier that is able to predict disease course from diagnosis in IBD patients. This represents a major step towards personalised therapy in IBD, and we will soon investigate whether this could make personalised medicine a reality in CD.Disclosure of InterestNone Declared
- Published
- 2017
- Full Text
- View/download PDF
27. A Treat-to-Target Approach in IBD: Contemporary Real-World Perspectives from an International Survey.
- Author
-
Sharip MT, Brezina B, De La Revilla Negro J, Subramanian S, Parkes M, Raine T, and Noor NM
- Abstract
Background/Objectives : The management of inflammatory bowel disease (IBD) varies due to differences in healthcare systems, treatment costs, access to diagnostics, and diverse clinical practices between specialists. Despite the frequent advocacy of a treat-to-target (T2T) approach, there is insufficient clarity on how clinicians implement T2T in real-world settings. We aim to conduct a large, global survey among IBD experts to identify current practices in management. Methods : A prospective, cross-sectional study was conducted using a 16-item survey divided into two sections-for ulcerative colitis (UC) and Crohn's disease (CD)-and distributed to practicing IBD clinicians. Results : A total of 261 respondents from 88 countries participated in the survey, with the majority (253/261) being physicians and eight being IBD nurse specialists. Despite global guidance, only a quarter of the respondents routinely perform an endoscopy to assess the response after starting an advanced therapy (28.4% in UC vs. 23.5% in CD). Moreover, despite an increasing academic focus on intestinal ultrasound (IUS), 171 (66%) of respondents in UC and 132 (51%) in CD reported that they do not routinely undertake IUS to guide treatment decisions. Faecal calprotectin for monitoring treatment response was routinely used by 87% (90% in UC and 84% in CD) of the respondents. Forty-five percent reported use of therapeutic drug monitoring (TDM) both proactively and reactively and 35% reported only using TDM reactively. Conclusions : Our study shows considerable variation in IBD management across different countries and interpretation of the T2T approach. This highlights the need for standardised and pragmatic guidelines to help improve outcomes for patients with IBD globally.
- Published
- 2025
- Full Text
- View/download PDF
28. MACB CKD Task Force updated recommendations for reporting estimated glomerular filtration rate and albuminuria in adults.
- Author
-
Sthaneshwar P, Lai LC, Thambiah SC, Lim SK, Zulkely A, Lee LY, Noor NM, Chuo PH, Ishak S, Anas SS, Soheimi SSA, and Aziddin RER
- Subjects
- Adult, Humans, Advisory Committees, Malaysia, Review Literature as Topic, Albuminuria diagnosis, Albuminuria physiopathology, Albuminuria urine, Glomerular Filtration Rate, Renal Insufficiency, Chronic diagnosis, Renal Insufficiency, Chronic physiopathology, Renal Insufficiency, Chronic urine
- Abstract
Chronic kidney disease (CKD) is a common clinical condition with significant health risks for patients and is widely recognised as a major public health concern. Laboratory medicine plays a crucial role in both diagnosing and managing CKD, as diagnosis and staging rely on estimated glomerular filtration rate (GFR) and evaluating albuminuria (or proteinuria). It was evident that the laboratory assessment of CKD in Malaysia is not standardised. In light of this, the Malaysian Association of Clinical Biochemistry CKD (MACB-CKD) Task Force issued a national recommendation for laboratory diagnosis of CKD in 2019. Recently, Kidney Disease: Improving Global Outcomes (KDIGO) updated its recommendations for the diagnosis, evaluation, management, and treatment of CKD. These guidelines incorporate the most recent evidence-based practices to support laboratory professionals in delivering optimal care for individuals with CKD, focusing on critical areas such as estimated GFR (eGFR), albuminuria assessment, and risk stratification. The latest National Institute for Health and Care Excellence (NICE) guidelines on CKD has also incorporated the Kidney Failure Risk Equation (KFRE) as a tool for predicting the likelihood of progression to end-stage kidney disease (ESKD) in CKD patients. Hence, the MACB-CKD Task Force has reviewed and updated its recommendations for laboratory reporting of eGFR and urine albumin in alignment with the latest guidelines.
- Published
- 2024
29. Review article: Novel therapies in inflammatory bowel disease - An update for clinicians.
- Author
-
Noor NM, Bourke A, and Subramanian S
- Subjects
- Humans, Janus Kinase Inhibitors therapeutic use, Crohn Disease drug therapy, Colitis, Ulcerative drug therapy, Gastrointestinal Agents therapeutic use, Inflammatory Bowel Diseases drug therapy
- Abstract
Background: Several new treatments including small molecules and biologics have been approved for the treatment of inflammatory bowel diseases in recent years. Clinicians and patients now have a wide variety of therapeutic options to choose from and these novel therapies provide several advantages including oral administration, lower immunogenicity, better selectivity and arguably better safety profiles. An increase in treatment options has increased the complexity of decision-making. Both patients and clinicians have had to become rapidly familiar with efficacy of new medications balanced against a range of pre-initiation requirements, dosing schedules and adverse event profiles., Aims: To provide a simple guide to practising clinicians on recently approved and emerging therapies and address key challenges around treatment strategies such as optimal sequencing and timing of treatment., Methods: We comprehensively searched the published literature and major conference abstracts to identify phase III placebo-controlled and active comparator trials for Crohn's disease and ulcerative colitis., Results: Data for recently approved therapies including selective Janus kinase inhibitors, sphingosine-1 receptor modulators and p19 interleukin (IL)-23 inhibitors have demonstrated improved patient outcomes in both Crohn's disease and ulcerative colitis. Further comparative head-to-head studies have improved our understanding of when and how to optimally use newer therapies, specifically for IL-23 inhibitors. Data for emerging treatment options and novel treatment strategies such as early effective treatment, combinations of treatments and implications for sequencing are continuing to transform IBD care continually., Conclusions: Recently approved novel therapies have expanded the range of medical options available to treat IBD. However, further data from long-term extension studies, real-world studies and head-to-head trials are warranted to better inform the long-term safety and optimal sequencing of treatments for patients living with IBD., (© 2024 John Wiley & Sons Ltd.)
- Published
- 2024
- Full Text
- View/download PDF
30. Unmasking the Steroid Curtain: Reevaluating Corticosteroid Use in IBD Clinical Trials.
- Author
-
Berinstein JA and Noor NM
- Published
- 2024
- Full Text
- View/download PDF
31. The need for affordable, pragmatic, investigator-led clinical trials of treatment strategies in inflammatory bowel disease.
- Author
-
Noor NM, Sebastian S, Parkes M, and Raine T
- Subjects
- Humans, Pragmatic Clinical Trials as Topic methods, Clinical Trials as Topic economics, Inflammatory Bowel Diseases drug therapy, Inflammatory Bowel Diseases economics, Inflammatory Bowel Diseases therapy
- Abstract
Competing Interests: NMN reports personal fees from Bristol Myers Squibb, Galapagos, Johnson & Johnson Innovative Medicine, Lilly, SBK Healthcare, and Takeda outside the submitted work; grants from Celltrion, Dr Falk Pharma, Johnson & Johnson Innovative Medicine, Pfizer, Pharmacosmos, and Tillotts Pharma outside the submitted work; and advisory board membership for Bristol Myers Squibb outside the submitted work. SS reports consulting fees from Takeda, AbbVie, Merck, Ferring, Pharmacosmos, Warner Chilcott, Johnson & Johnson Innovative Medicine, Dr Falk Pharma, Biohit, TriGenix, Celgene, and Tillots Pharma outside the submitted work; payment or honoraria from AbbVie, Takeda, Celltrion, Pfizer, Biogen, AbbVie, Johnson & Johnson Innovative Medicine, Merck, Warner Chilcott, and Dr Falk Pharma outside the submitted work; and is co-director of research for the South Asian IBD Alliance. MP reports personal fees from Johnson & Johnson Innovative Medicine and Takeda outside the submitted work; and grants from AstraZeneca, Galapagos, Gilead, Pfizer, and Eli Lilly outside the submitted work. TR reports personal fees from Abbvie, Arena, Aslan, AstraZeneca, Boehringer-Ingelheim, Bristol Myers Squibb, Eli Lilly, Ferring, Galapagos, Gilead, GlaxoSmithKline, Heptares, LabGenius, Novartis, Numab, Johnson & Johnson Innovative Medicine, Pfizer, Roche, Takeda, Union Chimique Belge (UCB), and Xap Therapeutics outside the submitted work; grants from AbbVie outside the submitted work; and fees from data monitoring board membership of UCB outside the submitted work. NMN and MP are supported by the National Institute for Health and Care Research (NIHR) Cambridge Biomedical Research Centre (NIHR203312). The views expressed are those of the authors and not necessarily those of the NIHR or the Department of Health and Social Care.
- Published
- 2024
- Full Text
- View/download PDF
32. The overlap between randomised evaluations of recruitment and retention interventions: An updated review of recruitment (Online Resource for Recruitment in Clinical triAls) and retention (Online Resource for Retention in Clinical triAls) literature.
- Author
-
Kearney A, Butlin L, Coffey T, Conway T, Cotterill S, Evans A, Fox J, Hunter A, Inglis S, Murphy L, Noor NM, Walker-Smith T, and Gamble C
- Subjects
- Humans, Databases, Factual, Research Design, Patient Dropouts, Patient Selection, Randomized Controlled Trials as Topic methods
- Abstract
Background: The Online Resource for Recruitment in Clinical triAls (ORRCA) and the Online Resource for Retention in Clinical triAls (ORRCA2) were established to organise and map the literature addressing participant recruitment and retention within clinical research. The two databases are updated on an ongoing basis using separate but parallel systematic reviews. However, recruitment and retention of research participants is widely acknowledged to be interconnected. While interventions aimed at addressing recruitment challenges can impact retention and vice versa, it is not clear how well they are simultaneously considered within methodological research. This study aims to report the recent update of ORRCA and ORRCA2 with a special emphasis on assessing crossover of the databases and how frequently randomised studies of methodological interventions measure the impact on both recruitment and retention outcomes., Methods: Two parallel systematic reviews were conducted in line with previously reported methods updating ORRCA (recruitment) and ORRCA2 (retention) with publications from 2018 and 2019. Articles were categorised according to their evidence type (randomised evaluation, non-randomised evaluation, application and observation) and against the recruitment and retention domain frameworks. Articles categorised as randomised evaluations were compared to identify studies appearing in both databases. For randomised studies that were only in one database, domain categories were used to assess whether the methodological intervention was likely to impact on the alternate construct. For example, whether a recruitment intervention might also impact retention., Results: In total, 806 of 17,767 articles screened for the recruitment database and 175 of 18,656 articles screened for the retention database were added as result of the update. Of these, 89 articles were classified as 'randomised evaluation', of which 6 were systematic reviews and 83 were randomised evaluations of methodological interventions. Ten of the randomised studies assessed recruitment and retention and were included in both databases. Of the randomised studies only in the recruitment database, 48/55 (87%) assessed the content or format of participant information which could have an impact on retention. Of the randomised studies only in the retention database, 6/18 (33%) assessed monetary incentives, 4/18 (22%) assessed data collection location and methods and 3/18 (17%) assessed non-monetary incentives, all of which could have an impact on recruitment., Conclusion: Only a small proportion of randomised studies of methodological interventions assessed the impact on both recruitment and retention despite having a potential impact on both outcomes. Where possible, an integrated approach analysing both constructs should be the new standard for these types of evaluations to ensure that improvements to recruitment are not at the expense of retention and vice versa., Competing Interests: Declaration of conflicting interestsThe author(s) declared no potential conflicts of interest with respect to the research, authorship and/or publication of this article.
- Published
- 2024
- Full Text
- View/download PDF
33. The Importance of Molecular Biological Analysis for the Laboratory Diagnostic of Homozygous Haemoglobin Malay.
- Author
-
Bahar R, Zulkafli Z, Zulkeflee RH, Hassan MN, Rahman Wan SWA, Noor NM, Ramli M, Hussin A, Abdullah AD, Iberahim S, Abdullah M, and Yusoff SM
- Abstract
Haemoglobin (Hb) Malay is variant haemoglobin with a β
++ thalassemia phenotype. The prevalence of Hb Malay in the Malaysian population was 5.5%. We describe a 58-year-old male who presented with symptomatic anaemia to the Hospital Universiti Sains Malaysia. Further history revealed that the patient had anaemia since the age of 28, and on regular follow-up at other hospital. Physical examination revealed pallor, jaundice and hepatosplenomegaly. The full blood count and peripheral blood smear showed hypochromic microcytic anaemia with anisopoikilocytosis, and many target cells. High-performance liquid chromatography results showed a β thalassemia trait. However, the diagnosis does not alight with the patient's condition. Bone marrow aspirate was completed and showed reactive changes and erythroid hyperplasia. A molecular test was then performed for β globin gene mutation detection using Multiplex Amplification Refractory Mutation System (M-ARMS) PCR method. This revealed the result as homozygous codon 19 mutation or Hb Malay. Therefore, in this case report we would like to highlight the laboratory approaches, the challenges faced by the usual haematological investigations and the importance role of molecular testing in the diagnosis of severe anaemia., (© 2024 R Bahar et al., published by Sciendo.)- Published
- 2024
- Full Text
- View/download PDF
34. Seeing the whole picture: Inflammatory bowel disease complications and extraintestinal manifestations on cross-sectional imaging.
- Author
-
Estevinho MM and Noor NM
- Published
- 2024
- Full Text
- View/download PDF
35. Vedolizumab and new-onset spondyloarthritis: Debunking the myth.
- Author
-
Roseira J, Marafini I, and Noor NM
- Published
- 2024
- Full Text
- View/download PDF
36. Preactive therapeutic drug monitoring (TDM): time to redefine TDM.
- Author
-
Papamichael K, Noor NM, and Cheifetz AS
- Subjects
- Humans, Drug Monitoring methods
- Published
- 2024
- Full Text
- View/download PDF
37. Treatment strategies and biomarkers in Crohn's disease: the PROFILE trial - Authors' reply.
- Author
-
Noor NM, Lee JC, Bond S, and Parkes M
- Subjects
- Humans, Crohn Disease drug therapy, Crohn Disease diagnosis, Biomarkers blood
- Published
- 2024
- Full Text
- View/download PDF
38. A biomarker-stratified comparison of top-down versus accelerated step-up treatment strategies for patients with newly diagnosed Crohn's disease (PROFILE): a multicentre, open-label randomised controlled trial.
- Author
-
Noor NM, Lee JC, Bond S, Dowling F, Brezina B, Patel KV, Ahmad T, Banim PJ, Berrill JW, Cooney R, De La Revilla Negro J, de Silva S, Din S, Durai D, Gordon JN, Irving PM, Johnson M, Kent AJ, Kok KB, Moran GW, Mowat C, Patel P, Probert CS, Raine T, Saich R, Seward A, Sharpstone D, Smith MA, Subramanian S, Upponi SS, Wiles A, Williams HRT, van den Brink GR, Vermeire S, Jairath V, D'Haens GR, McKinney EF, Lyons PA, Lindsay JO, Kennedy NA, Smith KGC, and Parkes M
- Subjects
- Adult, Humans, Male, Female, Infliximab therapeutic use, Azathioprine therapeutic use, Biomarkers, Immunologic Factors therapeutic use, Inflammation, Leukocyte L1 Antigen Complex, Crohn Disease diagnosis, Crohn Disease drug therapy, Crohn Disease complications
- Abstract
Background: Management strategies and clinical outcomes vary substantially in patients newly diagnosed with Crohn's disease. We evaluated the use of a putative prognostic biomarker to guide therapy by assessing outcomes in patients randomised to either top-down (ie, early combined immunosuppression with infliximab and immunomodulator) or accelerated step-up (conventional) treatment strategies., Methods: PROFILE (PRedicting Outcomes For Crohn's disease using a moLecular biomarker) was a multicentre, open-label, biomarker-stratified, randomised controlled trial that enrolled adults with newly diagnosed active Crohn's disease (Harvey-Bradshaw Index ≥7, either elevated C-reactive protein or faecal calprotectin or both, and endoscopic evidence of active inflammation). Potential participants had blood drawn to be tested for a prognostic biomarker derived from T-cell transcriptional signatures (PredictSURE-IBD assay). Following testing, patients were randomly assigned, via a secure online platform, to top-down or accelerated step-up treatment stratified by biomarker subgroup (IBDhi or IBDlo), endoscopic inflammation (mild, moderate, or severe), and extent (colonic or other). Blinding to biomarker status was maintained throughout the trial. The primary endpoint was sustained steroid-free and surgery-free remission to week 48. Remission was defined by a composite of symptoms and inflammatory markers at all visits. Flare required active symptoms (HBI ≥5) plus raised inflammatory markers (CRP >upper limit of normal or faecal calprotectin ≥200 μg/g, or both), while remission was the converse-ie, quiescent symptoms (HBI <5) or resolved inflammatory markers (both CRP ≤ the upper limit of normal and calprotectin <200 μg/g) or both. Analyses were done in the full analysis (intention-to-treat) population. The trial has completed and is registered (ISRCTN11808228)., Findings: Between Dec 29, 2017, and Jan 5, 2022, 386 patients (mean age 33·6 years [SD 13·2]; 179 [46%] female, 207 [54%] male) were randomised: 193 to the top-down group and 193 to the accelerated step-up group. Median time from diagnosis to trial enrolment was 12 days (range 0-191). Primary outcome data were available for 379 participants (189 in the top-down group; 190 in the accelerated step-up group). There was no biomarker-treatment interaction effect (absolute difference 1 percentage points, 95% CI -15 to 15; p=0·944). Sustained steroid-free and surgery-free remission was significantly more frequent in the top-down group than in the accelerated step-up group (149 [79%] of 189 patients vs 29 [15%] of 190 patients, absolute difference 64 percentage points, 95% CI 57 to 72; p<0·0001). There were fewer adverse events (including disease flares) and serious adverse events in the top-down group than in the accelerated step-up group (adverse events: 168 vs 315; serious adverse events: 15 vs 42), with fewer complications requiring abdominal surgery (one vs ten) and no difference in serious infections (three vs eight)., Interpretation: Top-down treatment with combination infliximab plus immunomodulator achieved substantially better outcomes at 1 year than accelerated step-up treatment. The biomarker did not show clinical utility. Top-down treatment should be considered standard of care for patients with newly diagnosed active Crohn's disease., Funding: Wellcome and PredictImmune Ltd., Competing Interests: Declaration of interests NMN reports personal fees from Galapagos, Janssen, Lilly, SBK Healthcare, and Takeda outside the submitted work; and grants from Dr Falk, Pfizer, Pharmacosmos, and Tillotts Pharma outside the submitted work. JCL reports consultancy fees from AbbVie, AgPlus Diagnostics, PredictImmune, and C4X Discover outside the submitted work; and grants from GSK outside the submitted work. KVP reports personal fees from AbbVie, DrFalk, Galapagos, Janssen, PredictImmune, Pfizer, and Takeda outside the submitted work; grants from AbbVie, Celltrion, Dr Falk, Ferring, Janssen, Takeda, and Tillotts Pharma outside the submitted work; and fees from advisory board membership of AbbVie, Galapagos, Janssen, and Pfizer outside the submitted work. TA reports personal fees from Amgen, Celltrion, Janssen, Lilly, Pfizer, and Tillotts Pharma; and grants from Biogen, Celltrion, Galapagos, Nova Pharmaceuticals, Pfizer, Roche, and Takeda outside the submitted work. JWB reports personal fees from Janssen outside the submitted work. RC reports personal fees from AbbVie, Galapagos, and Lilly outside the submitted work, grants from Celltrion, Ferring, and Tillotts Pharma outside the submitted work; and fees from advisory board membership of AbbVie and Bristol Myers Squibb outside the submitted work. SD reports personal fees from AbbVie, Ferring, Janssen, and Takeda outside the submitted work; grants from AbbVie, Dr Falk, and Janssen, outside the submitted work; and fees from advisory board membership of AbbVie outside the submitted work. DD reports personal fees from Takeda outside the submitted work; and grants from AbbVie and Janssen outside the submitted work. PMI reports personal fees from AbbVie, Arena, Boehringer-Ingelheim, BMS, Celgene, Celltrion, Dr Falk, Galapagos, Genentech, Gilead, Hospira, Janssen, Lilly, MSD, Pfizer, Prometheus, Sandoz, Samsung Bioepis, Sapphire Medical, Takeda, Topivert, VH2, Vifor Pharma, and Warner Chilcott outside the submitted work; and grants from AbbVie and Takeda outside the submitted work. AJK reports personal fees from AbbVie, Galapagos, and Takeda outside the submitted work; grants from AbbVie, Janssen, and Tillotts Pharma outside the submitted work; and fees from advisory board membership of AbbVie and Janssen outside the submitted work. CM reports grants from Janssen outside the submitted work. CSP reports personal fees from Dr Falk outside the submitted work. TR reports personal fees from AbbVie, Arena, Aslan, AstraZeneca, Boehringer-Ingelheim, BMS, Eli Lilly, Ferring, Galapagos, Gilead, GSK, Heptares, LabGenius, Novartis, Numab, Janssen, Pfizer, Roche, Takeda, UCB, and XAP therapeutics outside the submitted work; grants from AbbVie outside the submitted work; and fees from data monitoring board membership of UCB outside the submitted work. SS reports personal fees from AbbVie, Celltrion, Dr Falk, Ipsen, Janssen, and Takeda outside the submitted work. HRTW reports fees from advisory board membership of Pfizer outside the submitted work. SV reports personal fees from AbbVie, Abivax, AbolerISPharma, AgomAb, Alimentiv (formerly Robarts Clinical Trials), Arena Pharmaceuticals, AstraZeneca, BMS, Boehringer Ingelheim, Celgene, Cytoki Pharma, Dr Falk Pharma, Ferring, Galapagos, Genentech-Roche, Gilead, GSK, Hospira, Imidomics, Janssen, J&J, Lilly, Materia Prima, Mestag Therapeutics, MiroBio, Morphic, MrMHealth, MSD, Mundipharma, Pfizer, Prodigest, Progenity, Prometheus, Surrozen, Takeda, Theravance, Tillotts Pharma, VectivBio, Ventyx, and Zealand Pharma outside the submitted work; and grants from AbbVie, Galapagos, J&J, Pfizer, and Takeda outside the submitted work. VJ reports personal fees from AbbVie, Alimentiv (formerly Robarts Clinical Trials), Arena Pharmaceuticals, Asahi Kasei Pharma, Asieris, AstraZeneca, Avoro Capital, BMS, Celltrion, Endpoint Health, Enthera, Ferring, Flagship Pioneering, Fresenius Kabi, Galapagos, Gilde Healthcare, GSK, Genentech, Gilead, Innomar, JAMP, Janssen, Lilly, Merck, Metacrine, Mylan, Pandion, Pendopharm, Pfizer, Protagonist, Prometheus, Reistone Biopharma, Roche, Roivant, Sandoz, SCOPE, Second Genome, Sorriso Pharmaceuticals, Takeda, Teva, Topivert, Ventyx, and Vividion outside the submitted work; and fees from advisory board membership of AbbVie, Alimentiv (formerly Robarts Clinical Trials), Arena Pharmaceuticals, Asahi Kasei Pharma, Asieris, AstraZeneca, BMS, Celltrion, Ferring, Flagship Pioneering, Fresenius Kabi, Galapagos, Gilde Healthcare, GSK, Genentech, Gilead, Innomar, JAMP, Janssen, Lilly, Merck, Metacran, Mylan, Pandion, Pendopharm, Pfizer, Protagonist, Prometheus, Reistone Biopharma, Roche, Sandoz, SCOPE, Second Genome, Sorriso Pharmaceuticals, Takeda, Teva, Topivert, Ventyx, and Vividion outside the submitted work. GRDH reports personal fees from AbbVie, Alimentiv, AstraZeneca, Immunic, J&J, Lilly, Pfizer, Takeda, Tillotts, and Ventyx outside the submitted work; grants from AbbVie, BMS, Lilly, Pfizer, and Takeda outside the submitted work; and fees from advisory board membership of AstraZeneca, Galapagos, and Seres Health outside the submitted work. EFM reports being a co-founder and receiving consultancy fees from PredictImmune; and holds PredictImmune stock or stock options. PAL reports being a co-founder and receiving consultancy fees from PredictImmune; and holds PredictImmune stock or stock options. JOL reports personal fees from AbbVie, Atlantic Healthcare, Bristol Meyer Squibb, Celgene, Celltrion, Engytix, Eli Lilly, Ferring, Galapagos, Gilead, GSK, Janssen, MSD, Norgine, Pfizer, Shire, and Takeda outside the submitted work; and grants from AbbVie, Ferring, Gilead, Takeda, and Shire outside the submitted work. NAK reports personal fees from Amgen, Bristol Myers Squibb, Celltrion, Falk, Galapagos, Janssen, Pfizer, Pharmacosmos, Takeda, and Tillotts Pharma outside the submitted work; and reports data monitoring board membership for the BEACON study outside the submitted work. KGCS reports being a co-founder and receiving consultancy fees from Predictimmune; consultancy fees from GSK outside the submitted work; and holds PredictImmune stock or stock options. MP reports personal fees from Janssen and Takeda outside the submitted work; and grants from AstraZeneca, Galapagos, Gilead, and Pfizer outside the submitted work. All other authors declare no competing interests., (Copyright © 2024 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license. Published by Elsevier Ltd.. All rights reserved.)
- Published
- 2024
- Full Text
- View/download PDF
39. Correction: Patient-controlled analgesia morphine for the management of acute pain in the emergency department: a systematic review and meta-analysis.
- Author
-
Oon MB, Hisamuddin NNAR, Noor NM, and Yazid MB
- Published
- 2024
- Full Text
- View/download PDF
40. Endoscopic and Histological Placebo Rates in Crohn's Disease Clinical Trials: A Systematic Review and Meta-analysis.
- Author
-
Vuyyuru SK, Nguyen TM, Hogan M, Raine T, Noor NM, Narula N, Verstockt B, Feagan BG, Singh S, Ma C, and Jairath V
- Subjects
- Humans, Endoscopy, Remission Induction, Placebo Effect, Randomized Controlled Trials as Topic, Crohn Disease drug therapy
- Abstract
Background: Precise estimates of placebo response rates help efficient clinical trial design. In this systematic review and meta-analysis, we assessed contemporary placebo endoscopic and histological response rates in Crohn's disease (CD) clinical trials., Methods: MEDLINE, EMBASE, and Cochrane CENTRAL were searched from inception to April 2022 to identify placebo-controlled studies of pharmacological interventions for CD. Endoscopic response, remission, and mucosal healing rates for participants assigned to placebo in induction and maintenance studies were pooled using a random-effects model. Point estimates and associated 95% confidence intervals (CIs) were calculated., Results: In total, 16 studies (11 induction, 3 maintenance, 2 induction and maintenance) that randomized 1646 participants to placebo were eligible. For induction trials, the pooled placebo endoscopic response, endoscopic remission, and mucosal healing rates in participants assigned to placebo were 13% (95% CI, 10-16; I2 = 14.1%; P = .14), 6% (95% CI, 3-11; I2 = 74.7%; P < .001), and 6% (95% CI, 4-9; I2 = 26.9%; P = .29), respectively. The pooled endoscopic remission rate in patients who were bio-naïve was 10% (95% CI, 4-23) compared with only 4% (95% CI, 3-7) in bio-experienced patients. For maintenance trials, the pooled endoscopic response, remission, and mucosal healing rates were 7% (95% CI, 1-31; I2 = 78.2%; P = .004), 11% (95% CI, 4-27; I2 = 70.8%; P = .06), and 7% (95% CI, 3-15; I2 = 29.7; P = .23), respectively. Only 3 trials assessed histological outcomes., Conclusions: Endoscopic placebo rates vary according to trial phase and prior biologic exposure. These contemporary data will serve to inform CD trial design, sample size calculation, and end point selection for future trials., (© The Author(s) 2023. Published by Oxford University Press on behalf of Crohn’s & Colitis Foundation. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.)
- Published
- 2024
- Full Text
- View/download PDF
41. Exploring dietitians' views on digital nutrition educational tools in Malaysia: a qualitative study.
- Author
-
Manaf ZA, Rosli MHM, Noor NM, Jamil NA, Mazri FH, and Shahar S
- Abstract
Background/objectives: Dietitians frequently use nutrition education tools to facilitate dietary counselling sessions. Nevertheless, these tools may require adaptation to keep pace with technological advancements. This study had a 2-fold purpose: first, to identify the types of nutrition education tools currently in use, identify their limitations, and explore dietitians' perspectives on the importance of these tools; second, to investigate the features that dietitians prefer in digital nutrition education tools., Subjects/methods: A semi-structured face-to-face interview was conducted among 15 dietitians from selected public hospitals, primary care clinics, and teaching hospitals in Malaysia. Inductive thematic analysis of the responses was conducted using NVivo version 12 software., Results: Most dietitians used physical education tools including the healthy plate model, pamphlets, food models, and flip charts. These tools were perceived as important as they facilitate the nutrition assessment process, deliver nutrition intervention, and are time efficient. However, dietitians described the current educational tools as impersonal, outdated, limited in availability due to financial constraints, unhandy, and difficult to visualise. Alternatively, they strongly favoured digital education tools that provided instant feedback, utilised an automated system, included a local food database, were user-friendly, developed by experts in the field, and seamlessly integrated into the healthcare system., Conclusion: Presently, although dietitians have a preference for digital educational tools, they heavily rely on physical nutrition education tools due to their availability despite the perception that these tools are outdated, impersonal, and inconvenient. Transitioning to digital dietary education tools could potentially address these issues., Competing Interests: Conflict of Interest: The authors declare no potential conflicts of interests., (©2024 The Korean Nutrition Society and the Korean Society of Community Nutrition.)
- Published
- 2024
- Full Text
- View/download PDF
42. Effect of different temperature variations on the physiological state of catfish species: a systematic review.
- Author
-
Kasihmuddin SM, Cob ZC, Noor NM, and Das SK
- Subjects
- Animals, Climate Change, Stress, Physiological physiology, Catfishes physiology, Temperature
- Abstract
Catfish are a highly diverse group of fish that are found in various regions across the globe. The significance of catfish culture extends to various aspects, including food security, economic advancement, preservation of cultural legacy, and ecological stewardship. The catfish industry is presently encountering unprecedented challenges as a consequence of the variability in water temperature caused by climate change. Temperature is a significant abiotic component that regulates and restricts fish physiology throughout their life cycle. The impact of severe temperatures on various species of catfish is dependent upon the magnitude of the stressor and additional influencing factors. This paper presents an analysis of the effects of temperature fluctuations on various aspects of catfish species, including growth and survival, blood parameters, enzymatic and hormone response, oxygen consumption rates, sound generation and hearing skills, nutritional requirements, and other phenotypic attributes. While this review is certainly not exhaustive, it offers a broad synopsis of the ideal temperature ranges that are most favorable for several catfish species. In-depth research to investigate the interacting impacts of severe temperature occurrences in conjunction with other associated environmental stresses on a wider variety of catfish species is crucial in order to further our understanding of how catfish species will respond to the anticipated climate change in the future., (© 2024. The Author(s), under exclusive licence to Springer Nature B.V.)
- Published
- 2024
- Full Text
- View/download PDF
43. Real-world evaluation of care for type 2 diabetes in Malaysia: A cross-sectional analysis of the treatment adherence to guideline evaluation in type 2 diabetes (TARGET-T2D) study.
- Author
-
Lim LL, Hussein Z, Noor NM, Raof ASA, Mustafa N, Bidin MBL, Ghani RA, Samsuddin S, Yong SL, Foo SH, Raghuram K, Suwannasri P, W B WM, Chiew TK, and Chan SP
- Subjects
- Male, Humans, Adolescent, Adult, Middle Aged, Aged, Female, Cross-Sectional Studies, Glycated Hemoglobin, Cholesterol, LDL, Malaysia epidemiology, Treatment Adherence and Compliance, Diabetes Mellitus, Type 2
- Abstract
Aim: Given a lack of data on diabetes care performance in Malaysia, we conducted a cross-sectional study to understand the clinical characteristics, control of cardiometabolic risk factors, and patterns of use of guideline-directed medical therapy (GDMT) among patients with type 2 diabetes (T2D), who were managed at publicly-funded hospitals between December 2021 and June 2022., Methods: Patients aged ≥18 years with T2D from eight publicly-funded hospitals in the Greater Kuala Lumpur region, who had ≥2 outpatient visits within the preceding year and irrespective of treatment regimen, were eligible. The primary outcome was ≥2 treatment target attainment (defined as either HbA1c <7.0%, blood pressure [BP] <130/80 mmHg, or low-density lipoprotein cholesterol [LDL-C] <1.8 mmol/L). The secondary outcomes were the individual treatment target, a combination of all three treatment targets, and patterns of GDMT use. To assess for potential heterogeneity of study findings, all outcomes were stratified according to prespecified baseline characteristics namely 1) history of atherosclerotic cardiovascular disease (ASCVD; yes/no) and 2) clinic type (Diabetes specialist versus General medicine)., Results: Among 5094 patients (mean±SD age 59.0±13.2 years; T2D duration 14.8±9.2 years; HbA1c 8.2±1.9% (66±21 mmol/mol); BMI 29.6±6.2 kg/m2; 45.6% men), 99% were at high/very high cardiorenal risk. Attainment of ≥2 treatment targets was at 18%, being higher in General medicine than in Diabetes specialist clinics (20.8% versus 17.5%; p = 0.039). The overall statin coverage was 90%. More patients with prior ASCVD attained LDL-C <1.4 mmol/L than those without (13.5% versus 8.4%; p<0.001). Use of sodium-glucose cotransporter-2 (SGLT2) inhibitors (13.2% versus 43.2%), glucagon-like peptide-1 receptor agonists (GLP1-RAs) (1.0% versus 6.2%), and insulin (27.7% versus 58.1%) were lower in General medicine than in Diabetes specialist clinics., Conclusions: Among high-risk patients with T2D, treatment target attainment and use of GDMT were suboptimal., Competing Interests: LLL report receiving grants through her affiliated institutions and/or honoraria for consultancy and speaker bureau from Abbott, AstraZeneca, Boehringer Ingelheim, Merck Sharp & Dohme, Novo Nordisk, Roche, Sanofi, Servier, and Zuellig Pharma. SPC report receiving the research grant through her affiliated Society (Malaysian Endocrine and Metabolic Society) and honoraria for consultancy and speaker bureau from Abbott, AstraZeneca, Boehringer Ingelheim, Novo Nordisk, Roche, Sanofi, Servier, and Zuellig Pharma. KR and PS are employee of Boehringer Ingelheim. Other co-authors declared no potential conflict of interest. There are no patents, products in development or marketed products associated with this research to declare. This does not alter our adherence to PLOS ONE policies on sharing data and materials., (Copyright: © 2024 Lim et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.)
- Published
- 2024
- Full Text
- View/download PDF
44. Essential Oils as an Alternative Treatment for Migraine Headache: A Systematic Review and Meta-Analysis.
- Author
-
Murtey P, Noor NM, Ishak A, and Idris NS
- Abstract
Background: Alternative and complementary medicines are widely used to treat migraine headaches. This review aimed to determine the effectiveness of essential oils as an alternative treatment approach., Methods: A structured search was conducted to identify randomized trials comparing essential oils with a placebo for migraine headaches, using databases (MEDLINE and CENTRAL) to search for articles published between 1966 and 2021. We included trials involving adult males and females diagnosed with migraine headaches according to the International Headache Society. The outcomes included number of attacks, headache severity, associated symptoms, number of days of limited activity, headache duration, use of analgesics, and adverse effects. Seven trials were included with a total of 558 participants., Results: No difference was observed in the number of migraine headache attacks compared to placebo (mean difference [MD], -1.34; 95% confidence interval [CI], -3.31 to 0.64; I2=94%; P=0.190; four trials, 242 participants; moderate- quality evidence). There was no difference in this outcome between the essential oils treated group and the placebo (MD, -0.38; 95% CI, -1.76 to 0.99; I2 statistics=86%; P=0.580; five trials, 240 participants; moderate-quality evidence)., Conclusion: We found no significant difference between the use of essential oils and placebo in managing migraine headaches.
- Published
- 2024
- Full Text
- View/download PDF
45. Sustainable valorization approaches on crustacean wastes for the extraction of chitin, bioactive compounds and their applications - A review.
- Author
-
Azelee NIW, Dahiya D, Ayothiraman S, Noor NM, Rasid ZIA, Ramli ANM, Ravindran B, Iwuchukwu FU, and Selvasembian R
- Subjects
- Animals, Chitin chemistry, Crustacea metabolism, Seafood, Chitosan, Waste Management
- Abstract
The unscientific disposal of the most abundant crustacean wastes, especially those derived from marine sources, affects both the economy and the environment. Strategic waste collection and management is the need of the hour. Sustainable valorization approaches have played a crucial role in solving those issues as well as generating wealth from waste. The shellfishery wastes are rich in valuable bioactive compounds such as chitin, chitosan, minerals, carotenoids, lipids, and other amino acid derivatives. These value-added components possessed pleiotropic applications in different sectors viz., food, nutraceutical, cosmeceutical, agro-industrial, healthcare, and pharmaceutical sectors. The manuscript covers the recent status, scope of shellfishery management, and different bioactive compounds obtained from crustacean wastes. In addition, both sustainable and conventional routes of valorization approaches were discussed with their merits and demerits along with their combinations. The utilization of nano and microtechnology was also included in the discussion, as they have become prominent research areas in recent years. More importantly, the future perspectives of crustacean waste management and other potential valorization approaches that can be implemented on a large scale., Competing Interests: Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper., (Copyright © 2023 Elsevier B.V. All rights reserved.)
- Published
- 2023
- Full Text
- View/download PDF
46. Combination therapies: the next major frontier in IBD management.
- Author
-
Noor NM
- Subjects
- Humans, Combined Modality Therapy, Inflammatory Bowel Diseases drug therapy
- Published
- 2023
- Full Text
- View/download PDF
47. Results of the Eighth Scientific Workshop of ECCO: Diagnosing Postoperative Recurrence of Crohn's Disease After an Ileocolonic Resection With Ileocolonic Anastomosis.
- Author
-
Dragoni G, Allocca M, Myrelid P, Noor NM, Hammoudi N, Rivière P, Panis Y, and Ferrante M
- Abstract
Despite the introduction of potent biologic therapies, many patients with Crohn's disease [CD] still require an ileocolonic resection [ICR] during the course of their disease. Furthermore, the need of redo ICR has not decreased over the past few decades, highlighting the need for better strategies to prevent and treat postoperative recurrence [POR]. The first step to develop such a strategy would be to define and standardise the description of POR with adequate diagnostic instruments. In this article, we will describe the different methodologies used to report POR [endoscopic, histological, radiological, biochemical, clinical, and surgical], and review their potential benefits and limitations, as well as the optimal timing of evaluation., (© The Author(s) 2023. Published by Oxford University Press on behalf of European Crohn’s and Colitis Organisation. All rights reserved. For permissions, please email: journals.permissions@oup.com.)
- Published
- 2023
- Full Text
- View/download PDF
48. Innovations to improve the efficiency of phase II IBD clinical trials.
- Author
-
Noor NM and Raine T
- Subjects
- Humans, Inflammatory Bowel Diseases drug therapy, Clinical Trials, Phase II as Topic standards
- Published
- 2023
- Full Text
- View/download PDF
49. Leveraging Virtual Technology to Conduct Clinical Trials in Inflammatory Bowel Disease.
- Author
-
Noor NM and Siegel CA
- Abstract
Clinical trials have led to major advances in inflammatory bowel disease (IBD) care over the last few decades, yet in that time most clinical trial protocols in IBD have remained markedly the same. Many IBD protocols often still require face-to-face visits and monitoring, hospital-based medication administration, paper-based forms and questionnaires, and short follow-up periods resulting in limited long-term data. These factors have recently been recognized as likely contributors to the low recruitment and lack of diversity of participants across clinical trials in IBD. However, with increasing technological advances, there is now an opportunity for improvement. This article assesses a range of virtual innovations for how they may offer digital solutions to challenges currently encountered in IBD clinical trials. Such solutions include consideration for increasing patient diversity, digital invitation, remote consent and recruitment, virtual visits, remote patient monitoring and data collection, remote medication delivery and administration, remote clinical trial monitoring, and routinely collected health data for long-term follow-up. Adoption of virtual technology may drive the field toward patient centricity and more efficient trial protocols to allow for a new era in IBD clinical trials., (Copyright © 2023, Gastro-Hep Communications, Inc.)
- Published
- 2023
50. Protocol for a systematic review of the associations between inflammatory markers and lung function, muscle force and exercise capacity in people with COPD.
- Author
-
Noor NM, Mustaffa Z, Nizam A, Mohd Zim MA, Ng LWC, and Mirza FT
- Subjects
- Humans, Quality of Life, Muscles, Lung, Exercise Tolerance, Pulmonary Disease, Chronic Obstructive
- Abstract
Introduction: The prevalence of chronic obstructive pulmonary disease (COPD) has been on the rise, with acute exacerbation of COPD associated with the highest burden and multiple pulmonary and systemic consequences. People with COPD have been found to have an abnormal response of systemic inflammation. To date, although limited, there are studies that suggest negative associations between inflammatory markers and important clinical outcomes such as exercise capacity and muscle force. This protocol aims to systematically review the evidence for (i) the associations between inflammatory markers and lung function, muscle force and exercise capacity and (ii) the influence of other factors (eg, hospitalisation, exercise programme) on the level of inflammatory markers in people with COPD., Methods and Analysis: Scopus, PubMed, Cochrane, Web of Science and ProQuest will be searched from database inception to February 2023 using PEO search strategy (Population: adults with COPD; Exposure: inflammatory markers; Outcomes: lung function, muscle force and exercise capacity). Four reviewers working in pairs will independently screen articles for eligibility and extract data that fulfilled the inclusion criteria. Depending on the design of the included studies, either Cochrane risk-of-bias version 2 or the Newcastle-Ottawa Scale tools will be used to rate the methodological quality of the included studies. Effect sizes reported in each individual study will be standardised to Cohen's d and a random effects model will be used to calculate the pooled effect size for the association., Ethics and Dissemination: Ethical approval is unnecessary as this study will only use publicly available data. The findings will be disseminated through publication in peer-reviewed journals and conferences., Prospero Registration Number: CRD42022284446., Competing Interests: Competing interests: None declared., (© Author(s) (or their employer(s)) 2023. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.)
- Published
- 2023
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.